
<html lang="en"     class="pb-page"  data-request-id="eee8f135-4711-4ab9-aff3-76e79dbf34fe"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-11;wgroup:string:ACHS website Group;article:article:10.1021/jm300256z;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells" /></meta><meta name="dc.Creator" content="Davide  Staedler" /></meta><meta name="dc.Creator" content="Catherine  Chapuis-Bernasconi" /></meta><meta name="dc.Creator" content="Henrietta  Dehmlow" /></meta><meta name="dc.Creator" content="Holger  Fischer" /></meta><meta name="dc.Creator" content="Lucienne  Juillerat-Jeanneret" /></meta><meta name="dc.Creator" content="Johannes D.  Aebi" /></meta><meta name="dc.Description" content="Ten oxidosqualene cyclase inhibitors with high efficacy as cholesterol-lowering agents and of different chemical structure classes were evaluated as potential anticancer agents against human cancer..." /></meta><meta name="Description" content="Ten oxidosqualene cyclase inhibitors with high efficacy as cholesterol-lowering agents and of different chemical structure classes were evaluated as potential anticancer agents against human cancer..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 21, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300256z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300256z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300256z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300256z" /></link>
        
    
    

<title>Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300256z" /></meta><meta property="og:title" content="Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0014.jpeg" /></meta><meta property="og:description" content="Ten oxidosqualene cyclase inhibitors with high efficacy as cholesterol-lowering agents and of different chemical structure classes were evaluated as potential anticancer agents against human cancer cells from various tissue origins and nontumoral human-brain-derived endothelial cells. Inhibition of cancer cell growth was demonstrated at micromolar concentrations, comparable to the concentrations of statins necessary for antitumor effect. Human glioblastoma cells were among the most sensitive cells. These compounds were also able to decrease the proliferation of angiogenic brain-derived endothelial cells, as a model of tumor-induced neovasculation. Additive effects in human glioblastoma cells were also demonstrated for oxidosqualene cyclase inhibitors in combination with atorvastatin while maintaining selectivity against endothelial cells. Thus, not only statins targeting the 3-hydroxy-3-methylglutaryl coenzyme A reductase but also inhibitors of oxidosqualene cyclase decrease tumor growth, suggesting new therapeutic opportunities of combined anti-cholesterol agents for dual treatment of glioblastoma." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300256z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300256z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300256z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300256z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300256z&amp;href=/doi/10.1021/jm300256z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4990-5002</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300068n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3004043" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Staedler">Davide Staedler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Chapuis-Bernasconi">Catherine Chapuis-Bernasconi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henrietta++Dehmlow">Henrietta Dehmlow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Fischer">Holger Fischer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucienne++Juillerat-Jeanneret">Lucienne Juillerat-Jeanneret</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes+D.++Aebi">Johannes D. Aebi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), CH-1011 Lausanne, Switzerland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">F. Hoffmann-La Roche Ltd., Pharmaceutical Division, CH-4070 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>For L.J.-J.: phone, +41 21 314 7173; fax, +41 21 314 7115; e-mail, <a href="/cdn-cgi/l/email-protection#f39f86909a969d9d96dd99869a9f9f96819287b3909b8685dd909b"><span class="__cf_email__" data-cfemail="a2ced7c1cbc7ccccc78cc8d7cbcecec7d0c3d6e2c1cad7d48cc1ca">[email protected]</span></a>. For J.D.A.: phone, +41 61 688 7738; fax, +41 61 688 8367; e-mail, <a href="/cdn-cgi/l/email-protection#7f1510171e11111a0c511e1a1d163f0d101c171a511c1012"><span class="__cf_email__" data-cfemail="cda7a2a5aca3a3a8bee3aca8afa48dbfa2aea5a8e3aea2a0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300256z&amp;href=/doi/10.1021%2Fjm300256z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4990–5002</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 26, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 November 2011</li><li><span class="item_label"><b>Published</b> online</span>21 May 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300256z" title="DOI URL">https://doi.org/10.1021/jm300256z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4990%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavide%2BStaedler%252C%2BCatherine%2BChapuis-Bernasconi%252C%2BHenrietta%2BDehmlow%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D11%26contentID%3Djm300256z%26title%3DCytotoxic%2BEffects%2Bof%2BCombination%2Bof%2BOxidosqualene%2BCyclase%2BInhibitors%2Bwith%2BAtorvastatin%2Bin%2BHuman%2BCancer%2BCells%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5002%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300256z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1727</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300256z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Staedler&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Chapuis-Bernasconi&quot;},{&quot;first_name&quot;:&quot;Henrietta&quot;,&quot;last_name&quot;:&quot;Dehmlow&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Fischer&quot;},{&quot;first_name&quot;:&quot;Lucienne&quot;,&quot;last_name&quot;:&quot;Juillerat-Jeanneret&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;D. Aebi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;4990-5002&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300256z&quot;},&quot;abstract&quot;:&quot;Ten oxidosqualene cyclase inhibitors with high efficacy as cholesterol-lowering agents and of different chemical structure classes were evaluated as potential anticancer agents against human cancer cells from various tissue origins and nontumoral human-brain-derived endothelial cells. Inhibition of cancer cell growth was demonstrated at micromolar concentrations, comparable to the concentrations of statins necessary for antitumor effect. Human glioblastoma cells were among the most sensitive cells. These compounds were also able to decrease the proliferation of angiogenic brain-derived endothelial cells, as a model of tumor-induced neovasculation. Additive effects in human glioblastoma cells were also demonstrated for oxidosqualene cyclase inhibitors in combination with atorvastatin while maintaining selectivity against endothelial cells. Thus, not only statins targeting the 3-hydroxy-3-methylglutaryl coenzyme A reductase but also inhibitors of oxidosqualene cyclase decrease tumor growth, suggesting new thera&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300256z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300256z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300256z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300256z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300256z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300256z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300256z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300256z&amp;href=/doi/10.1021/jm300256z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300256z" /></input><a href="/doi/pdf/10.1021/jm300256z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300256z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300256z%26sid%3Dliteratum%253Aachs%26pmid%3D22533316%26genre%3Darticle%26aulast%3DStaedler%26date%3D2012%26atitle%3DCytotoxic%2BEffects%2Bof%2BCombination%2Bof%2BOxidosqualene%2BCyclase%2BInhibitors%2Bwith%2BAtorvastatin%2Bin%2BHuman%2BCancer%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D11%26spage%3D4990%26epage%3D5002%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jmcmar.2012.55.issue-11/production/jmcmar.2012.55.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Ten oxidosqualene cyclase inhibitors with high efficacy as cholesterol-lowering agents and of different chemical structure classes were evaluated as potential anticancer agents against human cancer cells from various tissue origins and nontumoral human-brain-derived endothelial cells. Inhibition of cancer cell growth was demonstrated at micromolar concentrations, comparable to the concentrations of statins necessary for antitumor effect. Human glioblastoma cells were among the most sensitive cells. These compounds were also able to decrease the proliferation of angiogenic brain-derived endothelial cells, as a model of tumor-induced neovasculation. Additive effects in human glioblastoma cells were also demonstrated for oxidosqualene cyclase inhibitors in combination with atorvastatin while maintaining selectivity against endothelial cells. Thus, not only statins targeting the 3-hydroxy-3-methylglutaryl coenzyme A reductase but also inhibitors of oxidosqualene cyclase decrease tumor growth, suggesting new therapeutic opportunities of combined anti-cholesterol agents for dual treatment of glioblastoma.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cholesterol is an essential lipid in the body, in particular for the stability and function of cell membranes and cell organelles and for cellular trafficking.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> An excess of cholesterol causes lipid disorders, such as hypercholesterolemia.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The rate-limiting enzyme for cholesterol biosynthesis is 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, and inhibitors of this enzyme, the statins, are used for the treatment of lipid disorders.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> In addition to their effects on hypercholesterolemia, statins were recently associated with a reduced risk of cancer progression, including melanoma, prostate, and colorectal cancers.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> These effects were in part due to the anti-inflammatory properties of statins, their inhibition of the mevalonate pathway, and HMG-CoA reductase-independent effects, such as the inhibition of protein–protein interaction.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Inhibition of cholesterol synthesis by statins modifies the composition of the cell membrane via the reduction of the isoprenoids farnesyl pyrophosphate and gerenylgeranyl pyrophosphate formation and the subsequent prenylation of small GTP-binding proteins. Statins also affect multiple cellular signaling pathways, such as the mitogen-activated protein kinases (MAPKs), phosphatidiylinsotiol 3 kinase (PI3K), AKT (protein kinase B), and the epidermal growth factor receptor (EGFR).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> In vitro statins cause tumor-cell death and growth inhibition, and induce cell cycle arrest.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> In vivo, statins inhibit cancer growth, including neuroblastoma, glioma, acute myeloblastic leukemia, and colorectal tumors.<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8, 10)</a> Statins have also shown antimetastatic activity<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> and can act additively or synergistically with anticancer chemotherapeutic drugs.<a onclick="showRef(event, 'ref6 ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref10">(6, 7, 10)</a> However, these effects were not always consistent, and it was suggested that the hydrophobicity of the statins is important for antitumor activity.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Statin concentrations as anticancer agents is much higher than statin concentrations necessary as antihyperlipidemic agents. In the past years, novel synthetic inhibitors of HMG-CoA reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins have also been evaluated.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Alternatively, new molecules that inhibit other enzymes of cholesterol biosynthesis, including inhibitors of the oxidosqualene/lanosterol cyclase (OSC) have been developed, also at Hoffmann-La Roche.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23">(16-23)</a> However, until now these inhibitors have been evaluated only for their anti-cholesterol potential. In this work we evaluated whether inhibitors of OSC, like the statins, may also be potential anticancer agents, either alone or in combination with the statin atorvastatin.</div><div class="NLM_p last">OSC is an enzyme downstream of mevalonate synthesis involved in the biosynthesis of steroids and chlolesterol. In cancer, the effects of statins are postulated to be related to the inhibition of the biosynthesis of mevalonate-derived farnesyl and geranylgeranyl groups required for isoprenylation of oncogenic proteins. Mevalonate is the initial molecule of diverse pathways important for signaling in cell growth, proliferation, migration, and survival. The inhibition of HMG-CoA reductase by statins results in a few hours in an increased level of the protein as a net result of a feedback mechanism, thus reducing the efficacy of the statins. The enzymatic-mediated biosynthesis of steroids, downstream of HMG-CoA reductase, originates with farnesyl pyrophosphate through reductive dimerization to squalene, then conversion of squalene to lanosterol through epoxidation of squalene by squalene epoxidase to produce 2,3-oxidosqualene. OSC then generates the tetracyclic precursor of cholesterol, lanosterol. Synthesis of 24(<i>S</i>),25-epoxycholesterol is favored over cholesterol synthesis under conditions of partial OSC inhibition, whereas complete OSC inhibition results in decreased synthesis of cholesterol and 24(<i>S</i>),25-epoxycholesterol. Because 24(<i>S</i>),25-epoxycholesterol not only represses HMG-CoA reductase activity but also enhances its degradation, this should result in the generation of a synergistic, self-limited, negative regulatory feedback loop.<a onclick="showRef(event, 'ref17 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref17 ref24 ref25 ref26 ref27 ref28">(17, 24-28)</a> Therefore, the first aim of our work was to evaluate new OSC inhibitors (OSCi) as in vitro anticancer agents, either as single agents or in combination with the statin atorvastatin, against human cancer cells of diverse origins, then to focus on human glioblastoma cells and human angiogenic brain-derived endothelial cells, hypothesizing that mevalonate depletion in tumor cells or endothelial cells may contribute to inhibition of tumor growth and angiogenesis.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses and characterization of compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>8</b>, and <b>9</b><a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref29'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref29">(17-20, 29)</a> have been previously described (structures shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Here we describe the syntheses of the alkynecyclohexyl inhibitors (compounds <b>5</b> and <b>6</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) and of the cyclohexylethyl inhibitor (compound <b>7</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) in which the cyclohexyl moiety of the already known compound <b>8</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was moved closer to the amine. Then the replacement of this important amine by an amide (compound <b>10</b>, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was done with only a minimal loss of inhibitory activity. Compound <b>1</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> bearing a rigid triphenyl ketone system, mimics the high energy intermediate of oxidosqualene cyclization to lanosterol.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> The benzylamine moiety of <b>1</b> was replaced by an oxyalkylamine (compound <b>2</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the benzophenone was replaced by a heteroaryl (compounds <b>3</b> and <b>4</b>),<a onclick="showRef(event, 'ref19 ref29'); return false;" href="javascript:void(0);" class="ref ref19 ref29">(19, 29)</a> by an alkyne cyclohexylcarbamate (compounds <b>5</b> and <b>6</b>), or an alkylcyclohexyl system (compounds <b>8</b> and <b>9</b>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and in Vitro Properties of the OSCi and AT</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0004.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All potency measurements were performed in triplicate. The standard error of the mean (sem) ranged between 10% and 20%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">All measurements were done in triplicate, and the reproducibility was ±0.1%.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Apparent permeability <i>P</i><sub>e</sub> from the PAMPA assay at pH 6.5;<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> All measurements were done in triplicate, and the reproducibility was ±4%.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Percent of the compound binding to the PAMPA lipid membrane; all measurements were done in triplicate, and the reproducibility was ±4%.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Human LN229, LN18, and HCEC cells were exposed to increasing concentrations (0, 2, 5, 10, 20, and 30 μM) of the OSCi compounds <b>1</b>–<b>10</b> or AT for 72 h. Then the MTT assay was performed and the IC<sub>50</sub> values were calculated. Results are the mean (standard deviations not shown, ≤10%) of triplicates of two independent experiments.</p></div></div><div></div></div><div class="NLM_p">The synthesis of the alkyne OSCi is depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Starting from <i>trans</i>-aminocyclohexanecarboxylic acid <b>11</b>, the aldehyde <b>12</b> was synthesized via the formation of the Weinreb amide, N-methylation of the Boc-protected amine, and lithium aluminum hydride reduction of the Weinreb amide. Corey–Fuchs alkyne introduction<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was followed by reaction with the appropriate halogenide to give intermediate <b>14</b>. SelectiveO-deprotection, mesylation, and cleavage of the Boc-protecting group using TFA gave amine <b>15</b>, which was converted to carbamate <b>16</b>. Amination and salt formation gave the two alkynes <b>5</b> and <b>6</b>. The synthesis of cyclohexylethyl linked OSCi <b>7</b> is described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Silyl protected <i>trans</i>-cyclohexyl <b>17</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was hydrogenated and deprotected with platinum oxide in ethanol/chloroform to form hydrochloride <b>18</b>, which after Boc protection and N-methylation gave alcohol <b>19</b>. Mesylation and deprotection provided amine <b>20</b> as the hydrochloride which could be reacted with the in situ generated N-methylated imidazole-1-carboxylic acid 4-trifluoromethylphenyl ester to give carbamate <b>21</b>. After reaction of <b>21</b> with ethyl-(2-hydroxyethyl)amine, compound <b>7</b> was converted to its citric acid salt and isolated by crystallization. The preparation of amide <b>10</b> is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Building block <b>19</b> was oxidized to carboxylic acid <b>22</b> using Sharpless conditions,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <i>N</i>-Boc deprotection yielded amino acid <b>23</b> as the hydrochloride salt. After heating in hexamethyldisilazane, the persilylated amino acid was reacted with 4-chlorophenyl chloroformate. Hydrolysis of the silyl ester during workup and coupling with 4-hydroxypiperidine gave amide <b>10</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Alkyne OSCi Compounds <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOMeNH·HCl, HOBT, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (b) NaH (55% in oil), MeI, DMF, 0 °C to rt, 84%; (c) LAH, THF, 0–15 °C, quantitative; (d) Ph<sub>3</sub>P, CBr<sub>4</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 62%; (e) (1) <i>n</i>-BuLi, THF, −78 °C; (2) DMPU; (3) 2-(2-bromoethoxy)tetrahydro-2<i>H</i>-pyran, THF, −78 °C to rt, 40%; (f) PPTs, MeOH, 55 °C, 77%; (g) MeSO<sub>2</sub>Cl, pyridine, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, quantitative; (i) 4-ClPhOCOCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (k) (1) ethyl-(2-hydroxyethyl)amine, MeOH, 65 °C; (2) HCl in dioxane, 59%; (l) (1) <i>N-</i>methylpropylamine, NaI, MeOH, 60 °C; (2) fumaric acid, EtOAc, EtOH, 76%.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Methylethylcyclohexyl OSCi <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PtO<sub>2</sub>, H<sub>2</sub> (1 atm), EtOH/9% CHCl<sub>3</sub>, 97%; (b) (1) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (2) Ac<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (3) MeI, NaH (55% in oil), DMF, 0 °C to rt, 68%, three steps; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 86%; (d) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (e) 4 M HCl in dioxane, rt, 92%; (f) (1) 4-trifluoromethylphenol, 1,1′-carbonyldiimidazol, CH<sub>2</sub>Cl<sub>2</sub>, rt; (2) (CH<sub>3</sub>)<sub>2</sub>SO<sub>4</sub>, Hünig's base, CH<sub>3</sub>CN, 80 °C; (3) <b>20</b>, Hünig's base, CH<sub>3</sub>CN, rt, 89%; (g) (1) ethyl-(2-hydroxyethyl)amine, DMA, 60 °C; (2) citric acid monohydrate, EtOAc, <i>i</i>-PrOH, <i>n</i>-pentane, 62%.</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Amide OSCi <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaIO<sub>4</sub>, RuCl<sub>3</sub>.H<sub>2</sub>O, CH<sub>3</sub>CN, CCl<sub>4</sub>, H<sub>2</sub>O, rt, 96%; (b) 4 M HCl in dioxane, rt, quantitative; (c) (1) HMDS, 145 °C; (2) 4-ClPhOCOCl, <i>i</i>-Pr<sub>2</sub>EtN, THF, 0 °C to rt, 57%; (d) (1) (COCl)<sub>2</sub>/DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (2) 4-hydroxypiperidine, CH<sub>2</sub>Cl<sub>2</sub>, 97%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds selected for the present experiments demonstrated the highest efficacy out of their congeners in the respective chemical class as cholesterol lowering agents in the hamster model of hypercholesterolhemeia (results not shown). The most advanced OSCi, compound <b>5</b>, had been previously shown to decrease very low density lipoproteins (VLDL) and low density lipoproteins (LDL) apoB100 in miniature pigs.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> For in vivo evaluations and the present experiments, the metabolic stability of the OSCi was determined in rat hepatocytes, assessing the efficacy and potency of each compound in reducing cholesterol production while increasing monooxidosqualene (MOS) levels.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The newly synthesized carbamates <b>5</b>, <b>6</b>, and <b>7</b> showed residual inhibitory activies greater than or equal to 60% after 24 h at 300 nM (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2). Amide <b>10</b>, which was structurally the least related OSCi, was less stable (76% inhibition after 8 h and 8% inhibition after 24 h). We also investigated the chemical stability at pH 4 and 7.4 at 37 °C and found no degradation of the OSCi. However, we observed lower recovery rates for compounds <b>2</b>, <b>4</b>, <b>6</b>, and <b>8</b> at pH 7.4, which is probably due to difficulties in keeping the compound in solution at this pH. However no degradation products were identified (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2).</div><div class="NLM_p">First we evaluated the OSCi in human cells, 11 cancer cell lines from various tissue origins, and 1 nontumoral human brain-derived endothelial cell line (HCEC). Only compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, and <b>8</b> displayed efficient antiproliferative properties toward the majority of the cell lines after 24, 48 or 72 h of exposure (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S3). The efficacy increased with the time of exposure, starting already after 24 h of exposure. In human cancer cells, the IC<sub>50</sub> values were dependent on the particular cell line considered (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In human brain-derived LN18 and LN229 glioblastoma cells and HCEC brain-derived endothelial cells compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> were the most efficient compounds, displaying IC<sub>50</sub> values lower than 10 μM for at least one tumor cell line (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), compound <b>1</b> being the most selective compound for tumor cells compared to nontumoral HCEC cells. Atorvastatin (AT) also displayed some selectivity for human brain-derived tumor cells compared to endothelial cells but became active only after 72 h of cell exposure. The effect of OSCi or AT on DNA synthesis by these cells exposed to the compounds for 24 h was also determined using the thymidine incorporation assay. As for cell survival assays, OSCi compounds <b>2</b>, <b>3</b>, and <b>4</b> were the most active inhibitors of DNA synthesis of the series against the three cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S4). OSCi compounds <b>1</b> and <b>5</b>–<b>9</b> decreased DNA synthesis with less efficacy than OSCi compounds <b>2</b>, <b>3</b>, and <b>4</b>, but the effects were comparable in the three cells, whereas AT and OSCi <b>10</b> were less efficient in inhibiting DNA synthesis in endothelial cells compared to glioblastoma cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S4). These results suggest an initial cytostatic effect of both OSCi and AT in human glioblastoma cells.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cytotoxic effects of a 72 h exposure of human glioblastoma and brain-derived endothelial cells to OSCi compounds <b>1</b>–<b>6</b>. Human LN18, LN229, and HCEC cells were exposed to increasing concentrations of compounds <b>1</b>–<b>6</b> for 72 h. Then the MTT assay was performed and IC<sub>50</sub> values were calculated. Results are the mean ± sd of triplicates of two independent experiments. IC<sub>50</sub> values are the mean (sd not shown, ≤10% of the values of the means) of triplicates of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cytotoxic effects of a 72 h exposure of human glioblastoma and brain-derived endothelial cells to OSCi compounds <b>7</b>–<b>10</b> and AT. Human LN18, LN229, and HCEC cells were exposed to increasing concentrations of compounds <b>7</b>–<b>10</b> and AT for 72 h. Then the MTT assay was performed and IC<sub>50</sub> values were calculated. Results are the mean ± sd of triplicates of two independent experiments. IC<sub>50</sub> values are the mean (sd not shown, ≤10% of the values of the means) of triplicates of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DNA synthesis in glioblastoma and endothelial cells exposed to OSCi or AT. Human LN18, LN229, and HCEC cells were exposed for 24 h to increasing concentrations of OSCi compounds <b>2</b>–<b>4</b> and AT. Then [<sup>3</sup>H]T incorporation was performed to evaluate DNA synthesis. Results are the mean of triplicates (sd not shown, <10% of the values of the means): ◇, <b>2</b>; □, <b>3</b>; ▲, <b>4</b>; △, AT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> after 72 h of Cell Exposure to Compounds <b>1</b>–<b>10</b> and AT<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">CaCo2</th><th class="colsep0 rowsep0" align="center">HeLe</th><th class="colsep0 rowsep0" align="center">KB</th><th class="colsep0 rowsep0" align="center">LnCap</th><th class="colsep0 rowsep0" align="center">LNZ308</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">Me300</th><th class="colsep0 rowsep0" align="center">OVCAR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">6.19</td><td class="colsep0 rowsep0" align="left">3.81</td><td class="colsep0 rowsep0" align="left">2.69</td><td class="colsep0 rowsep0" align="left">2.03</td><td class="colsep0 rowsep0" align="left">5.07</td><td class="colsep0 rowsep0" align="left">14.4</td><td class="colsep0 rowsep0" align="left">25.7</td><td class="colsep0 rowsep0" align="left">13.9</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">11.3</td><td class="colsep0 rowsep0" align="left">2.99</td><td class="colsep0 rowsep0" align="left">2.89</td><td class="colsep0 rowsep0" align="left">2.88</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">5.26</td><td class="colsep0 rowsep0" align="left">6.77</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">5.14</td><td class="colsep0 rowsep0" align="left">1.04</td><td class="colsep0 rowsep0" align="left">6.37</td><td class="colsep0 rowsep0" align="left">4.66</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">5.58</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">16.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">6.06</td><td class="colsep0 rowsep0" align="left">1.97</td><td class="colsep0 rowsep0" align="left">8.85</td><td class="colsep0 rowsep0" align="left">8.52</td><td class="colsep0 rowsep0" align="left">19.5</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">13.4</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">13.59</td><td class="colsep0 rowsep0" align="left">4.81</td><td class="colsep0 rowsep0" align="left">8.64</td><td class="colsep0 rowsep0" align="left">5.86</td><td class="colsep0 rowsep0" align="left">23.6</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">26.2</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">8.41</td><td class="colsep0 rowsep0" align="left">6.75</td><td class="colsep0 rowsep0" align="left">6.82</td><td class="colsep0 rowsep0" align="left">4.53</td><td class="colsep0 rowsep0" align="left">18.7</td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">18.9</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">22.7</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">23.2</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">6.93</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">1.06</td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="left">4.62</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">20.7</td><td class="colsep0 rowsep0" align="left">16.0</td><td class="colsep0 rowsep0" align="left">12.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">6.09</td><td class="colsep0 rowsep0" align="left">2.67</td><td class="colsep0 rowsep0" align="left">4.53</td><td class="colsep0 rowsep0" align="left">4.28</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">12.3</td><td class="colsep0 rowsep0" align="left">20.9</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">21.8</td><td class="colsep0 rowsep0" align="left">7.58</td><td class="colsep0 rowsep0" align="left">5.55</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">25.0</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AT</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">18.7</td><td class="colsep0 rowsep0" align="left">4.22</td><td class="colsep0 rowsep0" align="left">1.97</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">7.44</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Cells were treated with increasing concentrations (0, 2, 5, 10, 20, and 30 μM) of the OSCi compounds <b>1</b>–<b>10</b> and AT for 72 h. Then the MTT assay was performed and the IC<sub>50</sub> values were calculated. Results are the mean (sd not shown, ≤10% of the mean) of triplicates of two independent experiments. IC<sub>50</sub> values for LN18, LN229, and HCEC cells are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</p></div></div></div><div class="NLM_p">Thus, for further experiments, combining an OSCi with AT, we selected the most active OSCi compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> and the LN18 and LN229 cells as models of human glioblastoma cells and the nontumoral HCEC endothelial cells as model of nontumoral angiogenic brain-derived endothelial cells. Compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> at three different concentrations (2, 4, and 10 μM) were combined with three different concentrations of AT (2.5, 5, and 10 μM) for 72 h because for this treatment time, AT as single agent dose-dependently reduced cell survival more in LN18 and LN229 glioblastoma cancer cells than in nontumoral HCEC cells.</div><div class="NLM_p">Compound <b>1</b> with AT combinations did not enhance the cytotoxic effects of each drug separately (data not shown). In LN18 cells exposed to compound <b>2</b>, a cytotoxicity-enhancing effect of AT was seen at 2 and 4 μM compound <b>2</b>. In LN229 cells exposed to 2 μM compound <b>2</b>, a cytotoxicity-enhancing effect was detected well below the IC<sub>50</sub> values of both inhibitors. In HCEC cells, only at the highest concentrations of the OSCi (4 and 10 μM) was the AT effect on cell death seen (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In LN18 cells exposed to compound <b>3</b>, the addition of AT only decreased the survival of cells after exceeding the IC<sub>50</sub> of AT. In LN229 cells exposed to 2 μM compound <b>3</b>, the addition of 2.5 μM AT decreased cell survival by 80%. With higher concentration of compound <b>3</b> in LN18 and in LN229 cells, only the cytotoxic effect of the increased concentrations of the OSCi was seen. In HCEC cells no cytotoxicity-enhancing effect of compound <b>3</b> with AT was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). In LN18 cells exposed to compound <b>4</b> a cytotoxicity-enhancing effect with AT was seen. In LN229 cells exposed to 4 μM compound <b>4</b>, a pronounced cytotoxicity-enhancing effect with AT was demonstrated. In HCEC cells only the OSCi inhibitory effect was apparent (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cytotoxic effects of a 72 h cell exposure to <b>2</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>2</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxic effects of a 72 h cell exposure to <b>3</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>3</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cytotoxic effects of a 72 h cell exposure to <b>4</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>4</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Acetate is a precursor in the biosynthesis of cellular lipids, including sterols, lipoproteins, and glycolipids; thus, we evaluated the incorporation of radioactice acetate in trichloroacetic acid (TCA)precipitable high molecular weight cellular molecules and/or acid insoluble lipids in glioblastoma cells exposed to increasing concentrations of AT and OSCi <b>2</b> or <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). AT dose-dependently decreased <sup>14</sup>C-acetate incorporation in the LN229 cells and to a lesser extent in LN18 cells. Both OSCi compounda <b>2</b> and <b>3</b> increased the <sup>14</sup>C-acetate incorporation in both cell lines. From the known different mode of action of these molecules, this result was not unexpected and we can propose the following hypothesis. Statins inhibit at an early step of the biosynthesis of sterols, preventing accumulation of insoluble radioactive intermediates, while OSC inhibition would result in the accumulation of insoluble 2,3-oxidosqualene<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and/or additional high molecular weight molecules, such as lipoproteins. In the glioblastoma cells, the increase in the incorporation of <sup>14</sup>C-acetate induced by OSCi <b>2</b> was inhibited by AT addition, while for compound <b>3</b> the addition of AT had only a marginal influence (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Thus, also in human glioblastoma cells different cellular pathways can be selectively inhibited by an OSCi and a statin, as previously shown for other human cancer cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High molecular weight and acid-insoluble lipid synthesis in glioblastoma cells exposed to OSCi and AT. Human LN18 or LN229 cells were exposed for 24 h to increasing concentrations of AT or to 2 μM OSCi <b>2</b> or <b>3</b> in combination with increasing concentration of AT. Then <sup>14</sup>C-acetate incorporation was performed to evaluate high molecular weight lipid synthesis. Results are the mean of triplicates. Treatments were compared using the Student’s <i>t</i>-test: ∗, treated cells vs untreated cells; ○, AT–OSCi combination vs OSCi alone; ∗ and ○, <i>p</i> < 0.05; ∗∗ and ○○, <i>p</i> < 0.01; ∗∗∗ and ○○○, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Then the evaluation of possible additivity or synergism of OSCi and AT combinations was examined for combinations statistically significant using first for screening purposes the median effect model proposed by Chou.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This method proposes that a calculated combination index (CI) of ∼1 defines additivity and that CI < 1 defines synergism. First, the CI factor was calculated to select combinations with possible additive or synergistic effects (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S5). An additive effect was shown for a combination of AT with low concentrations of OSCi compounds <b>2</b>, <b>3</b>, and <b>4</b> in LN18 cells and OSCi compounds <b>2</b> and <b>3</b> in LN229 cells but only with high concentrations of OSCi <b>2</b> in HCEC cells (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S5). Combination of AT with low concentration of OSCi <b>3</b> in LN229 cells provided CI < 0.5. Thus, for this combination, the computational method proposed by Lee et al.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> was used to determine a possible synergism. According to this model, the interaction index (II) should be <1 and its confidence interval should not include 1 to prove synergism; otherwise, the combined effect is additive. For the combination of <b>3</b> with AT in LN229 human glioblastoma cells, the confidence interval included 1 (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1); thus, this combination did not suggest a possible synergism. Therefore, the additive effect of OSCi with AT in LN18 cells and LN229 cells does not appear to be dependent on the chemical structure class of the compounds, since these effects were observed for two different classes of OSCi but may depend on the physicochemical and/or biochemical characteristics, i.e., membrane permeability and hydrophobicity, which were determined (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) according to published procedures.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> From this information, it can be ruled out that limited cell membrane permeability was responsible for the observed effect, since the PAMPA (parallel artificial membrane permeation assay) membrane permeability (<i>P</i><sub>e</sub> PAMPA) was medium to high for all compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The only correlation we found was the correlation between the ratios of their cytotoxicity potency for the human brain-derived endothelial cells to the two human glioblastoma cells (IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN229) or IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN18)) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). For only log <i>D</i> at pH 7.4 an inverse correlation between the IC<sub>50</sub> ratios of HCEC to LN18 and LN229 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) was observed. However, the log <i>D</i> of AT (0.98) exerted a large influence on the plot. Thus, more polar OSCi compounds are more selective for inhibiting LN229 or LN18 growth, compared to nontumoral HCEC cells. It is interesting to note that the membrane fraction (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) measured in the PAMPA experiment did not correlate with the selectivity ratio (IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN229), <i>r</i><sup>2</sup> = 0.05) or the selectivity ratio (IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN18), <i>r</i><sup>2</sup> = 0.09). Hence, it can be excluded that the difference in unspecific binding to either of the cell membranes governs the observed selectivity. This suggests that log <i>D</i> (pH 7.4) must be taken into account for further development of selective anticancer therapeutic compounds.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Correlation between log <i>D</i> and IC<sub>50</sub>. (A) Correlation of the selectivity ratio IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN229) with log <i>D</i> at pH 7.4. Black line represents the regression line (<i>r</i><sup>2</sup> = 0.91; IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LNZ229) = (4.23 ± 0.17) – (log <i>D</i>)(1.33 ± 0.15), and dotted lines represent the 95% confidence interval. Cross-validation coefficient (leave-one-out method) is <i>q</i><sup>2</sup> = 0.88. (B) Correlation of the selectivity ratio IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN18) with log <i>D</i> at pH 7.4. Black line represents the regression line (<i>r</i><sup>2</sup> = 0.69; IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LNZ229) = (4.13 ± 0.32) – (log <i>D</i>)(0.87 ± 0.21), and dotted lines represent the 95% confidence interval. Cross-validation coefficient (leave-one-out method) is <i>q</i><sup>2</sup> = 0.66.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have evaluated several chemical classes of our best inhibitors of OSC, an enzyme downstream of the HMG-CoA reductase in the mevalonate pathway. We show here that OSCi compounds have the potential to decrease the growth of human cancer cells of diverse tissue origin at micromolar concentrations, comparable to the concentrations of statins necessary for antitumor effect. Human glioblastoma and brain-derived endothelial cells, as a model of tumor-induced angiogenic endothelial cells, were among the most sensitive cells. It has been shown that the brain is the most cholesterol-rich organ of the body and the intensive cholesterol metabolism in brain tumors cells, higher than in nontumoral cells,<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40-44)</a> suggests that the cholesterol pathway is a possible target for a specific pharmacological treatment of these tumors, thus opening interesting perspectives for the treatment of these very aggressive brain tumors. Previous studies have suggested that statins may have some antitumoral effect in brain cancers.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48 ref49 ref50">(45-50)</a> A phase I–II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme showed that high doses of lovastatin did not induce toxicity to the central nervous system (CNS).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> However, the concentrations of statins necessary to achieve anticancer effects were shown to be 10–100 times higher than their concentrations as cholesterol-lowering drugs, suggesting that drug combinations must be developed. We found that not only statins, targeting the HMG-CoA reductase, but also inhibitors of the OSC decrease tumor cell growth and that their combination enhances their antitumoral efficacy. As statins are known to up-regulate HMG-CoA reductase expression and as 24(<i>S</i>),25-epoxycholesterol, a product of the OSC, decreases HMG-CoA reductase activity and enhances its degradation, OSC was postulated to be an interesting target in combination with a statin, since this should result in the generation of a synergistic, self-limited, negative regulatory loop to deplete cancer cells from cholesterol. In support of this hypothesis additive effects of OSCi in combination with AT were demonstrated in human glioblastoma cells while maintaining selectivity against endothelial cells. Our results also suggest that the lipophilicity of the OSCi must be taken into account for selectivity, meaning that a more polar OSCi is more selective for inhibiting the growth of cancer cells and for further development of anti-cholesterol compounds in the context of cancer therapy. In summary, we have shown that not only statins targeting HMG-CoA reductase but also inhibitors of OSC decrease tumor cell growth, suggesting new therapeutic opportunities of combined anti-cholesterol agents for dual treatment of glioblastoma.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> General</h4><div class="NLM_p">The syntheses and characterizations of compounds <b>1</b>–<b>4</b>, <b>8</b>, and <b>9</b><a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref29'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref29">(17-20, 29)</a> have been previously described. The detailed synthesis and characterization of intermediate compounds <b>12</b>–<b>16</b> and <b>18</b>–<b>23</b> are provided as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p last">Reactions were carried out under an atmosphere of argon. Solvents and reagents were obtained from commercial sources and were used as received. All reactions were followed by TLC (TLC plates F254, Merck). Proton and carbon NMR spectra were obtained on a Bruker 300, 400, or 600 MHz instrument. The respective carbon NMR spectra were 75, 100, and 150 MHz. The chemical shifts (δ in ppm) are reported relative to tetramethylsilane as internal standard. NMR abbreviations are as follows: s, singlet; d, doublet; t, triplet; q, quadruplet; quint, quintuplet; m, multiplet; br, broadened. Purity was analyzed by <sup>1</sup>H NMR. In the <sup>1</sup>H NMR spectra, the acidic protons of the fumarate, HCl, and citrate salts were not seen unless listed. Mass spectra were recorded on an SSQ7000 (Finnigan-MAT) spectrometer for electron impact ionization. LC–MS (liquid chromatography–mass spectrometry) data were recorded on an Agilent 1290 LC with CTC PAL coupled to Agilent 6520 QTOF. HPLC was performed on Zorbax Eclipse Plus C18 2.1 mm × 50 mm, 1.8 μm (Agilent catalog no. 959757-902). Column temperature was 55°C. A gradient from 5% to 99% of eluent B in eluent A was used at a flow rate of 1 mL/min. Eluent B consisted of 80% acetonitrile/20% isopropanol/0.01% formic acid. Eluent A was 0.02% formic acid in water. UV detector was DAD, 220 ± 5 nm or 265 ± 35 nm. All compounds were characterized by <sup>1</sup>H NMR and MS and final compounds with microanalyses. Elemental analyses were performed by Solvias AG (Mattenstrasse, Postfach, CH-4002 Basel, Switzerland). Results of elemental analyses were within 0.4% of theoretical values. Solvents (<sup>1</sup>H NMR) and H<sub>2</sub>O content (Karl Fischer determination) were incorporated in the formula. Melting points (uncorrected) were determined using a Büchi 510 apparatus and are uncorrected. Silica gel 60 (0.04–0.063 mm, Merck) was used for flash chromatography. The purities of final compounds <b>5</b>, <b>6</b>, <b>7</b>, and <b>10</b> were analyzed by LC–MS and by elemental analysis and were found to be above 95%.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>trans</i>-(4-{5-[Ethyl-(2-hydroxyethyl)amino]pent-1-ynyl}cyclohexyl)methylcarbamic Acid 4-Chlorophenyl Ester Hydrochloride (<b>5</b>)</h4><div class="NLM_p last">A solution of <i>trans</i>-methanesulfonic acid 5-(4-methylaminocyclohexyl)pent-4-ynyl ester trifluoroacetate <b>(16)</b> (0.57 g, 1.33 mmol) and ethyl-(2-hydroxyethyl)amine (1.29 mL, 13.27 mmol, 10 equiv) in MeOH (13 mL) was stirred overnight at 65 °C. The appropriate portion was extracted with aqueous saturated NaHCO<sub>3</sub> solution/Et<sub>2</sub>O (3×) and aqueous 10% NaCl solution, and the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. Purification by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>, then CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5 to 9:1) gave <i>trans</i>-(4-{5-[ethyl-(2-hydroxyethyl)amino]pent-1-ynyl}cyclohexyl)methylcarbamic acid 4-chlorophenyl ester (0.35 g, 63%). MS <i>m</i>/<i>z</i>: 421.4 (M + H<sup>+</sup>, 1Cl). The amine was dissolved in dioxane (1 mL) and treated with 4 M HCl in dioxane (0.17 mL, 0.69 mmol, 1.1 equiv), filtered, and evaporated. Dissolving in CH<sub>2</sub>Cl<sub>2</sub> and evaporation (3×) gave after drying in high vacuum the desired compound as a yellow viscous oil (0.36 g, 59% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, rt) δ 9.36 (broad s, 1H), 7.43 and 7.15 (AA′-BB′-system, <i>J</i><sub>AB</sub> = 8.8 Hz, 4H), 5.32 (broad s, 1H), 3.9 and 3.8 (broad m, 1H, 3:1 mixture of rotamers), 3.70 (broad s, 2H), 3.2–3.0 (broad s, 6H), 2.88 and 2.79 (broad s, 3H, 3:1 mixture of rotamers), 2.23 (m, 3H), 1.95 (m, 2H), 1.85–1.55 (m, 6H), 1.39 (m, 2H), 1.18 (m, 3H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ 7.33–7.40 (m, 2H), 7.08–7.16 (m, 2H), 3.79–3.90 (m, 1H), 3.76 (t, <i>J</i> = 5.4 Hz, 2H), 3.06–3.22 (m, 6H), 2.86 (s, 3H), 2.25 (td, <i>J</i> = 6.9, 2.0 Hz, 2H), 2.15–2.22 (m, 1H), 1.93–2.04 (m, 2H), 1.77–1.88 (m, 2H), 1.68–1.75 (m, 2H), 1.60 (qd, <i>J</i> = 12.5, 3.4 Hz, 2H), 1.34–1.47 (m, 2H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.6, 153.2, 150.1, 129.1, 123.7, 85.0, 78.4, 55.2, 53.8, 50.6, 47.6, 40.0, 32.2, 28.8, 28.2, 28.0, 22.3, 15.4. MS <i>m</i>/<i>z</i>: 421.2 (M + H<sup>+</sup>, 1Cl). Anal. (C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>3</sub>·1.08HCl·1.6H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> <i>trans</i>-Methyl-{4-[5-(methylpropylamino)pent-1-ynyl]cyclohexyl}carbamic acid 4-Chloro-Phenyl Ester Fumarate (<b>6</b>)</h4><div class="NLM_p">A solution of <i>trans</i>-methanesulfonic acid 5-(4-methylaminocyclohexyl)pent-4-ynyl ester trifluoroacetate (<b>16</b>) (0.84 mg, 1.96 mmol) and <i>N-</i>methylpropylamine (3.02 mL, 29.44 mmol, 15 equiv) in MeOH (15 mL) was treated with sodium iodide (0.03 g, 0.2 mmol, 0.1 equiv), and the mixture was stirred overnight at 60 °C. The appropriate portion was extracted with aqueous saturated NaHCO<sub>3</sub> solution/Et<sub>2</sub>O (3×) and aqueous 10% NaCl solution, and the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. Purification by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>, then CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5 to 9:1) gave <i>trans</i>-methyl-{4-[5-(methylpropylamino)pent-1-ynyl]cyclohexyl}carbamic acid 4-chlorophenyl ester (0.75 g, 94%). MS <i>m</i>/<i>z</i>: 405.5 (M + H<sup>+</sup>, 1Cl).</div><div class="NLM_p last">The amine (0.7 g, 1.73 mmol) in EtOAc and fumaric acid (0.21 g, 1.81 mmol, 1.05 equiv) in EtOH were mixed and evaporated with EtOAc (3×). Slow (24 h) cooling of an EtOAc solution to 4 °C gave crystals. Filtration and washing with a small amount of EtOAc gave the desired product as white crystals (0.73 g, 81%). Mp: 95–98 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.43 and 7.15 (AA′-BB′-system, <i>J</i><sub>AB</sub> = 8.8 Hz, 4H), 6.55 (s, 2H), 3.82 (broad s, 1H), 2.88 and 2.78 (s, 3H, 3:1 mixture of rotamers), 2.55–2.4 (broad m, 4H), 2.29 (s, 3H), 2.16 (t, <i>J</i> = 6.8 Hz, 3H), 1.92 (m, 2H), 1.75–1.25 (m, 10H), 0.85 (t, <i>J</i> = 7.3 Hz, 3H). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O) δ 7.43 and 7.15 (AA′-BB′-system, <i>J</i><sub>AB</sub> = 8.8 Hz, 4H), 6.49 (s, 2), 3.80 (broad s, 1H), 2.95–2.70 (m, 7H), 2.57 (s, 3H), 2.20 (t, <i>J</i> = 6.0 Hz, 3H), 1.95 (m, 2H), 1.80–1.50 (m, 8H), 1.50–1.30 (m, 2H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ 165.9, 153.3, 150.5, 133.8, 129.1, 128.9, 123.2, 84.0, 79.9, 59.1, 55.8, 55.2, 41.7, 32.6, 29.1, 28.8, 28.4, 26.4, 19.8, 16.0, 11.4. MS <i>m</i>/<i>z</i>: 405.5 (M + H<sup>+</sup>, 1Cl). Anal. (C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>2</sub>·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.15H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>trans</i>-[2-(4-{[Ethyl-(2-hydroxyethyl)amino]methyl}cyclohexyl)ethyl]methylcarbamic Acid 4-Trifluoromethylphenyl Ester Citrate (<b>7</b>)</h4><div class="NLM_p">A solution of <i>trans</i>-methanesulfonic acid 4-{2-[methyl-(4-trifluoromethylphenoxycarbonyl)amino]ethyl}cyclohexylmethyl ester (<b>21</b>) (0.58, 1.33 mmol) and ethyl-(2-hydroxyethyl)amine (1.29 mL, 13.26 mmol, 10 equiv) in DMA (6 mL) was stirred for 3 days at 60 °C. The appropriate portion was extracted with aqueous 0.25 M NaOH/Et<sub>2</sub>O (3×), water, and aqueous saturated NaCl solution, and the organic phases were dried over MgSO<sub>4</sub>, filtered, and evaporated. Purification by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5) gave <i>trans</i>-[2-(4-{[ethyl-(2-hydroxyethyl)amino]methyl}cyclohexyl)ethyl]methylcarbamic acid 4-trifluoromethylphenyl ester (0.38 g, 67%). MS <i>m</i>/<i>z</i>: 431.3 (M + H<sup>+</sup>).</div><div class="NLM_p last">The amine (2.8 g, 6.50 mmol) and citric acid monohydrate (1.37 g, 6.50 mmol) were dissolved in hot EtOAc (28 mL)/<i>i</i>-PrOH (1.6 mL), then slowly (48 h) cooled to −20 °C. After 24 h additional <i>n</i>-pentane (10 mL) was mixed in to give after filtration and washing with a small amount of <i>n</i>-pentane the desired product as white crystals (3.76 g, 93%). Mp: 64 °C (slow dec). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ 8.08–10.06 (br s, <3H) 7.61–7.78 (m, 2H), 7.23–7.39 (m, 2H), 3.57 (t, <i>J</i> = 6.0 Hz, 2H), 3.38 (dd, <i>J</i> = 8.1, 7.3 Hz, 2H), 2.75–2.86 (m, 4H), 2.59 (d, <i>J</i><sub>AB</sub> = 15.3 Hz, 2H), 2.68 (d, <i>J</i><sub>AB</sub> = 15.3 Hz, 2H), 2.55 (d, <i>J</i> = 6.7 Hz, 2H), 2.60 (br s, 3H), 1.72–1.86 (m, 4H), 1.42–1.59 (m, 3H), 1.19–1.33 (m, 1H), 1.07 (t, <i>J</i> = 7.1 Hz, 3H), 0.82–1.04 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ ppm 170.8, 154.6, 153.1, 126.4 (q, <i>J</i> = 3.8), 122.1, 72.0, 60.6, 57.9, 56.1, 49.0, 47.0, 43.7, 35.2, 35.0, 34.6, 32.2, 30.9, 10.4. MS <i>m</i>/<i>z</i>: 431.3 (M + H<sup>+</sup>). Anal. (C<sub>22</sub>H<sub>33</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>·C<sub>6</sub>H<sub>8</sub>O<sub>7</sub>·0.06H<sub>2</sub>O) C, H, N, F.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>trans</i>-{2-[4-(4-Hydroxypiperidine-1-carbonyl)cyclohexyl]ethyl}methylcarbamic Acid 4-Chlorophenyl Ester (<b>10</b>)</h4><div class="NLM_p">A mixture of <i>trans</i>-4-(2-methylaminoethyl)cyclohexanecarboxylic acid·HCl (<b>23</b>) (9.75 g, 43.9 mmol) in hexamethyldisilazane (115 mL, 552 mmol, 12 equiv) was heated under reflux to 145 °C for 2.5 h. The solution was evaporated. The residue was suspended in THF (200 mL) and treated with 4-chlorophenyl chloroformate (6.77, 48.4 mmol, 1.1 equiv) at 0 °C, and the mixture was stirred at room temperature overnight. Water (10 mL) was added at room temperature followed by aqueous 1 M NaOH (110 mL, 2.5 equiv). Stirring was continued for 1 h at room temperature. The organic solvent was evaporated and the residue partitioned between <i>n</i>-hexane (3×) and H<sub>2</sub>O. The water phase was acidified with 1 M HCl and extracted with EtOAc (3×). This organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to yield the crude product. This residue was again partitioned between Et<sub>2</sub>O (3×) and aqueous saturated NaHCO<sub>3</sub> solution. The aqueous phase was acidified with aqueous 1 N HCl and extracted with EtOAc (3×). Drying over Na<sub>2</sub>SO<sub>4</sub> and evaporation gave pure <i>trans</i>-4-{2-[(4-chlorophenoxycarbonyl)methylamino]ethyl}cyclohexanecarboxylic acid as a brown oil (8.56 g, 57%). MS <i>m</i>/<i>z</i>: 338.1 (M – H<sup>–</sup>, 1Cl).</div><div class="NLM_p last">A solution of <i>trans</i>-4-{2-[(4-chlorophenoxycarbonyl)methylamino]ethyl}cyclohexanecarboxylic acid (7.46 g, 21.95 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) was treated at room temperature with 2 drops of DMF, followed by oxalyl chloride (0.28 mL, 2.08 mmol, 1.1 equiv) within 5 min, and stirring was continued for 90 min. The solution was evaporated, redissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL), and added to a cooled solution (0 °C) of 4-hydroxypiperidine (6.66 g, 65.86 mmol, 3 equiv) and Et<sub>3</sub>N (15.30 mL, 109.76 mmol, 5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (120 mL). The mixture was kept at room temperature for 1.5 h and then partitioned between Et<sub>2</sub>O (3×) and aqueous 10% KHSO<sub>4</sub> solution. The organic phases were washed once with aqueous 10% NaCl solution, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give the desired product (9.00 g, 97%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.43 and 7.13 (AA′-BB′-system, two rotamers, 4H), 4.71 (d, <i>J</i> = 10.5 Hz, 1H), 3.82 (m, 1H), 3.66 (m, 2H), 3.39 (m, 1H), 3.30 (m, 1H), 3.15 (m, 1H), 3.00 and 2.88 (s, 3H, 4:5 mixture of rotamers), 2.94 (m, 1H), 1.84–1.58 (m, 6H), 1.56–0.90 (m, 10H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ 7.30–7.45 (m, 2H), 7.03–7.17 (m, 2H), 4.21 (d, <i>J</i> = 4.3 Hz, 1H), 3.74–3.83 (m, 2H), 3.66–3.74 (m, 1H), 3.31–3.40 (m, 2H),3.03–3.14 (m, 2H), 2.95 (s, 3H), 2.49–2.54 (m, 1H), 1.75–1.84 (m, 2H), 1.61–1.75 (m, 4H), 1.45–1.55 (m, 2H), 1.22–1.45 (m, 5H), 0.98–1.11 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 120 °C) δ 173.4, 153.5, 150.5, 129.1, 123.2, 65.7, 46.8, 34.7, 34.5, 34.2, 31.9, 29.1. MS <i>m</i>/<i>z</i>: 423.2 (M + H<sup>+</sup>, 1Cl). Anal. (C<sub>22</sub>H<sub>31</sub>ClN<sub>2</sub>O<sub>4</sub>·0.55H<sub>2</sub>O·0.12C<sub>2</sub>H<sub>6</sub>O) C, H, N, Cl.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Physicochemical Characterization of the Inhibitors</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> log <i>D</i> Determination</h4><div class="NLM_p last">The high-throughput assay method is derived from the conventional “shake flask” method. The compound of interest is distributed between a 50 mM aqueous 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-hydroxypropane-1-sulfonic acid (TAPSO) buffer at pH 7.4 and 1-octanol. The distribution coefficient is then calculated from the difference in concentration in the aqueous phase before and after partitioning and the volume ratio of the two phases. A detailed description of the method can be found elsewhere.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> PAMPA</h4><div class="NLM_p last">For PAMPA, a “sandwich” is formed from a 96-well filter plate and a 96-well in-house-made Teflon plate such that each well is divided into two chambers: donor at the bottom and acceptor at the top, separated by a microfilter coated with a 10% (w/v) egg-phosphatidylcholine and 0.5% (w/v) cholesterol dissolved in dodecane. The distribution of a compound between the top compartment, the artificial membrane, and the bottom compartment is then determined. A detailed description of the method can be found elsewhere.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biology</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Evaluation of OSC Inhibition</h4><div class="NLM_p last">Inhibition of human liver microsomal 2,3-OSC was used to evaluate the inhibitory potency of the new molecules, essentially as described previously.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Briefly, OSC activity was measured in human liver microsomes in sodium phosphate buffer–EDTA–dithtiothreitol, pH 7.4. The inhibitors were dissolved in DMSO and diluted to the desired concentration in the buffer. [<sup>14</sup>C]<i>R</i>,<i>S-</i>MOS (12.8 mCi/mmol, 1 mM final concentration, 20 nCi/<i>í</i>L) in phosphate buffer/1% BSA was mixed with the microsomes, and the reaction proceeded for 1 h at 37 °C. The reaction was stopped by the addition of 10% KOH/MeOH. Then <i>n</i>-hexane/Et<sub>2</sub>O containing nonradioactive MOS and lanosterol as carriers was added. After shaking, the upper phase was evaporated and suspended in <i>n</i>-hexane/Et<sub>2</sub>O and applied to a silica gel plate for chromatographic separation using <i>n</i>-hexane/Et<sub>2</sub>O as the eluent. Radioactive MOS and lanosterol were detected on the silica gel plate using a phosphor imager (Molecular Dynamics). The ratio of MOS to lanosterol was determined from the radioactive bands in order to determine the yield of the reaction and OSC inhibition.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Cells and Cell Treatments</h4><div class="NLM_p last">Human A549 lung, CaCo2 colon, HeLa cervix, LnCap prostate, MCF-7 breast, OVCAR ovarian, and LN229 glioblastoma cancer cells are available from the ATCC (American Tissue Culture Collection, Manassas, VA, U.S.). Human LN18 and LNZ308 glioblastoma cells were a kind gift from AC Diserens, CHUV, Lausanne, Switzerlande. Human Me300 melanoma cells were from D. Rimoldi, Ludwig Institute, Lausanne branch, Switzerland, and KB head and neck cancer cells were from M. Barberi Heyob, University of Nancy, France. The human-brain-derived HCEC microvascular endothelial cell line was a kind gift of D. Staminirovic (Ottawa, Canada). All cells were grown in Dulbecco’s modified Eagle medium (DMEM) medium containing 4.5 g/L glucose, 10% heat-inactivated fetal calf serum (FCS), and penicillin/streptomycin (all cell culture reagents were obtained from Invitrogen, Basel, Switzerland). Unless otherwise specified, cells were grown for 24 h in 48-well plates (Costar, Corning, NY, U.S.). Then the compounds were added for the indicated times and concentrations. Compounds <b>2</b>, <b>3</b>, <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, and <b>9</b> were dissolved at 50 mM in water and compounds <b>1</b>, <b>4</b>, <b>10</b>, and AT in DMSO, and then they were diluted to 1 mM in cell culture medium containing FCS immediately before use.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Determination of Cytotoxicity</h4><div class="NLM_p last">Following exposure to the compounds, cell viability was assessed using the MTT assay (3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide, Sigma-Aldrich, 200 μg/mL final concentration), essentially as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Absorbance at 540 nm was measured in a multiwell plate reader (iEMS Reader, Labsystems, Bioconcept, Allschwil, Switzerland), and the absorbance values of treated cells were compared to the absorbance values of untreated cells. Experiments were conducted in triplicate wells and repeated twice. The mean ± standard deviation (sd) values were calculated.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Evaluation of DNA Synthesis</h4><div class="NLM_p last">Following cell exposure to the componds for 48 h, tritiated thymidine ([<sup>3</sup>H]T) (Amersham-Pharmacia, Glattbrugg, Switzerland, 400 nCi/mL final concentration) was added to the cells for 2–4 h. Then the cell layers were precipitated with 10% TCA and dissolved in 0.1% sodium dodecyl sulfate (SDS) in 0.1 N NaOH, and scintillation cocktail (Optiphase HI-Safe, PerkinElmer, Beaconsfield, U.K.) was added. Radioactivity was counted with a β-counter (WinSpectra, Wallac, Germany). The radioactivity counts of treated cells were compared to the radioactivity counts of untreated cells. Experiments were conducted in triplicate wells, and the mean ± sd values were calculated.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Acetate Incorporation</h4><div class="NLM_p last">Cells were seeded in a 48-well plate for 24 h and exposed to the chemicals for 24 h. Then [<sup>14</sup>C]sodium acetate (American Radiolabeled Chemicals, St. Louis, MO, U.S.; 10 nCi/mL final concentration) was added to the cells for 7.5 h. The cell layers were precipitated with 10% TCA and dissolved in 0.1% SDS in 0.1 N NaOH and scintillation cocktail (Optiphase HI-Safe). Radioactivity was counted in a β-counter (WinSpectra). The radioactivity counts of treated cells were compared to the radioactivity counts of untreated cells. Experiments were conducted in triplicate wells, and the mean ± sd values were calculated.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Evaluation of Results</h4><div class="NLM_p">Each experiment was repeated in triplicate wells at least twice. The mean and standard deviation values were calculated, and statistical significance was evaluated using the Student’s <i>t</i>-test.</div><div class="NLM_p last">Squared cross-validation coefficients according to the leave-one-out method (<i>q</i><sup>2</sup>) and the squared correlation coefficients (<i>r</i><sup>2</sup>) were calculated with SIMCA, version 12 (Umetrics Inc., Umea, Sweden).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/jm300256z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed protocols for chemical synthesis and characterization of compounds <b>12</b>–<b>16</b> and <b>18</b>–<b>23</b>; in vitro inhibitory stability and chemical stability of OSCi <b>1</b>–<b>10</b>; cytotoxicity of compounds <b>1</b>–<b>10</b> and AT after 24–72 h of cell exposure; IC<sub>50</sub> values for inhibition of DNA synthesis after 24 h of exposure of cells to compounds <b>1</b>–<b>10</b> and AT; evaluation of synergism or additivity of the effects of combination of compounds with AT in human endothelial and glioblastoma cells; evaluation of synergism of the effects of combination of compound <b>3</b> with AT in human LN229 glioblastoma cells. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300256z/suppl_file/jm300256z_si_001.pdf">jm300256z_si_001.pdf (414.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300256z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucienne Juillerat-Jeanneret</span> - <span class="hlFld-Affiliation affiliation">Centre Hospitalier Universitaire Vaudois (CHUV) and University of
Lausanne (UNIL), CH-1011 Lausanne, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#016d746268646f6f642f6b74686d6d6473607541626974772f6269216b6e69606f6f64722f6064636841736e6269642f626e6c"><span class="__cf_email__" data-cfemail="ef839a8c868a81818ac1859a8683838a9d8e9baf8c879a99c18c87">[email protected]</span> <span class="__cf_email__" data-cfemail="d4bebbbcb5babab1a7fab5b1b6bd94a6bbb7bcb1fab7bbb9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes D. Aebi</span> - <span class="hlFld-Affiliation affiliation">F. Hoffmann-La Roche Ltd., Pharmaceutical Division, CH-4070 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe928b9d979b90909bd0948b9792929b8c9f8abe9d968b88d09d96de9491969f90909b8dd09f9b9c97be8c919d969bd09d9193"><span class="__cf_email__" data-cfemail="305c455359555e5e551e5a45595c5c5542514470535845461e5358">[email protected]</span> <span class="__cf_email__" data-cfemail="d9b3b6b1b8b7b7bcaaf7b8bcbbb099abb6bab1bcf7bab6b4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Staedler</span> - <span class="hlFld-Affiliation affiliation">Centre Hospitalier Universitaire Vaudois (CHUV) and University of
Lausanne (UNIL), CH-1011 Lausanne, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Chemical
Sciences and Engineering, Ecole Polytechnique Fédérale
de Lausanne, CH-1015, Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Chapuis-Bernasconi</span> - <span class="hlFld-Affiliation affiliation">Centre Hospitalier Universitaire Vaudois (CHUV) and University of
Lausanne (UNIL), CH-1011 Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henrietta Dehmlow</span> - <span class="hlFld-Affiliation affiliation">F. Hoffmann-La Roche Ltd., Pharmaceutical Division, CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Fischer</span> - <span class="hlFld-Affiliation affiliation">F. Hoffmann-La Roche Ltd., Pharmaceutical Division, CH-4070 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d127e2632-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We sincerely thank Dr. Jean Ackermann, Dr. Christian Jenny, Dr. Francois Montavon, Felix Gruber, Marie-Paule Imhoff, Isabelle Kaufmann, Fritz Koch, Hans-Jakob Krebs, and Anke Kurt for their excellent and dedicated assistance; Dr. Olivier Morand, Gisela Flach, Corinne Handschin, and Elisabeth Von Der Mark for the OSC inhibition data; Dr. Caroline Wyss Gramberg, Dr. Inken Plitzko, Dr. Josef Schneider, and Christian Bartelmus for spectroscopic determination and analysis; Isabelle Parilla, Bjoern Wagner, and Severin Wendelspiess for determining the MDO data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">AT</td><td class="NLM_def"><p class="first last">atorvastatin</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">BuLi</td><td class="NLM_def"><p class="first last">butyllithium</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">combination index</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle Mmedium</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N-</i>(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">HCEC</td><td class="NLM_def"><p class="first last">human cerebral endothelial cell</p></td></tr><tr><td class="NLM_term">HMG-CoA</td><td class="NLM_def"><p class="first last">3-hydroxy-3-methylglutaryl coenzyme A</p></td></tr><tr><td class="NLM_term">HOBT</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole hydrate</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]T</td><td class="NLM_def"><p class="first last">tritiated thymidine</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration inhibiting 50% of enzymatic activity</p></td></tr><tr><td class="NLM_term">II</td><td class="NLM_def"><p class="first last">interaction index</p></td></tr><tr><td class="NLM_term">LN18, LN229</td><td class="NLM_def"><p class="first last">human glioblastoma cells</p></td></tr><tr><td class="NLM_term">MOS</td><td class="NLM_def"><p class="first last">monooxidosqualene</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">OSC</td><td class="NLM_def"><p class="first last">oxidosqualene cyclase</p></td></tr><tr><td class="NLM_term">OSCi</td><td class="NLM_def"><p class="first last">oxidosqualene cyclase inhibitor</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>e</sub></td><td class="NLM_def"><p class="first last">permeability</p></td></tr><tr><td class="NLM_term"><i>i</i>-Pr<sub>2</sub>NEt</td><td class="NLM_def"><p class="first last"><i>N-</i>ethyldiisopropylamine</p></td></tr><tr><td class="NLM_term">SDS</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate</p></td></tr><tr><td class="NLM_term">TAPSO</td><td class="NLM_def"><p class="first last">3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-hydroxypropane-1-sulfonic acid</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">trichloroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Maxfield, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabas, I.</span><span> </span><span class="NLM_article-title">Role of cholesterol and lipid organization in disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1038%2Fnature04399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16319881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gqs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=612-621&author=F.+R.+Maxfieldauthor=I.+Tabas&title=Role+of+cholesterol+and+lipid+organization+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cholesterol and lipid organization in disease</span></div><div class="casAuthors">Maxfield, Frederick R.; Tabas, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7068</span>),
    <span class="NLM_cas:pages">612-621</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane lipids are essential for biol. functions ranging from membrane trafficking to signal transduction.  The compn. of lipid membranes influences their organization and properties, so it is not surprising that disorders in lipid metab. and transport have a role in human disease.  Significant recent progress has enhanced our understanding of the mol. and cellular basis of lipid-assocd. disorders such as Tangier disease, Niemann-Pick disease type C and atherosclerosis.  These insights have also led to improved understanding of normal physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfcdtj-eo57bVg90H21EOLACvtfcHk0lgdl2ew8kpU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gqs73I&md5=ab2a1625086f45017125462ae9736e19</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature04399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04399%26sid%3Dliteratum%253Aachs%26aulast%3DMaxfield%26aufirst%3DF.%2BR.%26aulast%3DTabas%26aufirst%3DI.%26atitle%3DRole%2520of%2520cholesterol%2520and%2520lipid%2520organization%2520in%2520disease%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D612%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenmark, H.</span><span> </span><span class="NLM_article-title">Membranes and organelles</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.ceb.2008.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=18588977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslOnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=357-359&author=G.+Raposoauthor=H.+Stenmark&title=Membranes+and+organelles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Membranes and organelles</span></div><div class="casAuthors">Raposo, Graca; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-359</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKm4ZJ1nPOfbVg90H21EOLACvtfcHk0ljYzGV_sazj5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslOnt7g%253D&md5=87135619636900cb37d28147aa88933b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2008.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2008.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3DMembranes%2520and%2520organelles%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2008%26volume%3D20%26spage%3D357%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nissen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenhagen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasiela, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magorien, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganz, P.</span><span> </span><span class="NLM_article-title">Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1056%2FNEJMoa042000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15635110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=29-38&author=S.+E.+Nissenauthor=E.+M.+Tuzcuauthor=P.+Schoenhagenauthor=T.+Croweauthor=W.+J.+Sasielaauthor=J.+Tsaiauthor=J.+Orazemauthor=R.+D.+Magorienauthor=C.+O%E2%80%99Shaughnessyauthor=P.+Ganz&title=Statin+therapy%2C+LDL+cholesterol%2C+C-reactive+protein%2C+and+coronary+artery+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease</span></div><div class="casAuthors">Nissen, Steven E.; Tuzcu, E. Murat; Schoenhagen, Paul; Crowe, Tim; Sasiela, William J.; Tsai, John; Orazem, John; Magorien, Raymond D.; O'Shaughnessy, Charles; Ganz, Peter; Kutcher, M.; Burchenal, J.; Bailey, S.; Fischell, T.; Kerensky, R.; Iaffaldano, R.; Lopez, J.; Grines, C.; DeMariz, A.; Tobis, J.; Brodie, B.; Linker, D.; Forrester, J.; Smith, S.; Weiss, R.; Cooper, C.; Sharaf, B.; Miller, M.; Corbelli, J.; Kleaveland, J.; Garza, L.; Leesar, M.; DeLago, A.; Wickliffe, C.; Kuvin, J.; Kramer, P.; Gordon, P.; Sharma, S.; Leimbach, W.; Cleary, R., Jr.; Nair, R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Recent trials have demonstrated better outcomes with intensive than with moderate statin treatment.  Intensive treatment produced greater redns. in both low-d. lipoprotein (LDL) cholesterol and C-reactive protein (CRP), suggesting a relationship between these two biomarkers and disease progression.  We performed intravascular ultrasonog. in 502 patients with angiog. documented coronary disease.  Patients were randomly assigned to receive moderate treatment (40 mg of pravastatin orally per day) or intensive treatment (80 mg of atorvastatin orally per day).  Ultrasonog. was repeated after 18 mo to measure the progression of atherosclerosis.  Lipoprotein and CKP levels were measured at baseline and follow-up.  In the group as a whole, the mean LDL cholesterol level was reduced from 150.2 mg per dL (3.88 mmol per L) at baseline to 94.5 mg per dL (2.44 mmol per L) at 18 mo (P<0.001), and the geometric mean CRP level decreased from 2.9 to 2.3 mg per L (P<0.001). The correlation between the redn. in LDL cholesterol levels and that in CRP levels was weak but significant in the group as a whole (r=0.13, P=0.005), but not in either treatment group alone.  In univariate analyses, the percent change in the levels ofLDL cholesterol, CRP, apolipoprotein B-100, and non-high-d. lipoprotein cholesterol were related to the rate of progression of atherosclerosis.  After adjustment for the redn. in these lipid levels, the decrease in CRP levels was independently and significantly correlated with the rate of progression.  Patients with redns. in both LDL cholesterol and CRP that were greater than the median had significantly slower rates of progression than patients with redns. in both biomarkers that were less than the median (P=0.001).  For patients with coronary artery disease, the reduced rate of progression of atherosclerosis assocd. with intensive statin treatment, as compared with moderate statin treatment, is significantly related to greater redns. in the levels of both atherogenic lipoproteins and CRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4p1Tb_60barVg90H21EOLACvtfcHk0ljYzGV_sazj5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis12msQ%253D%253D&md5=9e6a1ab9d76bb115d5ecc5ce6d25f952</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa042000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa042000%26sid%3Dliteratum%253Aachs%26aulast%3DNissen%26aufirst%3DS.%2BE.%26aulast%3DTuzcu%26aufirst%3DE.%2BM.%26aulast%3DSchoenhagen%26aufirst%3DP.%26aulast%3DCrowe%26aufirst%3DT.%26aulast%3DSasiela%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DOrazem%26aufirst%3DJ.%26aulast%3DMagorien%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DC.%26aulast%3DGanz%26aufirst%3DP.%26atitle%3DStatin%2520therapy%252C%2520LDL%2520cholesterol%252C%2520C-reactive%2520protein%252C%2520and%2520coronary%2520artery%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mills, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachlis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereaux, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, D.</span><span> </span><span class="NLM_article-title">Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1769</span><span class="NLM_x">–</span> <span class="NLM_lpage">1781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.jacc.2008.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19022156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWht7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1769-1781&author=E.+J.+Millsauthor=B.+Rachlisauthor=P.+Wuauthor=P.+J.+Devereauxauthor=P.+Aroraauthor=D.+Perri&title=Primary+prevention+of+cardiovascular+mortality+and+events+with+statin+treatments%3A+a+network+meta-analysis+involving+more+than+65%2C000+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments</span></div><div class="casAuthors">Mills, Edward J.; Rachlis, Beth; Wu, Ping; Devereaux, Philip J.; Arora, Paul; Perri, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1769-1781</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: This study aimed to evaluate the effectiveness of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins) in primary prevention of cardiovascular events.  Background: The role of statins is well established for secondary prevention of cardiovascular disease (CVD) clin. events and mortality.  Little is known of their role in primary cardiovascular event prevention.  Methods: We conducted comprehensive searches of 10 electronic databases from inception to May 2008.  We contacted study investigators and maintained a comprehensive bibliog. of statin studies.  We included randomized trials of at least 12-mo duration in predominantly primary prevention populations.  Two reviewers independently extd. data in duplicate.  We performed random-effects meta-anal. and meta-regression, calcd. optimal information size, and conducted a mixed-treatment comparison anal.  Results: We included 20 randomized clin. trials.  We pooled 19 trials (n = 63,899) for all-cause mortality and found a relative risk (RR) of 0.93 (95% confidence interval [CI]: 0.87 to 0.99, p = 0.03 [I2 = 5%, 95% CI: 0% to 51%]).  Eighteen trials (n = 59,469) assessed cardiovascular deaths (RR: 0.89, 95% CI: 0.81 to 0.98, p = 0.01 [I2 = 0%, 95% CI: 0% to 41%]).  Seventeen trials (n = 53,371) found an RR of 0.85 (95% CI: 0.77 to 0.95, p = 0.004 [I2 = 61%, 95% CI: 38% to 77%]) for major cardiovascular events, and 17 trials (n = 52,976) assessed myocardial infarctions (RR: 0.77, 95% CI: 0.63 to 0.95, p = 0.01 [I2 = 59%, 95% CI: 24% to 74%]).  Incidence of cancer was not elevated in 10 trials (n = 45,469) (RR: 1.02, 95% CI: 0.94 to 1.11, p = 0.59 [I2 = 0%, 95% CI: 0% to 46%]), nor was rhabdomyolysis (RR: 0.97, 95% CI: 0.25 to 3.83, p = 0.96 [I2 = 0%, 95% CI: 0% to 40%]).  Our anal. included a sufficient sample to reliably answer our primary outcome of CVD mortality.  Conclusions: Statins have a clear role in primary prevention of CVD mortality and major events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSsTjHI6LyOLVg90H21EOLACvtfcHk0ljYzGV_sazj5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWht7jE&md5=01c76a061b4ff1ea122f82510beb1de1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%2BJ.%26aulast%3DRachlis%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DDevereaux%26aufirst%3DP.%2BJ.%26aulast%3DArora%26aufirst%3DP.%26aulast%3DPerri%26aufirst%3DD.%26atitle%3DPrimary%2520prevention%2520of%2520cardiovascular%2520mortality%2520and%2520events%2520with%2520statin%2520treatments%253A%2520a%2520network%2520meta-analysis%2520involving%2520more%2520than%252065%252C000%2520patients%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D1769%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Demierre, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, S. M.</span><span> </span><span class="NLM_article-title">Statins and cancer prevention</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1038%2Fnrc1751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16341084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=930-942&author=M.+F.+Demierreauthor=P.+D.+Higginsauthor=S.+B.+Gruberauthor=E.+Hawkauthor=S.+M.+Lippman&title=Statins+and+cancer+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Statins and cancer prevention</span></div><div class="casAuthors">Demierre, Marie-France; Higgins, Peter D. R.; Gruber, Stephen B.; Hawk, Ernest; Lippman, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">930-942</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Randomized controlled trials for preventing cardiovascular disease indicated that statins had provocative and unexpected benefits for reducing colorectal cancer and melanoma.  These findings have led to the intensive study of statins in cancer prevention, including recent, large population-based studies showing statin-assocd. redns. in overall, colorectal and prostate cancer.  Understanding the complex cellular effects (for example, on angiogenesis and inflammation) and the underlying mol. mechanisms of statins (for example, 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase-dependent processes that involve geranylgeranylation of Rho proteins, and HMG-CoA-independent processes that involve lymphocyte-function-assocd. antigen 1) will advance the development of molecularly targeted agents for preventing cancer.  This understanding might also help the development of drugs for other ageing-related diseases with interrelated mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUpknH20YHpLVg90H21EOLACvtfcHk0lj0q9QMWa6lLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbL&md5=7208173429dc76f12ebbc05c92858d38</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1751%26sid%3Dliteratum%253Aachs%26aulast%3DDemierre%26aufirst%3DM.%2BF.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%26aulast%3DGruber%26aufirst%3DS.%2BB.%26aulast%3DHawk%26aufirst%3DE.%26aulast%3DLippman%26aufirst%3DS.%2BM.%26atitle%3DStatins%2520and%2520cancer%2520prevention%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D930%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, L. L.</span><span> </span><span class="NLM_article-title">The statins as anticancer agents</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=12538446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1OnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=10-19&author=K.+K.+Chanauthor=A.+M.+Ozaauthor=L.+L.+Siu&title=The+statins+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Statins as Anticancer Agents</span></div><div class="casAuthors">Chan, Kelvin K. W.; Oza, Amit M.; Siu, Lillian L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-19</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  3-Hydroxy-3-methylgutaryl CoA reductase inhibitors, commonly referred to as the statins, have proven therapeutic and preventative effects in cardiovascular diseases.  Recently, there are emerging interests in their use as anticancer agents based on preclin. evidence of their antiproliferative, proapoptotic, anti-invasive, and radiosensitizing properties.  Inhibition of 3-hydroxy-3-methylgutaryl CoA reductase by the statins interferes with the rate-limiting step of the mevalonate pathway, leading to reduced levels of mevalonate and its downstream products, many of which play important roles in crit. cellular functions such as membrane integrity, cell signaling, protein synthesis, and cell cycle progression.  Perturbations of these processes in neoplastic cells by the statins may therefore result in control of tumor initiation, growth, and metastasis.  The statins have demonstrated growth inhibitory activity in cancer cell lines and preclin. tumor models in animals.  Phase I trials of statins in humans have demonstrated myotoxicity as their main dose-limiting toxicity, and Phase II trials in various tumor types are ongoing to evaluate their efficacy.  Potential future directions in the development of the statins as anticancer agents include combinations with chemotherapeutic or other mol.-targeted agents, combinations with radiotherapy, maintenance therapy in minimal disease status, and as chemopreventive therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoawbLu0I3bgrVg90H21EOLACvtfcHk0lj0q9QMWa6lLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1OnsQ%253D%253D&md5=d3d7bc0d32444b68b89a083ced0fe72c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BK.%26aulast%3DOza%26aufirst%3DA.%2BM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DThe%2520statins%2520as%2520anticancer%2520agents%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D10%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cemeus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitroulakos, J.</span><span> </span><span class="NLM_article-title">Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs11060-008-9627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=18566746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ejtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=9-17&author=C.+Cemeusauthor=T.+T.+Zhaoauthor=G.+M.+Barrettauthor=I.+A.+Lorimerauthor=J.+Dimitroulakos&title=Lovastatin+enhances+gefitinib+activity+in+glioblastoma+cells+irrespective+of+EGFRvIII+and+PTEN+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status</span></div><div class="casAuthors">Cemeus, Catia; Zhao, Tong T.; Barrett, Gordon M.; Lorimer, Ian A.; Dimitroulakos, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is commonly amplified and mutated in glioblastoma, making it a compelling therapeutic target.  Recent reports have demonstrated clin. activity of the EGFR inhibitors gefitinib and erlotinib in a subset of glioblastoma patients.  Co-expression of EGFRvIII, a constitutively active mutant receptor expressed in 50% of tumors, and PTEN, an inhibitor of PI3K activity, by glioblastoma cells is assocd. with clin. response to these EGFR kinase inhibitors.  PTEN loss and resulting increased PI3K pathway activity appears to act as a resistance factor.  A crit. therapeutic challenge is to identify agents that enhance the anti-cancer effects of these agents and promote responsiveness to EGFR kinase inhibitors in a broader spectrum of glioblastoma patients.  For example, combining gefitinib with inhibitors of the PI3K/AKT pathway show enhanced cytotoxicity in glioblastoma derived cell lines.  Here, we show that targeting HMG-CoA reductase with lovastatin, that can affect the activity of multiple cell signaling pathways, significantly enhanced the sensitivity of glioblastoma cells to the EGFR kinase inhibitor gefitinib in the five cell lines tested.  In an isogenic model system, U87MG glioblastoma cells expressing EGFRvIII and PTEN in relevant combinations, we show that combined gefitinib and lovastatin treatments induce potent synergistic cytotoxicity irresp. of EGFRvIII and PTEN status.  These studies demonstrate the potential of lovastatin to augment the cytotoxic effects of gefitinib and provide a rationale for combined statin/EGFR targeted therapies in glioblastoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCug6FDl9BLVg90H21EOLACvtfcHk0lj0q9QMWa6lLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ejtLbM&md5=46d84444d8d5b913ef5ceb9c3626139d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs11060-008-9627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-008-9627-0%26sid%3Dliteratum%253Aachs%26aulast%3DCemeus%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%2BT.%26aulast%3DBarrett%26aufirst%3DG.%2BM.%26aulast%3DLorimer%26aufirst%3DI.%2BA.%26aulast%3DDimitroulakos%26aufirst%3DJ.%26atitle%3DLovastatin%2520enhances%2520gefitinib%2520activity%2520in%2520glioblastoma%2520cells%2520irrespective%2520of%2520EGFRvIII%2520and%2520PTEN%2520status%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2008%26volume%3D90%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhavan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1126%2Fscisignal.2000446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=20009104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD1MfisFWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=ra82&author=D.+Guoauthor=R.+M.+Prinsauthor=J.+Dangauthor=D.+Kugaauthor=A.+Iwanamiauthor=H.+Sotoauthor=K.+Y.+Linauthor=T.+T.+Huangauthor=D.+Akhavanauthor=M.+B.+Hockauthor=S.+Zhuauthor=A.+A.+Kofmanauthor=S.+J.+Bensingerauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=S.+Horvathauthor=A.+D.+Watsonauthor=J.+G.+Kuhnauthor=H.+I.+Robinsauthor=M.+P.+Mehtaauthor=P.+Y.+Wenauthor=L.+M.+DeAngelisauthor=M.+D.+Pradosauthor=I.+K.+Mellinghoffauthor=T.+F.+Cloughesyauthor=P.+S.+Mischel&title=EGFR+signaling+through+an+Akt-SREBP-1-dependent%2C+rapamycin-resistant+pathway+sensitizes+glioblastomas+to+antilipogenic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy</span></div><div class="casAuthors">Guo Deliang; Prins Robert M; Dang Julie; Kuga Daisuke; Iwanami Akio; Soto Horacio; Lin Kelly Y; Huang Tiffany T; Akhavan David; Hock M Benjamin; Zhu Shaojun; Kofman Ava A; Bensinger Steve J; Yong William H; Vinters Harry V; Horvath Steve; Watson Andrew D; Kuhn John G; Robins H Ian; Mehta Minesh P; Wen Patrick Y; DeAngelis Lisa M; Prados Michael D; Mellinghoff Ingo K; Cloughesy Timothy F; Mischel Paul S</div><div class="citationInfo"><span class="NLM_cas:title">Science signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">101</span>),
    <span class="NLM_cas:pages">ra82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma, the most common malignant brain tumor, is among the most lethal and difficult cancers to treat.  Although epidermal growth factor receptor (EGFR) mutations are frequent in glioblastoma, their clinical relevance is poorly understood.  Studies of tumors from patients treated with the EGFR inhibitor lapatinib revealed that EGFR induces the cleavage and nuclear translocation of the master transcriptional regulator of fatty acid synthesis, sterol regulatory element-binding protein 1 (SREBP-1).  This response was mediated by Akt; however, clinical data from rapamycin-treated patients showed that SREBP-1 activation was independent of the mammalian target of rapamycin complex 1, possibly explaining rapamycin's poor efficacy in the treatment of such tumors.  Glioblastomas without constitutively active EGFR signaling were resistant to inhibition of fatty acid synthesis, whereas introduction of a constitutively active mutant form of EGFR, EGFRvIII, sensitized tumor xenografts in mice to cell death, which was augmented by the hydroxymethylglutaryl coenzyme A reductase inhibitor atorvastatin.  These results identify a previously undescribed EGFR-mediated prosurvival metabolic pathway and suggest new therapeutic approaches to treating EGFR-activated glioblastomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXniRaZIvVxeR_TJajKxJDfW6udTcc2eYQ4w4Ut6wHwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfisFWnsA%253D%253D&md5=5b64f105bfb1011d1932368049b8d140</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000446%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DDang%26aufirst%3DJ.%26aulast%3DKuga%26aufirst%3DD.%26aulast%3DIwanami%26aufirst%3DA.%26aulast%3DSoto%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DAkhavan%26aufirst%3DD.%26aulast%3DHock%26aufirst%3DM.%2BB.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DKofman%26aufirst%3DA.%2BA.%26aulast%3DBensinger%26aufirst%3DS.%2BJ.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DA.%2BD.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DRobins%26aufirst%3DH.%2BI.%26aulast%3DMehta%26aufirst%3DM.%2BP.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DDeAngelis%26aufirst%3DL.%2BM.%26aulast%3DPrados%26aufirst%3DM.%2BD.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DEGFR%2520signaling%2520through%2520an%2520Akt-SREBP-1-dependent%252C%2520rapamycin-resistant%2520pathway%2520sensitizes%2520glioblastomas%2520to%2520antilipogenic%2520therapy%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3Dra82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">van de Donk, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamphuis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhorst, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloem, A. C.</span><span> </span><span class="NLM_article-title">The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1362-1371&author=N.+W.+van+de+Donkauthor=M.+M.+Kamphuisauthor=H.+M.+Lokhorstauthor=A.+C.+Bloem&title=The+cholesterol+lowering+drug+lovastatin+induces+cell+death+in+myeloma+plasma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BDonk%26aufirst%3DN.%2BW.%26aulast%3DKamphuis%26aufirst%3DM.%2BM.%26aulast%3DLokhorst%26aufirst%3DH.%2BM.%26aulast%3DBloem%26aufirst%3DA.%2BC.%26atitle%3DThe%2520cholesterol%2520lowering%2520drug%2520lovastatin%2520induces%2520cell%2520death%2520in%2520myeloma%2520plasma%2520cells%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D1362%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Graaf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Noorden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchelaar, H. J.</span><span> </span><span class="NLM_article-title">Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.ctrv.2004.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15531395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=609-641&author=M.+R.+Graafauthor=D.+J.+Richelauthor=C.+J.+van+Noordenauthor=H.+J.+Guchelaar&title=Effects+of+statins+and+farnesyltransferase+inhibitors+on+the+development+and+progression+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer</span></div><div class="casAuthors">Graaf, Matthijs R.; Richel, Dick J.; van Noorden, Cornelis J. F.; Guchelaar, Henk-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-641</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Statins (3-hydroxy-3-methylglutaryl-CoA reductase inhibitors - HMG-CoA reductase inhibitors) have been approved for the treatment of lipid disorders.  Recently, in vivo studies with exptl. animals and in vitro studies indicated a possible role for statins in the treatment of malignancies.  Inhibition of the enzyme HMG-CoA reductase results in decreased farnesylation and geranylgeranylation of several proteins essential for cellular proliferation and survival.  Inhibition of Ras farnesylation was originally thought to be the mechanism that mediates statin-induced effects in cancer.  Consequently, specific inhibitors of the enzyme farnesyltransferase (FTIs) were developed.  Currently, the mechanisms that mediate statin- and FTI-induced antitumor effects are questioned.  It remains unclear which proteins and signal transduction cascades are involved.  This review focuses on the effects and possible therapeutic application of statins and FTIs.  Antitumor properties such as induction of growth arrest and apoptosis, inhibition of metastasis and inhibition of angiogenesis are discussed.  Furthermore, the mechanisms of statin- and farnesyltransferase inhibitor-induced effects and the involvement of a no. of cellular components (such as farnesylated and geranylgeranylated proteins, the mitogen-activated protein kinase signaling pathway, the phosphoinositide 3'-kinase signaling pathway, and cell cycle regulatory proteins) are reviewed.  In addn., clin. and epidemiol. data with respect to statins and farnesyltransferase inhibitors are summarized.  We propose that inhibitors of the mevalonate pathway are particularly effective when administered in combination with other drugs.  Therefore, the mechanisms and effects of combined therapy of statins or farnesyltransferase inhibitors with chemotherapeutics, biphosphonates, non-steroidal anti-inflammatory drugs, specific inhibitors of geranyltransferase and inhibitors of tyrosine kinase activity are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoESyyHl6XZlbVg90H21EOLACvtfcHk0ljJBGowjDYb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOltb0%253D&md5=b1694cb6866d6fb1fdb3af08440407f8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2004.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2004.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DGraaf%26aufirst%3DM.%2BR.%26aulast%3DRichel%26aufirst%3DD.%2BJ.%26aulast%3Dvan%2BNoorden%26aufirst%3DC.%2BJ.%26aulast%3DGuchelaar%26aufirst%3DH.%2BJ.%26atitle%3DEffects%2520of%2520statins%2520and%2520farnesyltransferase%2520inhibitors%2520on%2520the%2520development%2520and%2520progression%2520of%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2004%26volume%3D30%26spage%3D609%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirshahi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirshahi-Khorassani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, C.</span><span> </span><span class="NLM_article-title">Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=159-166&author=L.+Vincentauthor=W.+Chenauthor=L.+Hongauthor=F.+Mirshahiauthor=Z.+Mishalauthor=T.+Mirshahi-Khorassaniauthor=J.+P.+Vannierauthor=J.+Soriaauthor=C.+Soria&title=Inhibition+of+endothelial+cell+migration+by+cerivastatin%2C+an+HMG-CoA+reductase+inhibitor%3A+contribution+to+its+anti-angiogenic+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DMirshahi%26aufirst%3DF.%26aulast%3DMishal%26aufirst%3DZ.%26aulast%3DMirshahi-Khorassani%26aufirst%3DT.%26aulast%3DVannier%26aufirst%3DJ.%2BP.%26aulast%3DSoria%26aufirst%3DJ.%26aulast%3DSoria%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520endothelial%2520cell%2520migration%2520by%2520cerivastatin%252C%2520an%2520HMG-CoA%2520reductase%2520inhibitor%253A%2520contribution%2520to%2520its%2520anti-angiogenic%2520effect%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26spage%3D159%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Park, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iruela-Arispe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galper, J. B.</span><span> </span><span class="NLM_article-title">3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=143-150&author=H.+J.+Parkauthor=D.+Kongauthor=L.+Iruela-Arispeauthor=U.+Begleyauthor=D.+Tangauthor=J.+B.+Galper&title=3-Hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitors+interfere+with+angiogenesis+by+inhibiting+the+geranylgeranylation+of+RhoA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DIruela-Arispe%26aufirst%3DL.%26aulast%3DBegley%26aufirst%3DU.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DGalper%26aufirst%3DJ.%2BB.%26atitle%3D3-Hydroxy-3-methylglutaryl%2520coenzyme%2520A%2520reductase%2520inhibitors%2520interfere%2520with%2520angiogenesis%2520by%2520inhibiting%2520the%2520geranylgeranylation%2520of%2520RhoA%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Weis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeschen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassford, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, J. P.</span><span> </span><span class="NLM_article-title">Statins have biphasic effects on angiogenesis</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2002&pages=739-745&author=M.+Weisauthor=C.+Heeschenauthor=A.+J.+Glassfordauthor=J.+P.+Cooke&title=Statins+have+biphasic+effects+on+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DM.%26aulast%3DHeeschen%26aufirst%3DC.%26aulast%3DGlassford%26aufirst%3DA.%2BJ.%26aulast%3DCooke%26aufirst%3DJ.%2BP.%26atitle%3DStatins%2520have%2520biphasic%2520effects%2520on%2520angiogenesis%26jtitle%3DCirculation%26date%3D2002%26volume%3D105%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jozkowicz, A.</span><span> </span><span class="NLM_article-title">Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.2174%2F156800905774932824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16375664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=579-594&author=J.+Dulakauthor=A.+Jozkowicz&title=Anti-angiogenic+and+anti-inflammatory+effects+of+statins%3A+relevance+to+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-angiogenic and anti-inflammatory effects of statins: Relevance to anti-cancer therapy</span></div><div class="casAuthors">Dulak, Jozef; Jozkowicz, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-594</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is indispensable for the growth of solid tumors and angiogenic factors are also involved in the progression of hematol. malignancies.  Targeting the formation of blood vessels is therefore regarded as a promising strategy in cancer therapy.  Interestingly, besides demonstration of some beneficial effects of novel anti-angiogenic compds., recent data on the activity of already available drugs point to their potential application in anti-angiogenic therapy.  Among these are the statins, the inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase.  Statins are very efficient in the treatment of hypercholesterolemia in cardiovascular disorders; however, their effects are pleiotropic and some are not directly related to the inhibition of cholesterol synthesis.  Some reports particularly highlight the pro-angiogenic effects of statins, which are caused by low, nanomolar concns. and are regarded as beneficial for the treatment of cardiovascular diseases.  On the other hand, the anti-angiogenic activities, obsd. at micromolar concns. of statins, may be of special significance for cancer therapy.  Those effects are caused by the inhibition of both proliferation and migration and induction of apoptosis in endothelial cells.  Moreover, the statin-mediated inhibition of vascular endothelial growth factor synthesis, the major angiogenic mediator, may contribute to the attenuation of angiogenesis.  It has been suggested that the anti-cancer effect of statins can be potentially exploited for the cancer therapy.  However, several clin. trials aimed at the inhibition of tumor growth by treatment with very high doses of statins did not provide conclusive data.  Herein, the reasons for those outcomes are discussed and the rationale for further studies is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB1SwH-H3DS7Vg90H21EOLACvtfcHk0licXOGLbacIFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbfO&md5=07b5e4fca48272427faf638ee9fb0e5a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156800905774932824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800905774932824%26sid%3Dliteratum%253Aachs%26aulast%3DDulak%26aufirst%3DJ.%26aulast%3DJozkowicz%26aufirst%3DA.%26atitle%3DAnti-angiogenic%2520and%2520anti-inflammatory%2520effects%2520of%2520statins%253A%2520relevance%2520to%2520anti-cancer%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2005%26volume%3D5%26spage%3D579%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jakobisiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golab, J.</span><span> </span><span class="NLM_article-title">Statins can modulate effectiveness of antitumor therapeutic modalities</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19526461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=102-135&author=M.+Jakobisiakauthor=J.+Golab&title=Statins+can+modulate+effectiveness+of+antitumor+therapeutic+modalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Statins can modulate effectiveness of antitumor therapeutic modalities</span></div><div class="casAuthors">Jakobisiak, Marek; Golab, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-135</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Despite significant, frequently very strong, antiproliferative and tumoricidal effects of statins demonstrated in vitro, their antitumor effects in animal models are modest, and their efficacy in clin. trials has not been proven.  As such, statins seem unlikely to be ever regarded as antitumor agents.  However, statins are regularly taken by many elderly cancer patients for the prevention of cardiovascular events.  Owing to their pleiotropic effects in normal and tumor cells, statins interact in various ways with many antitumor treatment modalities, either potentiating or diminishing their effectiveness.  Elucidation of these interactions might affect the choice of treatment to be planned in cancer patients as some combinations might be contraindicated, whereas others might elicit potentiated antitumor effects but at a cost of increased general toxicity.  Some other combinations might induce either comparable or even stronger antitumor effects, but with a beneficial concomitant redn. of specific side effects.  Most of the studies reviewed in this article have been carried in vitro or in exptl. tumor models, but clin. relevance of the findings is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2TkIht3SE7Vg90H21EOLACvtfcHk0licXOGLbacIFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOgs7s%253D&md5=75ab40c894c808fe51d3701b5f18c0fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakobisiak%26aufirst%3DM.%26aulast%3DGolab%26aufirst%3DJ.%26atitle%3DStatins%2520can%2520modulate%2520effectiveness%2520of%2520antitumor%2520therapeutic%2520modalities%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2010%26volume%3D30%26spage%3D102%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Perchellet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perchellet, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crow, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buszek, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span> </span><span class="NLM_article-title">Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.3892%2Fijmm_00000274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19787197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=633-643&author=J.+P.+Perchelletauthor=E.+M.+Perchelletauthor=K.+R.+Crowauthor=K.+R.+Buszekauthor=N.+Brownauthor=S.+Ellappanauthor=G.+Gaoauthor=D.+Luoauthor=M.+Minatoyaauthor=G.+H.+Lushington&title=Novel+synthetic+inhibitors+of+3-hydroxy-3-methylglutaryl-coenzyme+A+%28HMG-CoA%29+reductase+activity+that+inhibit+tumor+cell+proliferation+and+are+structurally+unrelated+to+existing+statins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins</span></div><div class="casAuthors">Perchellet, Jean-Pierre H.; Perchellet, Elisabeth M.; Crow, Kyle R.; Buszek, Keith R.; Brown, Neil; Ellappan, Sampathkumar; Gao, Ge; Luo, Diheng; Minatoya, Machiko; Lushington, Gerald H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Pilot-scale libraries of eight-membered medium ring lactams (MRLs) and related tricyclic compds. (either seven-membered lactams, thiolactams or amines) were screened for their ability to inhibit the catalytic activity of human recombinant 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase in vitro.  A dozen of the synthetic compds. mimic the inhibition of purified HMG-CoA reductase activity caused by pravastatin, fluvastatin and sodium salts of lovastatin, mevastatin and simvastatin in this cell-free assay, suggesting direct interaction with the rate-limiting enzyme of cholesterol biosynthesis.  Moreover, several MRLs inhibit the metabolic activity of L1210 tumor cells in vitro to a greater degree than fluvastatin, lovastatin, mevastatin and simvastatin, whereas pravastatin is inactive.  Although the correlation between the concn.-dependent inhibitions of HMG-CoA reductase activity over 10 min in the cell-free assay and L1210 tumor cell proliferation over 4 days in culture is unclear, some bioactive MRLs elicit interesting combinations of statin-like (IC50: 7.4-8.0 μM) and anti-tumor (IC50: 1.4-2.3 μM) activities.  The HMG-CoA reductase-inhibiting activities of pravastatin and an MRL persist in the presence of increasing concns. of NADPH.  But increasing concns. of HMG-CoA block the HMG-CoA reductase-inhibiting activity of pravastatin without altering that of an MRL, suggesting that MRLs and existing statins may have different mechanisms of enzyme interaction and inhibition.  When tested together, suboptimal concns. of synthetic MRLs and existing statins have additive inhibitory effects on HMG-CoA reductase activity.  Preliminary mol. docking studies with MRL-based inhibitors indicate that these ligands fit sterically well into the HMG-CoA reductase statin-binding receptor model and, in contrast to mevastatin, may occupy a narrow channel housing the pyridinium moiety on NADP+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9i59AXS1MwbVg90H21EOLACvtfcHk0licXOGLbacIFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgtb3M&md5=e9ee144bc8bad5386535b394a1f4a8c7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3892%2Fijmm_00000274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm_00000274%26sid%3Dliteratum%253Aachs%26aulast%3DPerchellet%26aufirst%3DJ.%2BP.%26aulast%3DPerchellet%26aufirst%3DE.%2BM.%26aulast%3DCrow%26aufirst%3DK.%2BR.%26aulast%3DBuszek%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DEllappan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DMinatoya%26aufirst%3DM.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26atitle%3DNovel%2520synthetic%2520inhibitors%2520of%25203-hydroxy-3-methylglutaryl-coenzyme%2520A%2520%2528HMG-CoA%2529%2520reductase%2520activity%2520that%2520inhibit%2520tumor%2520cell%2520proliferation%2520and%2520are%2520structurally%2520unrelated%2520to%2520existing%2520statins%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2009%26volume%3D24%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gains, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengsfeld, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span> </span><span class="NLM_article-title">Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=373-390&author=O.+H.+Morandauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=Y.+H.+Jiauthor=N.+Gainsauthor=H.+Lengsfeldauthor=J.+Himber&title=Ro+48-8.071%2C+a+new+2%2C3-oxidosqualene%3Alanosterol+cyclase+inhibitor+lowering+plasma+cholesterol+in+hamsters%2C+squirrel+monkeys%2C+and+minipigs%3A+comparison+to+simvastatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DY.%2BH.%26aulast%3DGains%26aufirst%3DN.%26aulast%3DLengsfeld%26aufirst%3DH.%26aulast%3DHimber%26aufirst%3DJ.%26atitle%3DRo%252048-8.071%252C%2520a%2520new%25202%252C3-oxidosqualene%253Alanosterol%2520cyclase%2520inhibitor%2520lowering%2520plasma%2520cholesterol%2520in%2520hamsters%252C%2520squirrel%2520monkeys%252C%2520and%2520minipigs%253A%2520comparison%2520to%2520simvastatin%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1997%26volume%3D38%26spage%3D373%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Balliano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliaro-Bosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaldaferri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taramino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span> </span><span class="NLM_article-title">Oxidosqualene cyclase from <i>Saccharomyces cerevisiae</i>, <i>Trypanosoma cruzi</i>, <i>Pneumocystis carinii</i> and <i>Arabidopsis thaliana</i> expressed in yeast: a model for the development of novel antiparasitic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=718-723&author=G.+Ballianoauthor=H.+Dehmlowauthor=S.+Oliaro-Bossoauthor=M.+Scaldaferriauthor=S.+Taraminoauthor=F.+Violaauthor=G.+Caronauthor=J.+Aebiauthor=J.+Ackermann&title=Oxidosqualene+cyclase+from+Saccharomyces+cerevisiae%2C+Trypanosoma+cruzi%2C+Pneumocystis+carinii+and+Arabidopsis+thaliana+expressed+in+yeast%3A+a+model+for+the+development+of+novel+antiparasitic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalliano%26aufirst%3DG.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DOliaro-Bosso%26aufirst%3DS.%26aulast%3DScaldaferri%26aufirst%3DM.%26aulast%3DTaramino%26aufirst%3DS.%26aulast%3DViola%26aufirst%3DF.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DAckermann%26aufirst%3DJ.%26atitle%3DOxidosqualene%2520cyclase%2520from%2520Saccharomyces%2520cerevisiae%252C%2520Trypanosoma%2520cruzi%252C%2520Pneumocystis%2520carinii%2520and%2520Arabidopsis%2520thaliana%2520expressed%2520in%2520yeast%253A%2520a%2520model%2520for%2520the%2520development%2520of%2520novel%2520antiparasitic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D718%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolidon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von der Mark, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021120f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3354-3370&author=H.+Dehmlowauthor=J.+D.+Aebiauthor=S.+Jolidonauthor=Y.+H.+Jiauthor=E.+M.+von+der+Markauthor=J.+Himberauthor=O.+H.+Morand&title=Synthesis+and+structure%E2%80%93activity+studies+of+novel+orally+active+non-terpenoic+2%2C3-oxidosqualene+cyclase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm021120f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021120f%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DY.%2BH.%26aulast%3Dvon%2Bder%2BMark%26aufirst%3DE.%2BM.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%2520novel%2520orally%2520active%2520non-terpenoic%25202%252C3-oxidosqualene%2520cyclase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3354%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lenhart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinert, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene–hopene cyclase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2083</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0211218" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2083-2092&author=A.+Lenhartauthor=D.+J.+Reinertauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=O.+H.+Morandauthor=G.+E.+Schulz&title=Binding+structures+and+potencies+of+oxidosqualene+cyclase+inhibitors+with+the+homologous+squalene%E2%80%93hopene+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0211218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0211218%26sid%3Dliteratum%253Aachs%26aulast%3DLenhart%26aufirst%3DA.%26aulast%3DReinert%26aufirst%3DD.%2BJ.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DBinding%2520structures%2520and%2520potencies%2520of%2520oxidosqualene%2520cyclase%2520inhibitors%2520with%2520the%2520homologous%2520squalene%25E2%2580%2593hopene%2520cyclase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2083%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rowe, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argmann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyez, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegele, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, M. W.</span><span> </span><span class="NLM_article-title">Enhanced synthesis of the oxysterol 24(<i>S</i>),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=717-725&author=A.+H.+Roweauthor=C.+A.+Argmannauthor=J.+Y.+Edwardsauthor=C.+G.+Sawyezauthor=O.+H.+Morandauthor=R.+A.+Hegeleauthor=M.+W.+Huff&title=Enhanced+synthesis+of+the+oxysterol+24%28S%29%2C25-epoxycholesterol+in+macrophages+by+inhibitors+of+2%2C3-oxidosqualene%3Alanosterol+cyclase%3A+a+novel+mechanism+for+the+attenuation+of+foam+cell+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DA.%2BH.%26aulast%3DArgmann%26aufirst%3DC.%2BA.%26aulast%3DEdwards%26aufirst%3DJ.%2BY.%26aulast%3DSawyez%26aufirst%3DC.%2BG.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DHegele%26aufirst%3DR.%2BA.%26aulast%3DHuff%26aufirst%3DM.%2BW.%26atitle%3DEnhanced%2520synthesis%2520of%2520the%2520oxysterol%252024%2528S%2529%252C25-epoxycholesterol%2520in%2520macrophages%2520by%2520inhibitors%2520of%25202%252C3-oxidosqualene%253Alanosterol%2520cyclase%253A%2520a%2520novel%2520mechanism%2520for%2520the%2520attenuation%2520of%2520foam%2520cell%2520formation%26jtitle%3DCirc.%2520Res.%26date%3D2003%26volume%3D93%26spage%3D717%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Telford, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, M. W.</span><span> </span><span class="NLM_article-title">A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2608</span><span class="NLM_x">–</span> <span class="NLM_lpage">2614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1161%2F01.ATV.0000189158.28455.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16210564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Crt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2608-2614&author=D.+E.+Telfordauthor=S.+M.+Lipsonauthor=P.+H.+Barrettauthor=B.+G.+Sutherlandauthor=J.+Y.+Edwardsauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=O.+H.+Morandauthor=M.+W.+Huff&title=A+novel+inhibitor+of+oxidosqualene%3Alanosterol+cyclase+inhibits+very+low-density+lipoprotein+apolipoprotein+B100+%28apoB100%29+production+and+enhances+low-density+lipoprotein+apoB100+catabolism+through+marked+reduction+in+hepatic+cholesterol+content"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content</span></div><div class="casAuthors">Telford, Dawn E.; Lipson, Sara M.; Barrett, P. Hugh R.; Sutherland, Brian G.; Edwards, Jane Y.; Aebi, Johannes D.; Dehmlow, Henrietta; Morand, Olivier H.; Huff, Murray W.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2608-2614</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Inhibition of 2,3-oxidosqualene:lanosterol cyclase (OSC), an enzyme in the cholesterol synthesis pathway, has the unique ability to inhibit cholesterol synthesis while simultaneously enhancing oxysterol synthesis.  Our objectives were to det., in vivo, if a novel OSC inhibitor reduced low-d. lipoprotein (LDL) cholesterol and to define the mechanism(s) involved.  Methods and Results- Miniature pigs received the OSC inhibitor RO0717625 or placebo and a diet contg. fat (34% of energy) and 400 mg per day of cholesterol.  Treatment decreased plasma total cholesterol (-20%) and LDL cholesterol (-29%).  Apolipoprotein B (apoB) kinetic parameters were detd.  Very low-d. lipoprotein (VLDL) apoB pool size decreased 22% because of inhibition of VLDL prodn. (-43%).  LDL apoB pool size decreased 22% because of a 1.5-fold increase in fractional catabolic rate (FCR).  The increased FCR was assocd. with a 2-fold increase in hepatic LDL receptor mRNA.  Hepatic total and microsomal cholesterol were reduced by 16% and 27%, resp.  Plasma lathosterol concns. decreased 57%, reflecting inhibition of hepatic cholesterol synthesis.  Treatment reduced plasma plant sterols and decreased postprandial cholesterol transport in chylomicrons.  Conclusions- A novel OSC inhibitor, RO0717625, decreased VLDL and LDL apoB100 through decreased VLDL prodn. and enhanced LDL clearance.  Thus, OSC represents a potential therapeutic target for dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrth2VAtZAgNbVg90H21EOLACvtfcHk0ljofpo2MD2ltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Crt77K&md5=b23c92d64a726121408ede4088a0a076</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000189158.28455.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000189158.28455.94%26sid%3Dliteratum%253Aachs%26aulast%3DTelford%26aufirst%3DD.%2BE.%26aulast%3DLipson%26aufirst%3DS.%2BM.%26aulast%3DBarrett%26aufirst%3DP.%2BH.%26aulast%3DSutherland%26aufirst%3DB.%2BG.%26aulast%3DEdwards%26aufirst%3DJ.%2BY.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DHuff%26aufirst%3DM.%2BW.%26atitle%3DA%2520novel%2520inhibitor%2520of%2520oxidosqualene%253Alanosterol%2520cyclase%2520inhibits%2520very%2520low-density%2520lipoprotein%2520apolipoprotein%2520B100%2520%2528apoB100%2529%2520production%2520and%2520enhances%2520low-density%2520lipoprotein%2520apoB100%2520catabolism%2520through%2520marked%2520reduction%2520in%2520hepatic%2520cholesterol%2520content%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D2608%26epage%3D2614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitor for farnesyl pyrophosphate synthase in the mevalonate pathway</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5340</span><span class="NLM_x">–</span> <span class="NLM_lpage">5342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=5340-5342&author=J.+Gaoauthor=X.+Chuauthor=Y.+Qiuauthor=L.+Wuauthor=Y.+Qiaoauthor=J.+Wuauthor=D.+Li&title=Discovery+of+potent+inhibitor+for+farnesyl+pyrophosphate+synthase+in+the+mevalonate+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitor%2520for%2520farnesyl%2520pyrophosphate%2520synthase%2520in%2520the%2520mevalonate%2520pathway%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D5340%26epage%3D5342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisele, B.</span><span> </span><span class="NLM_article-title">Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=148-158&author=M.+Markauthor=P.+Mullerauthor=R.+Maierauthor=B.+Eisele&title=Effects+of+a+novel+2%2C3-oxidosqualene+cyclase+inhibitor+on+the+regulation+of+cholesterol+biosynthesis+in+HepG2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMark%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DEisele%26aufirst%3DB.%26atitle%3DEffects%2520of%2520a%2520novel%25202%252C3-oxidosqualene%2520cyclase%2520inhibitor%2520on%2520the%2520regulation%2520of%2520cholesterol%2520biosynthesis%2520in%2520HepG2%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1996%26volume%3D37%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Eisele, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budzinski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span> </span><span class="NLM_article-title">Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=564-575&author=B.+Eiseleauthor=R.+Budzinskiauthor=P.+M%C3%BCllerauthor=M.+Mark&title=Effects+of+a+novel+2%2C3-oxidosqualene+cyclase+inhibitor+on+cholesterol+biosynthesis+and+lipid+metabolism+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DB.%26aulast%3DBudzinski%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DP.%26aulast%3DMark%26aufirst%3DM.%26atitle%3DEffects%2520of%2520a%2520novel%25202%252C3-oxidosqualene%2520cyclase%2520inhibitor%2520on%2520cholesterol%2520biosynthesis%2520and%2520lipid%2520metabolism%2520in%2520vivo%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1997%26volume%3D38%26spage%3D564%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dollis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuber, F.</span><span> </span><span class="NLM_article-title">Effects of 2,3-oxidosqualene-lanosterol cyclase inhibitor, 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line Hep-G2</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=49-57&author=D.+Dollisauthor=F.+Schuber&title=Effects+of+2%2C3-oxidosqualene-lanosterol+cyclase+inhibitor%2C+2%2C3%3A22%2C23-dioxidosqualene+and+24%2C25-epoxycholesterol+on+the+regulation+of+cholesterol+biosynthesis+in+human+hepatoma+cell+line+Hep-G2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollis%26aufirst%3DD.%26aulast%3DSchuber%26aufirst%3DF.%26atitle%3DEffects%2520of%25202%252C3-oxidosqualene-lanosterol%2520cyclase%2520inhibitor%252C%25202%252C3%253A22%252C23-dioxidosqualene%2520and%252024%252C25-epoxycholesterol%2520on%2520the%2520regulation%2520of%2520cholesterol%2520biosynthesis%2520in%2520human%2520hepatoma%2520cell%2520line%2520Hep-G2%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D48%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Peffley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span> </span><span class="NLM_article-title">Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4′-(6-allyl-ethyl-amino-hexyloxy)-2′-fluoro-phenyl]-(4-bromophenyl)-methanone (RO0488071): comparison to simvastatin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=439-449&author=D.+M.+Peffleyauthor=A.+K.+Gayenauthor=O.+H.+Morand&title=Down-regulation+of+3-hydroxy-3-methylglutaryl+coenzyme+A+reductase+mRNA+levels+and+synthesis+in+syrian+hamster+C100+cells+by+the+oxidosqualene+cyclase+inhibitor+%5B4%E2%80%B2-%286-allyl-ethyl-amino-hexyloxy%29-2%E2%80%B2-fluoro-phenyl%5D-%284-bromophenyl%29-methanone+%28RO0488071%29%3A+comparison+to+simvastatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeffley%26aufirst%3DD.%2BM.%26aulast%3DGayen%26aufirst%3DA.%2BK.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DDown-regulation%2520of%25203-hydroxy-3-methylglutaryl%2520coenzyme%2520A%2520reductase%2520mRNA%2520levels%2520and%2520synthesis%2520in%2520syrian%2520hamster%2520C100%2520cells%2520by%2520the%2520oxidosqualene%2520cyclase%2520inhibitor%2520%255B4%25E2%2580%25B2-%25286-allyl-ethyl-amino-hexyloxy%2529-2%25E2%2580%25B2-fluoro-phenyl%255D-%25284-bromophenyl%2529-methanone%2520%2528RO0488071%2529%253A%2520comparison%2520to%2520simvastatin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D56%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gardner, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, S. P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, R. Y.</span><span> </span><span class="NLM_article-title">An oxysterol-derived positive signal for 3-hydroxy-3-methylglutaryl-CoA reductase degradation in yeast</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">8681</span><span class="NLM_x">–</span> <span class="NLM_lpage">8694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=8681-8694&author=R.+G.+Gardnerauthor=H.+Shanauthor=S.+P.+T.+Matsudaauthor=R.+Y.+Hampton&title=An+oxysterol-derived+positive+signal+for+3-hydroxy-3-methylglutaryl-CoA+reductase+degradation+in+yeast"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DR.%2BG.%26aulast%3DShan%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DS.%2BP.%2BT.%26aulast%3DHampton%26aufirst%3DR.%2BY.%26atitle%3DAn%2520oxysterol-derived%2520positive%2520signal%2520for%25203-hydroxy-3-methylglutaryl-CoA%2520reductase%2520degradation%2520in%2520yeast%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D8681%26epage%3D8694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum-Kaelin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chucholowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maerki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von der Mark, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span> </span><span class="NLM_article-title">Oxidosqualene cyclase (OSC) inhibitors for the treatment of dyslipidemia</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=72-76&author=H.+Dehmlowauthor=J.+Ackermannauthor=J.+Aebiauthor=D.+Blum-Kaelinauthor=A.+Chucholowskiauthor=P.+Coassoloauthor=P.+Hartmanauthor=M.+Kansyauthor=H.+P.+Maerkiauthor=O.+Morandauthor=E.+Von+der+Markauthor=N.+Pandayauthor=A.+Rufauthor=R.+Thomaauthor=T.+Schulz-Gasch&title=Oxidosqualene+cyclase+%28OSC%29+inhibitors+for+the+treatment+of+dyslipidemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAckermann%26aufirst%3DJ.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DChucholowski%26aufirst%3DA.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DHartman%26aufirst%3DP.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMaerki%26aufirst%3DH.%2BP.%26aulast%3DMorand%26aufirst%3DO.%26aulast%3DVon%2Bder%2BMark%26aufirst%3DE.%26aulast%3DPanday%26aufirst%3DN.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26atitle%3DOxidosqualene%2520cyclase%2520%2528OSC%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520dyslipidemia%26jtitle%3DChimia%26date%3D2005%26volume%3D59%26spage%3D72%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Jolidon, S.; Polak-Wyss, A.; Hartman, P. G.; Guerry, P.</span><span> </span><span class="NLM_article-title">2,3-Oxidosqualenelanosterol Cyclase: An Attractive Target for Antifungal Drug Design</span>. In  <span class="citation_source-book">Recent Advances in the Chemistry of Anti-Infective Agents</span>; <span class="NLM_contrib-group">Bentley, P. H.; Ponsford, R</span>, Eds.; <span class="NLM_publisher-name">Bookcraft Ltd.</span>: <span class="NLM_publisher-loc">Bath, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=223-233&author=S.+Jolidon&author=A.+Polak-Wyss&author=P.+G.+Hartman&author=P.+Guerryauthor=P.+H.+Bentley&author=R+Ponsford&title=Recent+Advances+in+the+Chemistry+of+Anti-Infective+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJolidon%26aufirst%3DS.%26atitle%3D2%252C3-Oxidosqualenelanosterol%2520Cyclase%253A%2520An%2520Attractive%2520Target%2520for%2520Antifungal%2520Drug%2520Design%26btitle%3DRecent%2520Advances%2520in%2520the%2520Chemistry%2520of%2520Anti-Infective%2520Agents%26aulast%3DBentley%26aufirst%3DP.%2BH.%26pub%3DBookcraft%2520Ltd%26date%3D1993%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span> </span><span class="NLM_article-title">Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=118-122&author=R.+Thomaauthor=T.+Schulz-Gaschauthor=B.+D%E2%80%99Arcyauthor=J.+Benzauthor=J.+Aebiauthor=H.+Dehmlowauthor=M.+Hennigauthor=M.+Stihleauthor=A.+Ruf&title=Insight+into+steroid+scaffold+formation+from+the+structure+of+human+oxidosqualene+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DInsight%2520into%2520steroid%2520scaffold%2520formation%2520from%2520the%2520structure%2520of%2520human%2520oxidosqualene%2520cyclase%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span> </span><span class="NLM_article-title">Synthetic method for conversion of formyl groups into ethynyl groups</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1972&pages=3769-3772&author=E.+J.+Coreyauthor=P.+L.+Fuchs&title=Synthetic+method+for+conversion+of+formyl+groups+into+ethynyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26atitle%3DSynthetic%2520method%2520for%2520conversion%2520of%2520formyl%2520groups%2520into%2520ethynyl%2520groups%26jtitle%3DTetrahedron%2520Lett.%26date%3D1972%26volume%3D36%26spage%3D3769%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">Amino acid salt catalyzed intramolecular Robinson annulation</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5412</span><span class="NLM_x">–</span> <span class="NLM_lpage">5414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=5412-5414&author=P.+Liauthor=H.+Yamamoto&title=Amino+acid+salt+catalyzed+intramolecular+Robinson+annulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DAmino%2520acid%2520salt%2520catalyzed%2520intramolecular%2520Robinson%2520annulation%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D36%26spage%3D5412%26epage%3D5414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Carlsen, P. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3936</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00332a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=3936-3938&author=P.+H.+J.+Carlsenauthor=T.+Katsukiauthor=V.+S.+Martinauthor=K.+B.+Sharpless&title=A+greatly+improved+procedure+for+ruthenium+tetroxide+catalyzed+oxidations+of+organic+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span></div><div class="casAuthors">Carlsen, Per H. J.; Katsuki, Tsutomu; Martin, Victor S.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3936-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Addn. of MeCN to the traditional CCl4/H2O solvent system for RuO4-catalyzed oxidns. causes a great improvement apparently by preventing formation of insol. Ru species and thereby maintaining high catalyst activity.  Applications of the new catalytic system to the oxidn. of org. substrates (olefins, alcs., 1,2-diols, arom. rings, and ethers) are described.  Primary Me ethers are oxidized directly to the esters.  The Ru analog of the abnormal permanganate oxidn. of 1,5-dienes was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRHM2swdg5rVg90H21EOLACvtfcHk0lhmktBKxZtuGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D&md5=ed05bc7a5eb549752691f363f6f2893c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00332a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00332a045%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsen%26aufirst%3DP.%2BH.%2BJ.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DV.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520greatly%2520improved%2520procedure%2520for%2520ruthenium%2520tetroxide%2520catalyzed%2520oxidations%2520of%2520organic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D3936%26epage%3D3938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Brusselmans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Sande, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Veldhoven, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claessens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, J. V.</span><span> </span><span class="NLM_article-title">Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">18777</span><span class="NLM_x">–</span> <span class="NLM_lpage">18785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=18777-18785&author=K.+Brusselmansauthor=L.+Timmermansauthor=T.+Van+de+Sandeauthor=P.+P.+Van+Veldhovenauthor=G.+Guanauthor=I.+Schechterauthor=F.+Claessensauthor=G.+Verhoevenauthor=J.+V.+Swinnen&title=Squalene+synthase%2C+a+determinant+of+Raft-associated+cholesterol+and+modulator+of+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrusselmans%26aufirst%3DK.%26aulast%3DTimmermans%26aufirst%3DL.%26aulast%3DVan%2Bde%2BSande%26aufirst%3DT.%26aulast%3DVan%2BVeldhoven%26aufirst%3DP.%2BP.%26aulast%3DGuan%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DClaessens%26aufirst%3DF.%26aulast%3DVerhoeven%26aufirst%3DG.%26aulast%3DSwinnen%26aufirst%3DJ.%2BV.%26atitle%3DSqualene%2520synthase%252C%2520a%2520determinant%2520of%2520Raft-associated%2520cholesterol%2520and%2520modulator%2520of%2520cancer%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D18777%26epage%3D18785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span> <span class="citation_source-journal">Pharm. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1124%2Fpr.58.3.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16968952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=621-681&author=T.+C.+Chou&title=Theoretical+basis%2C+experimental+design%2C+and+computerized+simulation+of+synergism+and+antagonism+in+drug+combination+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-681</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The median-effect equation derived from the mass-action law principle at equil. steady state via math. induction and deduction for different reaction sequences and mechanisms and different types of inhibition has been shown to be the unified theory for the Michaelis-Menten equation, Hill equation, Henderson-Hasselbalch equation, and Scatchard equation.  It is shown that dose and effect are interchangeable via defined parameters.  This general equation for the single drug effect has been extended to the multiple drug effect equation for n drugs.  These equations provide the theor. basis for the combination index (CI)-isobologram equation that allows quant. detn. of drug interactions, where CI < 1, = 1, and > 1 indicate synergism, additive effect, and antagonism, resp.  Based on these algorithms, computer software has been developed to allow automated simulation of synergism and antagonism at all dose or effect levels.  It displays the dose-effect curve, median-effect plot, combination index plot, isobologram, dose-redn. index plot, and polygonogram for in vitro or in vivo studies.  This theor. development, exptl. design, and computerized data anal. have facilitated dose-effect anal. for single drug evaluation or carcinogen and radiation risk assessment, as well as for drug or other entity combinations in a vast field of disciplines of biomedical sciences.  In this review, selected examples of applications are given, and step-by-step examples of exptl. designs and real data anal. are also illustrated.  The merging of the mass-action law principle with math. induction-deduction has been proven to be a unique and effective scientific method for general theory development.  The median-effect principle and its mass-action law based computer software are gaining increased applications in biomedical sciences, from how to effectively evaluate a single compd. or entity to how to beneficially use multiple drugs or modalities in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToLhZ8Njyh7Vg90H21EOLACvtfcHk0li0-bQkiKnt0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL&md5=374c53e0772c679d1cdb08ff3112be90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.10%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DTheoretical%2520basis%252C%2520experimental%2520design%252C%2520and%2520computerized%2520simulation%2520of%2520synergism%2520and%2520antagonism%2520in%2520drug%2520combination%2520studies%26jtitle%3DPharm.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D621%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotan, R.</span><span> </span><span class="NLM_article-title">Interaction index and different methods for determining drug interaction in combination therapy</span> <span class="citation_source-journal">J. Biopharm. Stat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1080%2F10543400701199593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=17479394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ntVaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=461-480&author=J.+J.+Leeauthor=M.+Kongauthor=G.+D.+Ayersauthor=R.+Lotan&title=Interaction+index+and+different+methods+for+determining+drug+interaction+in+combination+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction index and different methods for determining drug interaction in combination therapy</span></div><div class="casAuthors">Lee J J; Kong M; Ayers G D; Lotan R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biopharmaceutical statistics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-80</span>
        ISSN:<span class="NLM_cas:issn">1054-3406</span>.
    </div><div class="casAbstract">Studying and understanding the joint effect of combined treatments is important in pharmacology and in the development of combination therapies.  The Loewe additivity model is one of the best general reference models for evaluating drug interactions.  Based on this model, synergy occurs when the interaction index is less than one, while antagonism occurs when interaction index is greater than one.  We expanded the meaning of the interaction index, and propose a procedure to calculate the interaction index and its associated confidence interval under the assumption that the dose-effect curve for a single agent follows Chou and Talalay's median effect equation.  In addition, we review four response surface models based on the Loewe additivity model using a single parameter to determine drug interactions.  We describe each of these models in the context of Loewe additivity model and discuss their relative advantages and disadvantages.  We also provide S-PLUS/R code for each approach to facilitate the implementation of these commonly used methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEZu1z3QFjiIFEOhA_Im3cfW6udTcc2eYh48q_fKqn9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ntVaqsw%253D%253D&md5=e9e3cca66e2099f4c5bc549b147d3a96</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F10543400701199593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10543400701199593%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKong%26aufirst%3DM.%26aulast%3DAyers%26aufirst%3DG.%2BD.%26aulast%3DLotan%26aufirst%3DR.%26atitle%3DInteraction%2520index%2520and%2520different%2520methods%2520for%2520determining%2520drug%2520interaction%2520in%2520combination%2520therapy%26jtitle%3DJ.%2520Biopharm.%2520Stat.%26date%3D2007%26volume%3D17%26spage%3D461%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wuitschik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Oxetanes in drug discovery: structural and synthetic insights</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+Muller&title=Oxetanes+in+drug+discovery%3A+structural+and+synthetic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0li0-bQkiKnt0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520drug%2520discovery%253A%2520structural%2520and%2520synthetic%2520insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeability assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeability+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljumUShbDLKhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bjorkhem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, S.</span><span> </span><span class="NLM_article-title">Brain cholesterol: long secret life behind a barrier</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">806</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1161%2F01.ATV.0000120374.59826.1b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=14764421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3jtlKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=806-815&author=I.+Bjorkhemauthor=S.+Meaney&title=Brain+cholesterol%3A+long+secret+life+behind+a+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Brain cholesterol: long secret life behind a barrier</span></div><div class="casAuthors">Bjorkhem Ingemar; Meaney Steve</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, thrombosis, and vascular biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">806-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although an immense knowledge has accumulated concerning regulation of cholesterol homeostasis in the body, this does not include the brain, where details are just emerging.  Approximately 25% of the total amount of the cholesterol present in humans is localized to this organ, most of it present in myelin.  Almost all brain cholesterol is a product of local synthesis, with the blood-brain barrier efficiently protecting it from exchange with lipoprotein cholesterol in the circulation.  Thus, there is a highly efficient apolipoprotein-dependent recycling of cholesterol in the brain, with minimal losses to the circulation.  Under steady-state conditions, most of the de novo synthesis of cholesterol in the brain appears to be balanced by excretion of the cytochrome P-450-generated oxysterol 24S-hydroxycholesterol.  This oxysterol is capable of escaping the recycling mechanism and traversing the blood-brain barrier.  Cholesterol levels and cholesterol turnover are affected in neurodegenerating disorders, and the capacity for cholesterol transport and recycling in the brain seems to be of importance for the development of such diseases.  The possibility has been discussed that administration of inhibitors of cholesterol synthesis may reduce the prevalence of Alzheimer disease.  No firm conclusions can, however, be drawn from the studies presented thus far.  In the present review, the most recent advances in our understanding of cholesterol turnover in the brain is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTADxmZBcvS7GLFM_lbR1VmfW6udTcc2eb1i7apa1xQw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3jtlKktw%253D%253D&md5=4273c1fb2054333fdeca963d01ba6fd8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000120374.59826.1b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000120374.59826.1b%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkhem%26aufirst%3DI.%26aulast%3DMeaney%26aufirst%3DS.%26atitle%3DBrain%2520cholesterol%253A%2520long%2520secret%2520life%2520behind%2520a%2520barrier%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D806%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dietschy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turley, S. D.</span><span> </span><span class="NLM_article-title">Cholesterol metabolism in the central nervous system during early development and in the mature animal</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1375-1397&author=J.+M.+Dietschyauthor=S.+D.+Turley&title=Cholesterol+metabolism+in+the+central+nervous+system+during+early+development+and+in+the+mature+animal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26aulast%3DTurley%26aufirst%3DS.%2BD.%26atitle%3DCholesterol%2520metabolism%2520in%2520the%2520central%2520nervous%2520system%2520during%2520early%2520development%2520and%2520in%2520the%2520mature%2520animal%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D1375%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Natali, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siculella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnoni, G. V.</span><span> </span><span class="NLM_article-title">Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=1966-1975&author=F.+Nataliauthor=L.+Siculellaauthor=S.+Salvatiauthor=G.+V.+Gnoni&title=Oleic+acid+is+a+potent+inhibitor+of+fatty+acid+and+cholesterol+synthesis+in+C6+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatali%26aufirst%3DF.%26aulast%3DSiculella%26aufirst%3DL.%26aulast%3DSalvati%26aufirst%3DS.%26aulast%3DGnoni%26aufirst%3DG.%2BV.%26atitle%3DOleic%2520acid%2520is%2520a%2520potent%2520inhibitor%2520of%2520fatty%2520acid%2520and%2520cholesterol%2520synthesis%2520in%2520C6%2520glioma%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2007%26volume%3D48%26spage%3D1966%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Prasanna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samid, D.</span><span> </span><span class="NLM_article-title">Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1046%2Fj.1471-4159.1996.66020710.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=8592143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaK28XnsFCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=710-716&author=P.+Prasannaauthor=A.+Thibaultauthor=L.+Liuauthor=D.+Samid&title=Lipid+metabolism+as+a+target+for+brain+cancer+therapy%3A+synergistic+activity+of+lovastatin+and+sodium+phenylacetate+against+human+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells</span></div><div class="casAuthors">Prasanna, Premakala; Thibault, Alain; Liu, Lei; Samid, Dvorit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-16</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Malignant gliomas, the most common form of primary brain tumors, are highly dependent on the mevalonate (MVA) pathway for the synthesis of lipid moieties crit. to cell replication.  Human glioblastoma cells were uniquely vulnerable to growth arrest by lovastatin, a competitive inhibitor of the enzyme regulating MVA synthesis, 3-hydroxy-3-methylglutaryl CoA reductase.  The sodium salt of phenylacetic acid (NaPA), an inhibitor of MVA-pyrophosphate decarboxylase, the enzyme that controls MVA use, acted synergistically with lovastatin to suppress malignant growth.  When used at pharmacol. attainable concns., the two compds. induced profound cytostasis and loss of malignant properties such as invasiveness and expression of the transforming growth factor-β2 gene, coding for a potent immunosuppressive cytokine.  Supplementation with exogenous ubiquinone, an end product of the MVA pathway, failed to rescue the cells, suggesting that decreased synthesis of intermediary products are responsible for the antitumor effects obsd.  In addn. to blocking the MVA pathway, lovastatin alone and in combination with NaPA increased the expression of the peroxisome proliferator-activated receptor, a transcription factor implicated in the control of lipid metab., cell growth, and differentiation.  The results indicate that targeting lipid metab. with lovastatin, used alone or in combination with the arom. fatty acid NaPA, may offer a novel approach to the treatment of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeUuw69KG02LVg90H21EOLACvtfcHk0lj9HiF1hzo3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFCrsQ%253D%253D&md5=de460f19aa8823b663f61749e88ead30</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.66020710.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.66020710.x%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DP.%26aulast%3DThibault%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSamid%26aufirst%3DD.%26atitle%3DLipid%2520metabolism%2520as%2520a%2520target%2520for%2520brain%2520cancer%2520therapy%253A%2520synergistic%2520activity%2520of%2520lovastatin%2520and%2520sodium%2520phenylacetate%2520against%2520human%2520glioma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D710%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brown, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, V.</span><span> </span><span class="NLM_article-title">Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1046%2Fj.1471-4159.2000.740847.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=10646538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFyhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=847-859&author=R.+C.+Brownauthor=C.+Cascioauthor=V.+Papadopoulos&title=Pathways+of+neurosteroid+biosynthesis+in+cell+lines+from+human+brain%3A+regulation+of+dehydroepiandrosterone+formation+by+oxidative+stress+and+beta-amyloid+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and β-amyloid peptide</span></div><div class="casAuthors">Brown, Rachel C.; Cascio, Caterina; Papadopoulos, Vassilios</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">847-859</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Neurosteroids in rodents can originate from peripheral tissues or be locally synthesized in specific brain areas.  There is, as yet, no information about the synthesis and regulation of neurosteroids in human brain.  The authors examd. the ability of human brain cells to synthesize steroids from a radiolabeled precursor and the mRNA and protein expression of key components of peripheral steroidogenic machinery.  Oligodendrocytes are the source of pregnenolone in human brain.  Human astrocytes do not synthesize radiolabeled pregnenolone, nor do human neurons.  There is potential for all three cell types to metabolize pregnenolone to other neurosteroids, including dehydroepiandrosterone.  MRNA and protein for cytochrome P 450 17α-hydroxylase were found in all cell types, although no activity could be demonstrated.  The authors examd. the ability of the cells to make dehydroepiandrosterone via an alternative pathway induced by treatment with Fe2+.  Oligodendrocytes and astrocytes make dehydroepiandrosterone via this pathway, but neurons do not.  In searching for a natural regulator of dehydroepiandrosterone formation, the authors obsd. that treating oligodendrocytes with β-amyloid, which increases reactive oxygen species, also increased dehydroepiandrosterone formation.  These effects of β-amyloid were blocked by vitamin E.  These results indicate that human brain makes steroids in a cell-specific manner and suggest that dehydroepiandrosterone synthesis can be regulated by intracellular free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEpV7929f0LVg90H21EOLACvtfcHk0lj9HiF1hzo3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFyhtg%253D%253D&md5=5c3cf430542dc6a7a4acc6f93d97b94b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.740847.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.740847.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DCascio%26aufirst%3DC.%26aulast%3DPapadopoulos%26aufirst%3DV.%26atitle%3DPathways%2520of%2520neurosteroid%2520biosynthesis%2520in%2520cell%2520lines%2520from%2520human%2520brain%253A%2520regulation%2520of%2520dehydroepiandrosterone%2520formation%2520by%2520oxidative%2520stress%2520and%2520beta-amyloid%2520peptide%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D847%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Bababeygy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polevaya, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youssef, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prugpichailers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veeravagu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, V.</span><span> </span><span class="NLM_article-title">HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4901</span><span class="NLM_x">–</span> <span class="NLM_lpage">4908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=20044596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=4901-4908&author=S.+R.+Bababeygyauthor=N.+V.+Polevayaauthor=S.+Youssefauthor=A.+Sunauthor=A.+Xiongauthor=T.+Prugpichailersauthor=A.+Veeravaguauthor=L.+C.+Houauthor=L.+Steinmanauthor=V.+Tse&title=HMG-CoA+reductase+inhibition+causes+increased+necrosis+and+apoptosis+in+an+in+vivo+mouse+glioblastoma+multiforme+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model</span></div><div class="casAuthors">Bababeygy, Simon R.; Polevaya, Nika V.; Youssef, Sawsan; Sun, Amy; Xiong, Anming; Prugpichailers, Tiffany; Veeravagu, Anand; Hou, Lewis C.; Steinman, Lawrence; Tse, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4901-4908</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Statins are thought to have tumorolytic properties, reducing angiogenesis by inhibiting pro-angiogenic factors and inducing apoptosis of mural pericytes within the tumor vascular tree.  Materials and Methods: An orthotopic mouse glioblastoma (GL-26) model was used to investigate the effect of simvastatin on glioblastoma vasculature in vivo.  GL-26 cells were implanted into the striatum of C5LKa mice treated with either control, low- or high-dose simvastatin.  Brains were analyzed for necrotic vol., apoptosis, morphol. and pericytic cells within the vascular tree.  Results: Low-dose simvastatin increased necrosis and apoptosis compared to both control and high-dose simvastatin groups.  High-dose simvastatin increased vessel caliber by reducing pericytic cells along the tumor vessel wall compared to both control and low-dose simvastatin groups.  Conclusion: Simvastatin has a dual effect on tumorigenesis.  At high doses, it may worsen instead of "normalizing" tumor angio-architecture, albeit low doses affect tumor cell survival by promoting necrosis and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_a8Gg8UmX_rVg90H21EOLACvtfcHk0lj9HiF1hzo3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gqtb4%253D&md5=5a33d79a148a329594cca5c98b37e593</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBababeygy%26aufirst%3DS.%2BR.%26aulast%3DPolevaya%26aufirst%3DN.%2BV.%26aulast%3DYoussef%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DPrugpichailers%26aufirst%3DT.%26aulast%3DVeeravagu%26aufirst%3DA.%26aulast%3DHou%26aufirst%3DL.%2BC.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DTse%26aufirst%3DV.%26atitle%3DHMG-CoA%2520reductase%2520inhibition%2520causes%2520increased%2520necrosis%2520and%2520apoptosis%2520in%2520an%2520in%2520vivo%2520mouse%2520glioblastoma%2520multiforme%2520model%26jtitle%3DAnticancer%2520Res.%26date%3D2009%26volume%3D29%26spage%3D4901%26epage%3D4908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Bouterfa, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattelmeyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czub, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vordermark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2761</span><span class="NLM_x">–</span> <span class="NLM_lpage">2771</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=10953355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=2761-2771&author=H.+L.+Bouterfaauthor=V.+Sattelmeyerauthor=S.+Czubauthor=D.+Vordermarkauthor=K.+Roosenauthor=J.+C.+Tonn&title=Inhibition+of+Ras+farnesylation+by+lovastatin+leads+to+downregulation+of+proliferation+and+migration+in+primary+cultured+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells</span></div><div class="casAuthors">Bouterfa, Hakim L.; Sattelmeyer, Vera; Czub, Stefanie; Vordermark, Dirk; Roosen, Klaus; Tonn, Jorg Christian</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2761-2771</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Malignant astrocytomas are the most common primary intracranial human tumors.  All therapeutic approaches are limited due to their high proliferative capacity and their ability to diffusely invade the brain.  Amplification of tyrosine kinase receptors and their signaling pathways have been implicated as contributing to the mol. pathogenesis of astrocytomas, providing possible new targets for therapeutic intervention.  In particular, astrocytomas, although lacking oncogenic Ras mutations, have elevated levels of activated Ras.  Lovastatin, an inhibitor of the β-hydroxy-β-methylglutary CoA reductase (HMG-CoA-reductase), is currently used to treat patients with hypercholesterolemia.  In addn., it inhibits isoprenylation of several members of the Ras superfamily of proteins and therefore has multiple cellular effects including the redn. of proliferation.  Materials and methods: In this study, we investigated the impact of lovastatin on two human glioma cell lines and on 15 primary cell cultures established from biopsies of patients with glioblastoma multiforme (GBM).  Proliferation of glioma cell lines and primary tumor cells was detd. by cell counting and by using the MTT assay.  The cell morphol. was analyzed by staining of actin filaments with phalloidin.  Apoptosis was measured using the TUNEL assay.  To investigate the influence of this drug on glioma cell motility, tumor cell migration was investigated using three dimensional spheroid disintegration assays.  In addn., tumor cell invasion was analyzed with a confrontational assay between tumor spheroids and rat brain aggregates.  Results: Inhibition of farnesyl biosynthesis using lovastatin led to a block in Ras mediated signaling, indicated by lower MAPK activity.  Consequently, tumor cell proliferation was reduced up to 80%.  Lovastatin appeared to decrease glioma viability by inducing apoptosis, as indicated by morphol. changes and increase of TUNEL pos. cells.  Lovastatin acts through isoprenoid depletion, because supplementation of the media with 50-100 μM mevalonate restored all τηε obsd. effects.  Invasion of tumor cells into brain tissue was not effected while migration was reduced βν about 30-40% in cells treated with high concns. (≥100 μM) of lovastatin.  This was surprising because drug treatment at lower concns. led to a disruption of the actin cytoskeleton, as indicated by Phalloidin staining.  Conclusion: Our data strongly suggest that inhibition of elevated Ras activity by lovastatin effectively targets the MAPK and probably other signaling pathways thus offering a pharmacol. based approach for a potential treatment of human astrocytomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTsVV-qEOx5rVg90H21EOLACvtfcHk0lj9HiF1hzo3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGjurc%253D&md5=8d4f1f80c307f4e26f96f49cfe4841b4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouterfa%26aufirst%3DH.%2BL.%26aulast%3DSattelmeyer%26aufirst%3DV.%26aulast%3DCzub%26aufirst%3DS.%26aulast%3DVordermark%26aufirst%3DD.%26aulast%3DRoosen%26aufirst%3DK.%26aulast%3DTonn%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520Ras%2520farnesylation%2520by%2520lovastatin%2520leads%2520to%2520downregulation%2520of%2520proliferation%2520and%2520migration%2520in%2520primary%2520cultured%2520human%2520glioblastoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2000%26volume%3D20%26spage%3D2761%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Chan, D. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. C.</span><span> </span><span class="NLM_article-title">Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs11060-007-9475-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=17928957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=273-283&author=D.+Y.+L.+Chanauthor=G.+G.+Chenauthor=W.+S.+Poonauthor=P.+C.+Liu&title=Lovastatin+sensitized+human+glioblastoma+cells+to+TRAIL-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis</span></div><div class="casAuthors">Chan, David Y. L.; Chen, George G.; Poon, Wai S.; Liu, Pi C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-283</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synergy study with chemotherapeutic agents is a common in vitro strategy in the search for effective cancer therapy.  For non-chemotherapeutic agents, efficacious synergistic effects are uncommon.  Here, we have examd. two non-chemotherapeutic agents for synergistic effects: lovastatin and Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) for synergistic effects; on three human malignant glioblastoma cell lines, M059K, M59J, and A172.  Cells treated with lovastatin plus TRAIL for 48 h showed 50% apoptotic cell death, whereas TRAIL alone (1,000 ng/mL) did not, suggesting that lovastatin sensitized the glioblastoma cells to TRAIL attack.  Cell cycle anal. indicated that lovastatin increased G0-G1 arrest in these cells.  Annexin V study demonstrated that apoptosis was the predominant mode of cell death.  We conclude that the combination of lovastatin and TRAIL enhances apoptosis synergistically.  Moreover, lovastatin sensitized glioblastoma cells to TRAIL, suggesting a new strategy to treat glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdhZO34oWmsLVg90H21EOLACvtfcHk0li_vZxZagumbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVKrtr4%253D&md5=97904c857897914d2728183c34f92889</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11060-007-9475-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-007-9475-3%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BY.%2BL.%26aulast%3DChen%26aufirst%3DG.%2BG.%26aulast%3DPoon%26aufirst%3DW.%2BS.%26aulast%3DLiu%26aufirst%3DP.%2BC.%26atitle%3DLovastatin%2520sensitized%2520human%2520glioblastoma%2520cells%2520to%2520TRAIL-induced%2520apoptosis%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2008%26volume%3D86%26spage%3D273%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lytle, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashikubo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, K. M.</span><span> </span><span class="NLM_article-title">Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1111%2Fj.1471-4159.2004.02319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15030401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtValtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=168-178&author=Z.+Jiangauthor=X.+Zhengauthor=R.+A.+Lytleauthor=R.+Higashikuboauthor=K.+M.+Rich&title=Lovastatin-induced+up-regulation+of+the+BH3-only+protein%2C+Bim%2C+and+cell+death+in+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells</span></div><div class="casAuthors">Jiang, Zhihong; Zheng, Xiao; Lytle, Richard A.; Higashikubo, Ryuji; Rich, Keith M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-178</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mechanism of lovastatin-induced cell death was examd. in three established human glioblastoma cell lines; U87, U251, and U138.  Changes in potential modifiers of apoptosis, including Bcl-2 family proteins and MAP kinase targets after such lovastatin treatment, were evaluated.  Lovastatin (5 μM) treatment causes extensive cell death in two of the cell lines, U87 and U251; but only minimal in a third, U138.  Lovastatin-induced death occurs in correlation with significantly increased levels of the BH3-only protein, Bim.  The up-regulation of Bim levels was directly assocd. with an increased incidence of apoptosis.  Lovastatin treatment in U87 cells results in activation of targets of three major mitogen-activating protein kinase cascades including Erk1/2, JNK and p38.  Changes in levels of Bim, as well as increase phosphorylation of Erk1/2, c-jun, and p38 are all prevented by co-incubation of lovastatin and the isoprenylation metabolite, geranylgeranyl pyrophosphate.  Inhibition of the MAP kinase pathways failed to block the increased expression of Bim expression or cell death.  Further elucidation of the mechanisms of lovastatin-induced up-regulation of Bim and apoptosis in glioblastoma cells are important in detg. a potential role for lovastatin as a chemotherapy agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquABveZl4oebVg90H21EOLACvtfcHk0li_vZxZagumbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtValtrg%253D&md5=ede6f0786a97c8f1e9af1c2fac77faaf</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02319.x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLytle%26aufirst%3DR.%2BA.%26aulast%3DHigashikubo%26aufirst%3DR.%26aulast%3DRich%26aufirst%3DK.%2BM.%26atitle%3DLovastatin-induced%2520up-regulation%2520of%2520the%2520BH3-only%2520protein%252C%2520Bim%252C%2520and%2520cell%2520death%2520in%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D89%26spage%3D168%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groscurth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span> </span><span class="NLM_article-title">Lovastatin and phenylacetate induce apoptosis, but not differentiation in human malignant glioma cells</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=11307620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1ejs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=217-224&author=F.+Schmidtauthor=P.+Groscurthauthor=M.+Kermerauthor=J.+Dichgansauthor=M.+Weller&title=Lovastatin+and+phenylacetate+induce+apoptosis%2C+but+not+differentiation+in+human+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells</span></div><div class="casAuthors">Schmidt, Friederike; Groscurth, Peter; Kermer, Monika; Dichgans, Johannes; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-224</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Induction of differentiation is an attractive approach to the management of infiltrative tumors such as malignant glioma.  Here, we report that lovastatin and phenylacetate induce apoptosis, but fail to induce differentiation, in malignant glioma cell lines and untransformed rat astrocytes.  Lovastatin and phenylacetate promote p21 accumulation but fail to induce cell cycle arrest.  BCL-2 gene transfer inhibits apoptosis induced by lovastatin but not apoptosis induced by phenylacetate.  Wild-type p53 gene transfer promotes lovastatin-induced apoptosis in p53 wild-type LN-229 cells but not in p53 mutant T98G cells.  Phenylacetate-induced apoptosis is attenuated by wild-type p53 gene transfer in both cell lines.  Neither lovastatin nor phenylacetate modulate glioma cell sensitivity to CD95 ligand-induced apoptosis or cancer chemotherapy.  Thus, this study provides no rationale for clin. trials of lovastatin or phenylacetate in the differentiation therapy of malignant glioma.  We conclude that neoplastic glioma cells as well as untransformed rat astrocytes are refractory to the induction of differentiation by lovastatin and phenylacetate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqjgv3e7RILVg90H21EOLACvtfcHk0li_vZxZagumbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1ejs7o%253D&md5=402b54895a8238250b2d125bdf12755e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DGroscurth%26aufirst%3DP.%26aulast%3DKermer%26aufirst%3DM.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DLovastatin%2520and%2520phenylacetate%2520induce%2520apoptosis%252C%2520but%2520not%2520differentiation%2520in%2520human%2520malignant%2520glioma%2520cells%26jtitle%3DActa%2520Neuropathol.%26date%3D2001%26volume%3D101%26spage%3D217%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Tapia-Perez, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirches, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firsching, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span> </span><span class="NLM_article-title">Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs00280-010-1535-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=21120479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ggur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1193-1201&author=J.+H.+Tapia-Perezauthor=E.+Kirchesauthor=C.+Mawrinauthor=R.+Firschingauthor=T.+Schneider&title=Cytotoxic+effect+of+different+statins+and+thiazolidinediones+on+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells</span></div><div class="casAuthors">Tapia-Perez, Jorge Humberto; Kirches, Elmar; Mawrin, Christian; Firsching, Raimund; Schneider, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1193-1201</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma multiforme is still a tumor with very poor prognosis.  Statins are actually used for the treatment of dyslipidemias and thiazolidinediones for improving insulin sensitivity in diabetes.  Statins are inhibitors of the cholesterol pathway, while thiazolidinediones are peroxisomal proliferator activator receptor γ (PPAR) agonists.  For both, a potent pro-apoptotic activity has been suggested.  Methods: We compared the antiglioma effect of simvastatin, atorvastatin, lovastatin, pravastatin, rosuvastatin, rosiglitazone, pioglitazone and their combinations at several concns. on human glioblastoma cell lines U87, U 138, LN 405 and rat RG II.  The cytotoxic effect was assessed using a cell proliferation assay after 48 and 144 h.  Caspase 3 activity and the addn. of isoprenoids and PPAR-γ inhibitor GW9662 were assessed.  Expts. were as well conducted under hypoxia for 24 h.  Results: We demonstrated a significant cytotoxic effect with a combination of statins plus pioglitazone.  The effect was obsd. after 48 h and dramatically increased after 144 h.  The combination of 2 types of statins (synthetic and natural) allowed a fivefold dose redn.  Statin effect was reversed with isoprenoids and partially with PPAR-γ antagonists, while thiazolidinediones effect was slightly affected by PPAR-γ antagonists.  A marked increase in caspase 3 activity was achieved by combining atorvastatin with lovastatin.  Cytotoxicity of the combination of statins and thiazolidinediones did not decrease under hypoxia.  Conclusion: The assessed combination of statins with thiazolidinediones shows a synergistic cytotoxic effect against glioblastoma cells in vitro, which could represent a feasible therapeutic schema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprue_iYzZQA7Vg90H21EOLACvtfcHk0liVTBeM5b4dIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ggur4%253D&md5=62ff839d2e4a80f16cd54cdd9633d7ce</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1535-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1535-2%26sid%3Dliteratum%253Aachs%26aulast%3DTapia-Perez%26aufirst%3DJ.%2BH.%26aulast%3DKirches%26aufirst%3DE.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DFirsching%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DT.%26atitle%3DCytotoxic%2520effect%2520of%2520different%2520statins%2520and%2520thiazolidinediones%2520on%2520malignant%2520glioma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1193%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Larner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laws, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffrey, M.</span><span> </span><span class="NLM_article-title">A phase I–II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme</span> <span class="citation_source-journal">Am. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1097%2F00000421-199812000-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=9856659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADyaK1M%252Fnt1Ckuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=579-583&author=J.+Larnerauthor=J.+Janeauthor=E.+Lawsauthor=R.+Packerauthor=C.+Myersauthor=M.+Shaffrey&title=A+phase+I%E2%80%93II+trial+of+lovastatin+for+anaplastic+astrocytoma+and+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme</span></div><div class="casAuthors">Larner J; Jane J; Laws E; Packer R; Myers C; Shaffrey M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-83</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">Malignant gliomas are thought to be highly dependent on the mevalonate pathway for cell growth.  Lovastatin, a cholesterol-lowering drug, inhibits not only the rate-limiting step in the mevalonate pathway (hepatic hydroxymethyl glutaryl coenzyme A reductase), but also the prenylation of several key regulatory proteins including ras and the small guanosine triphosphate binding proteins.  Therefore, from August 1994 through March 1996, 18 patients with either anaplastic glioma or glioblastoma multiforme were entered into a trial testing the safety of high-dose lovastatin with or without radiation.  Although the response data is too premature to evaluate activity, the fact that high doses of lovastatin are well tolerated with concurrent radiation suggests that central nervous system toxicity will not be a significant limiting toxicity as more selective farnesyltransferase inhibitors are brought into the clinic as radiation sensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHlAOaaBCqzHthwrmtH4OBfW6udTcc2eaKDGZ7Q6ALLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252Fnt1Ckuw%253D%253D&md5=e3e4d0a66e1b0df4cf46b575ac32fc63</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1097%2F00000421-199812000-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-199812000-00010%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DJ.%26aulast%3DJane%26aufirst%3DJ.%26aulast%3DLaws%26aufirst%3DE.%26aulast%3DPacker%26aufirst%3DR.%26aulast%3DMyers%26aufirst%3DC.%26aulast%3DShaffrey%26aufirst%3DM.%26atitle%3DA%2520phase%2520I%25E2%2580%2593II%2520trial%2520of%2520lovastatin%2520for%2520anaplastic%2520astrocytoma%2520and%2520glioblastoma%2520multiforme%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1998%26volume%3D21%26spage%3D579%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum-Kaelin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Endothelin-converting-enzyme-1 inhibition and growth of human glioblastoma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040857x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=483-498&author=Y.+Bergerauthor=H.+Dehmlowauthor=D.+Blum-Kaelinauthor=E.+A.+Kitasauthor=B.+M.+L%C3%B6fflerauthor=J.+D.+Aebiauthor=L.+Juillerat-Jeanneret&title=Endothelin-converting-enzyme-1+inhibition+and+growth+of+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm040857x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040857x%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DKitas%26aufirst%3DE.%2BA.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.%2BM.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DEndothelin-converting-enzyme-1%2520inhibition%2520and%2520growth%2520of%2520human%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D483%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">David W. Christianson</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Chemical Biology of Terpenoid Cyclases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (17)
                                     , 11570-11648. <a href="https://doi.org/10.1021/acs.chemrev.7b00287" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00287%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DStructural%252Band%252BChemical%252BBiology%252Bof%252BTerpenoid%252BCyclases%26aulast%3DChristianson%26aufirst%3DDavid%2BW.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20052017%26date%3D25082017%26volume%3D117%26issue%3D17%26spage%3D11570%26epage%3D11648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanhao  Chen</span>, <span class="hlFld-ContribAuthor ">Jingwei  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiabo  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, and <span class="hlFld-ContribAuthor ">Ruibo  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Concerted Cyclization of Lanosterol C-Ring and D-Ring Under Human Oxidosqualene Cyclase Catalysis: An ab Initio QM/MM MD Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2014,</strong> <em>10 </em>
                                    (3)
                                     , 1109-1120. <a href="https://doi.org/10.1021/ct400949b" title="DOI URL">https://doi.org/10.1021/ct400949b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ct400949b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fct400949b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DConcerted%252BCyclization%252Bof%252BLanosterol%252BC-Ring%252Band%252BD-Ring%252BUnder%252BHuman%252BOxidosqualene%252BCyclase%252BCatalysis%25253A%252BAn%252Bab%252BInitio%252BQM%25252FMM%252BMD%252BStudy%26aulast%3DChen%26aufirst%3DNanhao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D30102013%26date%3D05022014%26date%3D11032014%26date%3D24012014%26volume%3D10%26issue%3D3%26spage%3D1109%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabella  Giacomini</span>, <span class="hlFld-ContribAuthor ">Federico  Gianfanti</span>, <span class="hlFld-ContribAuthor ">Maria Andrea  Desbats</span>, <span class="hlFld-ContribAuthor ">Genny  Orso</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Berretta</span>, <span class="hlFld-ContribAuthor ">Tommaso  Prayer-Galetti</span>, <span class="hlFld-ContribAuthor ">Eugenio  Ragazzi</span>, <span class="hlFld-ContribAuthor ">Veronica  Cocetta</span>. </span><span class="cited-content_cbyCitation_article-title">Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.682911" title="DOI URL">https://doi.org/10.3389/fonc.2021.682911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.682911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.682911%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DCholesterol%252BMetabolic%252BReprogramming%252Bin%252BCancer%252Band%252BIts%252BPharmacological%252BModulation%252Bas%252BTherapeutic%252BStrategy%26aulast%3DGiacomini%26aufirst%3DIsabella%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Madan</span>, <span class="hlFld-ContribAuthor ">David M.  Virshup</span>, <span class="hlFld-ContribAuthor ">W. David  Nes</span>, <span class="hlFld-ContribAuthor ">David J.  Leaver</span>. </span><span class="cited-content_cbyCitation_article-title">Unearthing the Janus-face cholesterogenesis pathways in cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>36 </em>, 114611. <a href="https://doi.org/10.1016/j.bcp.2021.114611" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114611%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DUnearthing%252Bthe%252BJanus-face%252Bcholesterogenesis%252Bpathways%252Bin%252Bcancer%26aulast%3DMadan%26aufirst%3DBabita%26date%3D2021%26volume%3D36%26spage%3D114611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donata  Pluskota-Karwatka</span>, <span class="hlFld-ContribAuthor ">Marcin  Hoffmann</span>. </span><span class="cited-content_cbyCitation_article-title">Computational studies on statins photoactivity. </span><span class="cited-content_cbyCitation_journal-name">Physical Sciences Reviews</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/psr-2020-0033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fpsr-2020-0033%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Sciences%2520Reviews%26atitle%3DComputational%252Bstudies%252Bon%252Bstatins%252Bphotoactivity%26aulast%3DPluskota-Karwatka%26aufirst%3DDonata%26date%3D2020%26date%3D2021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke R  Gudde</span>, <span class="hlFld-ContribAuthor ">Martin  Hulce</span>, <span class="hlFld-ContribAuthor ">Alexander H  Largen</span>, <span class="hlFld-ContribAuthor ">Josef D  Franke</span>. </span><span class="cited-content_cbyCitation_article-title">Sterol synthesis is essential for viability in the planctomycete bacterium
              Gemmata obscuriglobus. </span><span class="cited-content_cbyCitation_journal-name">FEMS Microbiology Letters</span><span> <strong>2019,</strong> <em>366 </em>
                                    (3)
                                     <a href="https://doi.org/10.1093/femsle/fnz019" title="DOI URL">https://doi.org/10.1093/femsle/fnz019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/femsle/fnz019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ffemsle%2Ffnz019%26sid%3Dliteratum%253Aachs%26jtitle%3DFEMS%2520Microbiology%2520Letters%26atitle%3DSterol%252Bsynthesis%252Bis%252Bessential%252Bfor%252Bviability%252Bin%252Bthe%252Bplanctomycete%252Bbacterium%252BGemmata%252Bobscuriglobus%26aulast%3DGudde%26aufirst%3DLuke%2BR%26date%3D2019%26date%3D2019%26volume%3D366%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Palko-Łabuz</span>, <span class="hlFld-ContribAuthor ">Kamila  Środa-Pomianek</span>, <span class="hlFld-ContribAuthor ">Olga  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Edyta  Kostrzewa-Susłow</span>, <span class="hlFld-ContribAuthor ">Anna  Uryga</span>, <span class="hlFld-ContribAuthor ">Krystyna  Michalak</span>. </span><span class="cited-content_cbyCitation_article-title">MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>109 </em>, 1511-1522. <a href="https://doi.org/10.1016/j.biopha.2018.10.169" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.10.169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.10.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.10.169%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DMDR%252Breversal%252Band%252Bpro-apoptotic%252Beffects%252Bof%252Bstatins%252Band%252Bstatins%252Bcombined%252Bwith%252Bflavonoids%252Bin%252Bcolon%252Bcancer%252Bcells%26aulast%3DPalko-%25C5%2581abuz%26aufirst%3DAnna%26date%3D2019%26volume%3D109%26spage%3D1511%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyin  Chen</span>, <span class="hlFld-ContribAuthor ">Fengguo  Xu</span>, <span class="hlFld-ContribAuthor ">Pu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Deng</span>, <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Synthesis of α-Amyrin, β-Amyrin, and Lupeol: The Potential Natural Inhibitors of Human Oxidosqualene Cyclase. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (12)
                                     , 1700178. <a href="https://doi.org/10.1002/ardp.201700178" title="DOI URL">https://doi.org/10.1002/ardp.201700178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700178%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DPractical%252BSynthesis%252Bof%252B%2525CE%2525B1-Amyrin%25252C%252B%2525CE%2525B2-Amyrin%25252C%252Band%252BLupeol%25253A%252BThe%252BPotential%252BNatural%252BInhibitors%252Bof%252BHuman%252BOxidosqualene%252BCyclase%26aulast%3DChen%26aufirst%3DDongyin%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D12%26spage%3D1700178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Keller</span>, <span class="hlFld-ContribAuthor ">Annette  Wolfgardt</span>, <span class="hlFld-ContribAuthor ">Christoph  Müller</span>, <span class="hlFld-ContribAuthor ">Rainer  Wilcken</span>, <span class="hlFld-ContribAuthor ">Frank M.  Böckler</span>, <span class="hlFld-ContribAuthor ">Simonetta  Oliaro-Bosso</span>, <span class="hlFld-ContribAuthor ">Terenzio  Ferrante</span>, <span class="hlFld-ContribAuthor ">Gianni  Balliano</span>, <span class="hlFld-ContribAuthor ">Franz  Bracher</span>. </span><span class="cited-content_cbyCitation_article-title">Arylpiperidines as a new class of oxidosqualene cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 13-22. <a href="https://doi.org/10.1016/j.ejmech.2015.12.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DArylpiperidines%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Boxidosqualene%252Bcyclase%252Binhibitors%26aulast%3DKeller%26aufirst%3DMarco%26date%3D2016%26volume%3D109%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte  Kürten</span>, <span class="hlFld-ContribAuthor ">Mathias  Uhlén</span>, <span class="hlFld-ContribAuthor ">Per-Olof  Syrén</span>. </span><span class="cited-content_cbyCitation_article-title">Overexpression of functional human oxidosqualene cyclase in Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2015,</strong> <em>115 </em>, 46-53. <a href="https://doi.org/10.1016/j.pep.2015.04.015" title="DOI URL">https://doi.org/10.1016/j.pep.2015.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2015.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2015.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DOverexpression%252Bof%252Bfunctional%252Bhuman%252Boxidosqualene%252Bcyclase%252Bin%252BEscherichia%252Bcoli%26aulast%3DK%25C3%25BCrten%26aufirst%3DCharlotte%26date%3D2015%26volume%3D115%26spage%3D46%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Maione</span>, <span class="hlFld-ContribAuthor ">Simonetta  Oliaro-Bosso</span>, <span class="hlFld-ContribAuthor ">Claudia  Meda</span>, <span class="hlFld-ContribAuthor ">Federica  Di Nicolantonio</span>, <span class="hlFld-ContribAuthor ">Federico  Bussolino</span>, <span class="hlFld-ContribAuthor ">Gianni  Balliano</span>, <span class="hlFld-ContribAuthor ">Franca  Viola</span>, <span class="hlFld-ContribAuthor ">Enrico  Giraudo</span>. </span><span class="cited-content_cbyCitation_article-title">The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep09054" title="DOI URL">https://doi.org/10.1038/srep09054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep09054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep09054%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252Bcholesterol%252Bbiosynthesis%252Benzyme%252Boxidosqualene%252Bcyclase%252Bis%252Ba%252Bnew%252Btarget%252Bto%252Bimpair%252Btumour%252Bangiogenesis%252Band%252Bmetastasis%252Bdissemination%26aulast%3DMaione%26aufirst%3DFederica%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanhao  Chen</span>, <span class="hlFld-ContribAuthor ">Shenglong  Wang</span>, <span class="hlFld-ContribAuthor ">Lidia  Smentek</span>, <span class="hlFld-ContribAuthor ">B. Andes  Hess</span>, <span class="hlFld-ContribAuthor ">Ruibo  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Biosynthetic Mechanism of Lanosterol: Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (30)
                                     , 8817-8820. <a href="https://doi.org/10.1002/ange.201501986" title="DOI URL">https://doi.org/10.1002/ange.201501986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201501986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201501986%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DBiosynthetic%252BMechanism%252Bof%252BLanosterol%25253A%252BCyclization%26aulast%3DChen%26aufirst%3DNanhao%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D30%26spage%3D8817%26epage%3D8820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanhao  Chen</span>, <span class="hlFld-ContribAuthor ">Shenglong  Wang</span>, <span class="hlFld-ContribAuthor ">Lidia  Smentek</span>, <span class="hlFld-ContribAuthor ">B. Andes  Hess</span>, <span class="hlFld-ContribAuthor ">Ruibo  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Biosynthetic Mechanism of Lanosterol: Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (30)
                                     , 8693-8696. <a href="https://doi.org/10.1002/anie.201501986" title="DOI URL">https://doi.org/10.1002/anie.201501986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201501986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201501986%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DBiosynthetic%252BMechanism%252Bof%252BLanosterol%25253A%252BCyclization%26aulast%3DChen%26aufirst%3DNanhao%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D30%26spage%3D8693%26epage%3D8696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dipanwita  Roy</span>, <span class="hlFld-ContribAuthor ">Satinath  Sarkar</span>, <span class="hlFld-ContribAuthor ">Radha M.  Laha</span>, <span class="hlFld-ContribAuthor ">Nabyendu  Pramanik</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Maiti</span>. </span><span class="cited-content_cbyCitation_article-title">Ni(0)–Cu(
              i
              ): a powerful combo catalyst for simultaneous coupling and cleavage of the C–N bond with cyclization to valuable amide-based pyrroles and 4-pyridones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (90)
                                     , 73346-73351. <a href="https://doi.org/10.1039/C5RA12115A" title="DOI URL">https://doi.org/10.1039/C5RA12115A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA12115A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA12115A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNi%2525280%252529%2525E2%252580%252593Cu%252528%252Bi%252B%252529%25253A%252Ba%252Bpowerful%252Bcombo%252Bcatalyst%252Bfor%252Bsimultaneous%252Bcoupling%252Band%252Bcleavage%252Bof%252Bthe%252BC%2525E2%252580%252593N%252Bbond%252Bwith%252Bcyclization%252Bto%252Bvaluable%252Bamide-based%252Bpyrroles%252Band%252B4-pyridones%26aulast%3DRoy%26aufirst%3DDipanwita%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D90%26spage%3D73346%26epage%3D73351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yayun  Liang</span>, <span class="hlFld-ContribAuthor ">Cynthia  Besch-Williford</span>, <span class="hlFld-ContribAuthor ">Johannes D.  Aebi</span>, <span class="hlFld-ContribAuthor ">Benford  Mafuvadze</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Cook</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Zou</span>, <span class="hlFld-ContribAuthor ">Salman M.  Hyder</span>. </span><span class="cited-content_cbyCitation_article-title">Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2014,</strong> <em>146 </em>
                                    (1)
                                     , 51-62. <a href="https://doi.org/10.1007/s10549-014-2996-5" title="DOI URL">https://doi.org/10.1007/s10549-014-2996-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-014-2996-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-014-2996-5%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DCholesterol%252Bbiosynthesis%252Binhibitors%252Bas%252Bpotent%252Bnovel%252Banti-cancer%252Bagents%25253A%252Bsuppression%252Bof%252Bhormone-dependent%252Bbreast%252Bcancer%252Bby%252Bthe%252Boxidosqualene%252Bcyclase%252Binhibitor%252BRO%252B48-8071%26aulast%3DLiang%26aufirst%3DYayun%26date%3D2014%26date%3D2014%26volume%3D146%26issue%3D1%26spage%3D51%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jen-Chieh  Chuang</span>, <span class="hlFld-ContribAuthor ">Mark A.  Valasek</span>, <span class="hlFld-ContribAuthor ">Adam M.  Lopez</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Posey</span>, <span class="hlFld-ContribAuthor ">Joyce J.  Repa</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Turley</span>. </span><span class="cited-content_cbyCitation_article-title">Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>88 </em>
                                    (3)
                                     , 351-363. <a href="https://doi.org/10.1016/j.bcp.2014.01.031" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.01.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.01.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DSustained%252Band%252Bselective%252Bsuppression%252Bof%252Bintestinal%252Bcholesterol%252Bsynthesis%252Bby%252BRo%252B48-8071%25252C%252Ban%252Binhibitor%252Bof%252B2%25252C3-oxidosqualene%25253Alanosterol%252Bcyclase%25252C%252Bin%252Bthe%252BBALB%25252Fc%252Bmouse%26aulast%3DChuang%26aufirst%3DJen-Chieh%26date%3D2014%26volume%3D88%26issue%3D3%26spage%3D351%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martijn  Risseeuw</span>, <span class="hlFld-ContribAuthor ">Mark  Overhand</span>, <span class="hlFld-ContribAuthor ">George W. J.  Fleet</span>, <span class="hlFld-ContribAuthor ">Michela I.  Simone</span>. </span><span class="cited-content_cbyCitation_article-title">A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2013,</strong> <em>45 </em>
                                    (4)
                                     , 613-689. <a href="https://doi.org/10.1007/s00726-013-1521-1" title="DOI URL">https://doi.org/10.1007/s00726-013-1521-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-013-1521-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-013-1521-1%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DA%252Bcompendium%252Bof%252Bcyclic%252Bsugar%252Bamino%252Bacids%252Band%252Btheir%252Bcarbocyclic%252Band%252Bheterocyclic%252Bnitrogen%252Banalogues%26aulast%3DRisseeuw%26aufirst%3DMartijn%26date%3D2013%26date%3D2013%26volume%3D45%26issue%3D4%26spage%3D613%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Lange</span>, <span class="hlFld-ContribAuthor ">Marco  Keller</span>, <span class="hlFld-ContribAuthor ">Christoph  Müller</span>, <span class="hlFld-ContribAuthor ">Simonetta  Oliaro-Bosso</span>, <span class="hlFld-ContribAuthor ">Gianni  Balliano</span>, <span class="hlFld-ContribAuthor ">Franz  Bracher</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>63 </em>, 758-764. <a href="https://doi.org/10.1016/j.ejmech.2013.03.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAminopropylindenes%252Bderived%252Bfrom%252BGrundmann%252527s%252Bketone%252Bas%252Ba%252Bnovel%252Bchemotype%252Bof%252Boxidosqualene%252Bcyclase%252Binhibitors%26aulast%3DLange%26aufirst%3DStefanie%26date%3D2013%26volume%3D63%26spage%3D758%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. S. Hari Narayana  Moorthy</span>, <span class="hlFld-ContribAuthor ">Nuno M. F. S. A.  Cerqueira</span>, <span class="hlFld-ContribAuthor ">Maria J.  Ramos</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">Combined ligand and structure based binding mode analysis of oxidosqualene cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (45)
                                     , 23409. <a href="https://doi.org/10.1039/c3ra43670e" title="DOI URL">https://doi.org/10.1039/c3ra43670e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra43670e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra43670e%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCombined%252Bligand%252Band%252Bstructure%252Bbased%252Bbinding%252Bmode%252Banalysis%252Bof%252Boxidosqualene%252Bcyclase%252Binhibitors%26aulast%3DMoorthy%26aufirst%3DN.%2BS.%2BHari%2BNarayana%26date%3D2013%26volume%3D3%26issue%3D45%26spage%3D23409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Alkyne OSCi Compounds <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOMeNH·HCl, HOBT, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (b) NaH (55% in oil), MeI, DMF, 0 °C to rt, 84%; (c) LAH, THF, 0–15 °C, quantitative; (d) Ph<sub>3</sub>P, CBr<sub>4</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 62%; (e) (1) <i>n</i>-BuLi, THF, −78 °C; (2) DMPU; (3) 2-(2-bromoethoxy)tetrahydro-2<i>H</i>-pyran, THF, −78 °C to rt, 40%; (f) PPTs, MeOH, 55 °C, 77%; (g) MeSO<sub>2</sub>Cl, pyridine, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, quantitative; (i) 4-ClPhOCOCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (k) (1) ethyl-(2-hydroxyethyl)amine, MeOH, 65 °C; (2) HCl in dioxane, 59%; (l) (1) <i>N-</i>methylpropylamine, NaI, MeOH, 60 °C; (2) fumaric acid, EtOAc, EtOH, 76%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Methylethylcyclohexyl OSCi <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PtO<sub>2</sub>, H<sub>2</sub> (1 atm), EtOH/9% CHCl<sub>3</sub>, 97%; (b) (1) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (2) Ac<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (3) MeI, NaH (55% in oil), DMF, 0 °C to rt, 68%, three steps; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 86%; (d) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, quantitative; (e) 4 M HCl in dioxane, rt, 92%; (f) (1) 4-trifluoromethylphenol, 1,1′-carbonyldiimidazol, CH<sub>2</sub>Cl<sub>2</sub>, rt; (2) (CH<sub>3</sub>)<sub>2</sub>SO<sub>4</sub>, Hünig's base, CH<sub>3</sub>CN, 80 °C; (3) <b>20</b>, Hünig's base, CH<sub>3</sub>CN, rt, 89%; (g) (1) ethyl-(2-hydroxyethyl)amine, DMA, 60 °C; (2) citric acid monohydrate, EtOAc, <i>i</i>-PrOH, <i>n</i>-pentane, 62%.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Amide OSCi <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaIO<sub>4</sub>, RuCl<sub>3</sub>.H<sub>2</sub>O, CH<sub>3</sub>CN, CCl<sub>4</sub>, H<sub>2</sub>O, rt, 96%; (b) 4 M HCl in dioxane, rt, quantitative; (c) (1) HMDS, 145 °C; (2) 4-ClPhOCOCl, <i>i</i>-Pr<sub>2</sub>EtN, THF, 0 °C to rt, 57%; (d) (1) (COCl)<sub>2</sub>/DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (2) 4-hydroxypiperidine, CH<sub>2</sub>Cl<sub>2</sub>, 97%.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cytotoxic effects of a 72 h exposure of human glioblastoma and brain-derived endothelial cells to OSCi compounds <b>1</b>–<b>6</b>. Human LN18, LN229, and HCEC cells were exposed to increasing concentrations of compounds <b>1</b>–<b>6</b> for 72 h. Then the MTT assay was performed and IC<sub>50</sub> values were calculated. Results are the mean ± sd of triplicates of two independent experiments. IC<sub>50</sub> values are the mean (sd not shown, ≤10% of the values of the means) of triplicates of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cytotoxic effects of a 72 h exposure of human glioblastoma and brain-derived endothelial cells to OSCi compounds <b>7</b>–<b>10</b> and AT. Human LN18, LN229, and HCEC cells were exposed to increasing concentrations of compounds <b>7</b>–<b>10</b> and AT for 72 h. Then the MTT assay was performed and IC<sub>50</sub> values were calculated. Results are the mean ± sd of triplicates of two independent experiments. IC<sub>50</sub> values are the mean (sd not shown, ≤10% of the values of the means) of triplicates of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DNA synthesis in glioblastoma and endothelial cells exposed to OSCi or AT. Human LN18, LN229, and HCEC cells were exposed for 24 h to increasing concentrations of OSCi compounds <b>2</b>–<b>4</b> and AT. Then [<sup>3</sup>H]T incorporation was performed to evaluate DNA synthesis. Results are the mean of triplicates (sd not shown, <10% of the values of the means): ◇, <b>2</b>; □, <b>3</b>; ▲, <b>4</b>; △, AT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cytotoxic effects of a 72 h cell exposure to <b>2</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>2</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxic effects of a 72 h cell exposure to <b>3</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>3</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cytotoxic effects of a 72 h cell exposure to <b>4</b>–AT combination. Human LN18 (A), LN229 (B), and HCEC (C) cells were treated with 2, 4, and 10 μM OSCi <b>4</b> in combination with 2.5, 5, and 10 μM AT for 72 h. Then the MTT assay was performed. Results are the mean ± sd of triplicates of two independent experiments. Treated cells were compared to untreated cells using the Student’s <i>t</i>-test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High molecular weight and acid-insoluble lipid synthesis in glioblastoma cells exposed to OSCi and AT. Human LN18 or LN229 cells were exposed for 24 h to increasing concentrations of AT or to 2 μM OSCi <b>2</b> or <b>3</b> in combination with increasing concentration of AT. Then <sup>14</sup>C-acetate incorporation was performed to evaluate high molecular weight lipid synthesis. Results are the mean of triplicates. Treatments were compared using the Student’s <i>t</i>-test: ∗, treated cells vs untreated cells; ○, AT–OSCi combination vs OSCi alone; ∗ and ○, <i>p</i> < 0.05; ∗∗ and ○○, <i>p</i> < 0.01; ∗∗∗ and ○○○, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/medium/jm-2012-00256z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Correlation between log <i>D</i> and IC<sub>50</sub>. (A) Correlation of the selectivity ratio IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN229) with log <i>D</i> at pH 7.4. Black line represents the regression line (<i>r</i><sup>2</sup> = 0.91; IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LNZ229) = (4.23 ± 0.17) – (log <i>D</i>)(1.33 ± 0.15), and dotted lines represent the 95% confidence interval. Cross-validation coefficient (leave-one-out method) is <i>q</i><sup>2</sup> = 0.88. (B) Correlation of the selectivity ratio IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LN18) with log <i>D</i> at pH 7.4. Black line represents the regression line (<i>r</i><sup>2</sup> = 0.69; IC<sub>50</sub>(HCEC)/IC<sub>50</sub>(LNZ229) = (4.13 ± 0.32) – (log <i>D</i>)(0.87 ± 0.21), and dotted lines represent the 95% confidence interval. Cross-validation coefficient (leave-one-out method) is <i>q</i><sup>2</sup> = 0.66.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300256z/production/images/large/jm-2012-00256z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300256z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Maxfield, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabas, I.</span><span> </span><span class="NLM_article-title">Role of cholesterol and lipid organization in disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1038%2Fnature04399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16319881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gqs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=612-621&author=F.+R.+Maxfieldauthor=I.+Tabas&title=Role+of+cholesterol+and+lipid+organization+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cholesterol and lipid organization in disease</span></div><div class="casAuthors">Maxfield, Frederick R.; Tabas, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7068</span>),
    <span class="NLM_cas:pages">612-621</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane lipids are essential for biol. functions ranging from membrane trafficking to signal transduction.  The compn. of lipid membranes influences their organization and properties, so it is not surprising that disorders in lipid metab. and transport have a role in human disease.  Significant recent progress has enhanced our understanding of the mol. and cellular basis of lipid-assocd. disorders such as Tangier disease, Niemann-Pick disease type C and atherosclerosis.  These insights have also led to improved understanding of normal physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfcdtj-eo57bVg90H21EOLACvtfcHk0ljXCwCHGBbQeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gqs73I&md5=ab2a1625086f45017125462ae9736e19</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature04399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04399%26sid%3Dliteratum%253Aachs%26aulast%3DMaxfield%26aufirst%3DF.%2BR.%26aulast%3DTabas%26aufirst%3DI.%26atitle%3DRole%2520of%2520cholesterol%2520and%2520lipid%2520organization%2520in%2520disease%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D612%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenmark, H.</span><span> </span><span class="NLM_article-title">Membranes and organelles</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.ceb.2008.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=18588977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslOnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=357-359&author=G.+Raposoauthor=H.+Stenmark&title=Membranes+and+organelles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Membranes and organelles</span></div><div class="casAuthors">Raposo, Graca; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-359</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKm4ZJ1nPOfbVg90H21EOLACvtfcHk0ljXCwCHGBbQeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslOnt7g%253D&md5=87135619636900cb37d28147aa88933b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2008.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2008.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3DMembranes%2520and%2520organelles%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2008%26volume%3D20%26spage%3D357%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nissen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenhagen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasiela, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magorien, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganz, P.</span><span> </span><span class="NLM_article-title">Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1056%2FNEJMoa042000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15635110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=29-38&author=S.+E.+Nissenauthor=E.+M.+Tuzcuauthor=P.+Schoenhagenauthor=T.+Croweauthor=W.+J.+Sasielaauthor=J.+Tsaiauthor=J.+Orazemauthor=R.+D.+Magorienauthor=C.+O%E2%80%99Shaughnessyauthor=P.+Ganz&title=Statin+therapy%2C+LDL+cholesterol%2C+C-reactive+protein%2C+and+coronary+artery+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease</span></div><div class="casAuthors">Nissen, Steven E.; Tuzcu, E. Murat; Schoenhagen, Paul; Crowe, Tim; Sasiela, William J.; Tsai, John; Orazem, John; Magorien, Raymond D.; O'Shaughnessy, Charles; Ganz, Peter; Kutcher, M.; Burchenal, J.; Bailey, S.; Fischell, T.; Kerensky, R.; Iaffaldano, R.; Lopez, J.; Grines, C.; DeMariz, A.; Tobis, J.; Brodie, B.; Linker, D.; Forrester, J.; Smith, S.; Weiss, R.; Cooper, C.; Sharaf, B.; Miller, M.; Corbelli, J.; Kleaveland, J.; Garza, L.; Leesar, M.; DeLago, A.; Wickliffe, C.; Kuvin, J.; Kramer, P.; Gordon, P.; Sharma, S.; Leimbach, W.; Cleary, R., Jr.; Nair, R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Recent trials have demonstrated better outcomes with intensive than with moderate statin treatment.  Intensive treatment produced greater redns. in both low-d. lipoprotein (LDL) cholesterol and C-reactive protein (CRP), suggesting a relationship between these two biomarkers and disease progression.  We performed intravascular ultrasonog. in 502 patients with angiog. documented coronary disease.  Patients were randomly assigned to receive moderate treatment (40 mg of pravastatin orally per day) or intensive treatment (80 mg of atorvastatin orally per day).  Ultrasonog. was repeated after 18 mo to measure the progression of atherosclerosis.  Lipoprotein and CKP levels were measured at baseline and follow-up.  In the group as a whole, the mean LDL cholesterol level was reduced from 150.2 mg per dL (3.88 mmol per L) at baseline to 94.5 mg per dL (2.44 mmol per L) at 18 mo (P<0.001), and the geometric mean CRP level decreased from 2.9 to 2.3 mg per L (P<0.001). The correlation between the redn. in LDL cholesterol levels and that in CRP levels was weak but significant in the group as a whole (r=0.13, P=0.005), but not in either treatment group alone.  In univariate analyses, the percent change in the levels ofLDL cholesterol, CRP, apolipoprotein B-100, and non-high-d. lipoprotein cholesterol were related to the rate of progression of atherosclerosis.  After adjustment for the redn. in these lipid levels, the decrease in CRP levels was independently and significantly correlated with the rate of progression.  Patients with redns. in both LDL cholesterol and CRP that were greater than the median had significantly slower rates of progression than patients with redns. in both biomarkers that were less than the median (P=0.001).  For patients with coronary artery disease, the reduced rate of progression of atherosclerosis assocd. with intensive statin treatment, as compared with moderate statin treatment, is significantly related to greater redns. in the levels of both atherogenic lipoproteins and CRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4p1Tb_60barVg90H21EOLACvtfcHk0ljXCwCHGBbQeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis12msQ%253D%253D&md5=9e6a1ab9d76bb115d5ecc5ce6d25f952</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa042000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa042000%26sid%3Dliteratum%253Aachs%26aulast%3DNissen%26aufirst%3DS.%2BE.%26aulast%3DTuzcu%26aufirst%3DE.%2BM.%26aulast%3DSchoenhagen%26aufirst%3DP.%26aulast%3DCrowe%26aufirst%3DT.%26aulast%3DSasiela%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DOrazem%26aufirst%3DJ.%26aulast%3DMagorien%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DC.%26aulast%3DGanz%26aufirst%3DP.%26atitle%3DStatin%2520therapy%252C%2520LDL%2520cholesterol%252C%2520C-reactive%2520protein%252C%2520and%2520coronary%2520artery%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mills, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachlis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereaux, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, D.</span><span> </span><span class="NLM_article-title">Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1769</span><span class="NLM_x">–</span> <span class="NLM_lpage">1781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.jacc.2008.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19022156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWht7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1769-1781&author=E.+J.+Millsauthor=B.+Rachlisauthor=P.+Wuauthor=P.+J.+Devereauxauthor=P.+Aroraauthor=D.+Perri&title=Primary+prevention+of+cardiovascular+mortality+and+events+with+statin+treatments%3A+a+network+meta-analysis+involving+more+than+65%2C000+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments</span></div><div class="casAuthors">Mills, Edward J.; Rachlis, Beth; Wu, Ping; Devereaux, Philip J.; Arora, Paul; Perri, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1769-1781</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: This study aimed to evaluate the effectiveness of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins) in primary prevention of cardiovascular events.  Background: The role of statins is well established for secondary prevention of cardiovascular disease (CVD) clin. events and mortality.  Little is known of their role in primary cardiovascular event prevention.  Methods: We conducted comprehensive searches of 10 electronic databases from inception to May 2008.  We contacted study investigators and maintained a comprehensive bibliog. of statin studies.  We included randomized trials of at least 12-mo duration in predominantly primary prevention populations.  Two reviewers independently extd. data in duplicate.  We performed random-effects meta-anal. and meta-regression, calcd. optimal information size, and conducted a mixed-treatment comparison anal.  Results: We included 20 randomized clin. trials.  We pooled 19 trials (n = 63,899) for all-cause mortality and found a relative risk (RR) of 0.93 (95% confidence interval [CI]: 0.87 to 0.99, p = 0.03 [I2 = 5%, 95% CI: 0% to 51%]).  Eighteen trials (n = 59,469) assessed cardiovascular deaths (RR: 0.89, 95% CI: 0.81 to 0.98, p = 0.01 [I2 = 0%, 95% CI: 0% to 41%]).  Seventeen trials (n = 53,371) found an RR of 0.85 (95% CI: 0.77 to 0.95, p = 0.004 [I2 = 61%, 95% CI: 38% to 77%]) for major cardiovascular events, and 17 trials (n = 52,976) assessed myocardial infarctions (RR: 0.77, 95% CI: 0.63 to 0.95, p = 0.01 [I2 = 59%, 95% CI: 24% to 74%]).  Incidence of cancer was not elevated in 10 trials (n = 45,469) (RR: 1.02, 95% CI: 0.94 to 1.11, p = 0.59 [I2 = 0%, 95% CI: 0% to 46%]), nor was rhabdomyolysis (RR: 0.97, 95% CI: 0.25 to 3.83, p = 0.96 [I2 = 0%, 95% CI: 0% to 40%]).  Our anal. included a sufficient sample to reliably answer our primary outcome of CVD mortality.  Conclusions: Statins have a clear role in primary prevention of CVD mortality and major events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSsTjHI6LyOLVg90H21EOLACvtfcHk0lhVyRu_WVWe-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWht7jE&md5=01c76a061b4ff1ea122f82510beb1de1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%2BJ.%26aulast%3DRachlis%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DDevereaux%26aufirst%3DP.%2BJ.%26aulast%3DArora%26aufirst%3DP.%26aulast%3DPerri%26aufirst%3DD.%26atitle%3DPrimary%2520prevention%2520of%2520cardiovascular%2520mortality%2520and%2520events%2520with%2520statin%2520treatments%253A%2520a%2520network%2520meta-analysis%2520involving%2520more%2520than%252065%252C000%2520patients%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D1769%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Demierre, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, S. M.</span><span> </span><span class="NLM_article-title">Statins and cancer prevention</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1038%2Fnrc1751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16341084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=930-942&author=M.+F.+Demierreauthor=P.+D.+Higginsauthor=S.+B.+Gruberauthor=E.+Hawkauthor=S.+M.+Lippman&title=Statins+and+cancer+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Statins and cancer prevention</span></div><div class="casAuthors">Demierre, Marie-France; Higgins, Peter D. R.; Gruber, Stephen B.; Hawk, Ernest; Lippman, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">930-942</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Randomized controlled trials for preventing cardiovascular disease indicated that statins had provocative and unexpected benefits for reducing colorectal cancer and melanoma.  These findings have led to the intensive study of statins in cancer prevention, including recent, large population-based studies showing statin-assocd. redns. in overall, colorectal and prostate cancer.  Understanding the complex cellular effects (for example, on angiogenesis and inflammation) and the underlying mol. mechanisms of statins (for example, 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase-dependent processes that involve geranylgeranylation of Rho proteins, and HMG-CoA-independent processes that involve lymphocyte-function-assocd. antigen 1) will advance the development of molecularly targeted agents for preventing cancer.  This understanding might also help the development of drugs for other ageing-related diseases with interrelated mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUpknH20YHpLVg90H21EOLACvtfcHk0lhVyRu_WVWe-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbL&md5=7208173429dc76f12ebbc05c92858d38</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1751%26sid%3Dliteratum%253Aachs%26aulast%3DDemierre%26aufirst%3DM.%2BF.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%26aulast%3DGruber%26aufirst%3DS.%2BB.%26aulast%3DHawk%26aufirst%3DE.%26aulast%3DLippman%26aufirst%3DS.%2BM.%26atitle%3DStatins%2520and%2520cancer%2520prevention%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D930%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, L. L.</span><span> </span><span class="NLM_article-title">The statins as anticancer agents</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=12538446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1OnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=10-19&author=K.+K.+Chanauthor=A.+M.+Ozaauthor=L.+L.+Siu&title=The+statins+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Statins as Anticancer Agents</span></div><div class="casAuthors">Chan, Kelvin K. W.; Oza, Amit M.; Siu, Lillian L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-19</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  3-Hydroxy-3-methylgutaryl CoA reductase inhibitors, commonly referred to as the statins, have proven therapeutic and preventative effects in cardiovascular diseases.  Recently, there are emerging interests in their use as anticancer agents based on preclin. evidence of their antiproliferative, proapoptotic, anti-invasive, and radiosensitizing properties.  Inhibition of 3-hydroxy-3-methylgutaryl CoA reductase by the statins interferes with the rate-limiting step of the mevalonate pathway, leading to reduced levels of mevalonate and its downstream products, many of which play important roles in crit. cellular functions such as membrane integrity, cell signaling, protein synthesis, and cell cycle progression.  Perturbations of these processes in neoplastic cells by the statins may therefore result in control of tumor initiation, growth, and metastasis.  The statins have demonstrated growth inhibitory activity in cancer cell lines and preclin. tumor models in animals.  Phase I trials of statins in humans have demonstrated myotoxicity as their main dose-limiting toxicity, and Phase II trials in various tumor types are ongoing to evaluate their efficacy.  Potential future directions in the development of the statins as anticancer agents include combinations with chemotherapeutic or other mol.-targeted agents, combinations with radiotherapy, maintenance therapy in minimal disease status, and as chemopreventive therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoawbLu0I3bgrVg90H21EOLACvtfcHk0lhVyRu_WVWe-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1OnsQ%253D%253D&md5=d3d7bc0d32444b68b89a083ced0fe72c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BK.%26aulast%3DOza%26aufirst%3DA.%2BM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DThe%2520statins%2520as%2520anticancer%2520agents%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D10%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cemeus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitroulakos, J.</span><span> </span><span class="NLM_article-title">Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs11060-008-9627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=18566746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ejtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=9-17&author=C.+Cemeusauthor=T.+T.+Zhaoauthor=G.+M.+Barrettauthor=I.+A.+Lorimerauthor=J.+Dimitroulakos&title=Lovastatin+enhances+gefitinib+activity+in+glioblastoma+cells+irrespective+of+EGFRvIII+and+PTEN+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status</span></div><div class="casAuthors">Cemeus, Catia; Zhao, Tong T.; Barrett, Gordon M.; Lorimer, Ian A.; Dimitroulakos, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is commonly amplified and mutated in glioblastoma, making it a compelling therapeutic target.  Recent reports have demonstrated clin. activity of the EGFR inhibitors gefitinib and erlotinib in a subset of glioblastoma patients.  Co-expression of EGFRvIII, a constitutively active mutant receptor expressed in 50% of tumors, and PTEN, an inhibitor of PI3K activity, by glioblastoma cells is assocd. with clin. response to these EGFR kinase inhibitors.  PTEN loss and resulting increased PI3K pathway activity appears to act as a resistance factor.  A crit. therapeutic challenge is to identify agents that enhance the anti-cancer effects of these agents and promote responsiveness to EGFR kinase inhibitors in a broader spectrum of glioblastoma patients.  For example, combining gefitinib with inhibitors of the PI3K/AKT pathway show enhanced cytotoxicity in glioblastoma derived cell lines.  Here, we show that targeting HMG-CoA reductase with lovastatin, that can affect the activity of multiple cell signaling pathways, significantly enhanced the sensitivity of glioblastoma cells to the EGFR kinase inhibitor gefitinib in the five cell lines tested.  In an isogenic model system, U87MG glioblastoma cells expressing EGFRvIII and PTEN in relevant combinations, we show that combined gefitinib and lovastatin treatments induce potent synergistic cytotoxicity irresp. of EGFRvIII and PTEN status.  These studies demonstrate the potential of lovastatin to augment the cytotoxic effects of gefitinib and provide a rationale for combined statin/EGFR targeted therapies in glioblastoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCug6FDl9BLVg90H21EOLACvtfcHk0lhVyRu_WVWe-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ejtLbM&md5=46d84444d8d5b913ef5ceb9c3626139d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs11060-008-9627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-008-9627-0%26sid%3Dliteratum%253Aachs%26aulast%3DCemeus%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%2BT.%26aulast%3DBarrett%26aufirst%3DG.%2BM.%26aulast%3DLorimer%26aufirst%3DI.%2BA.%26aulast%3DDimitroulakos%26aufirst%3DJ.%26atitle%3DLovastatin%2520enhances%2520gefitinib%2520activity%2520in%2520glioblastoma%2520cells%2520irrespective%2520of%2520EGFRvIII%2520and%2520PTEN%2520status%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2008%26volume%3D90%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhavan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1126%2Fscisignal.2000446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=20009104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD1MfisFWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=ra82&author=D.+Guoauthor=R.+M.+Prinsauthor=J.+Dangauthor=D.+Kugaauthor=A.+Iwanamiauthor=H.+Sotoauthor=K.+Y.+Linauthor=T.+T.+Huangauthor=D.+Akhavanauthor=M.+B.+Hockauthor=S.+Zhuauthor=A.+A.+Kofmanauthor=S.+J.+Bensingerauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=S.+Horvathauthor=A.+D.+Watsonauthor=J.+G.+Kuhnauthor=H.+I.+Robinsauthor=M.+P.+Mehtaauthor=P.+Y.+Wenauthor=L.+M.+DeAngelisauthor=M.+D.+Pradosauthor=I.+K.+Mellinghoffauthor=T.+F.+Cloughesyauthor=P.+S.+Mischel&title=EGFR+signaling+through+an+Akt-SREBP-1-dependent%2C+rapamycin-resistant+pathway+sensitizes+glioblastomas+to+antilipogenic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy</span></div><div class="casAuthors">Guo Deliang; Prins Robert M; Dang Julie; Kuga Daisuke; Iwanami Akio; Soto Horacio; Lin Kelly Y; Huang Tiffany T; Akhavan David; Hock M Benjamin; Zhu Shaojun; Kofman Ava A; Bensinger Steve J; Yong William H; Vinters Harry V; Horvath Steve; Watson Andrew D; Kuhn John G; Robins H Ian; Mehta Minesh P; Wen Patrick Y; DeAngelis Lisa M; Prados Michael D; Mellinghoff Ingo K; Cloughesy Timothy F; Mischel Paul S</div><div class="citationInfo"><span class="NLM_cas:title">Science signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">101</span>),
    <span class="NLM_cas:pages">ra82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma, the most common malignant brain tumor, is among the most lethal and difficult cancers to treat.  Although epidermal growth factor receptor (EGFR) mutations are frequent in glioblastoma, their clinical relevance is poorly understood.  Studies of tumors from patients treated with the EGFR inhibitor lapatinib revealed that EGFR induces the cleavage and nuclear translocation of the master transcriptional regulator of fatty acid synthesis, sterol regulatory element-binding protein 1 (SREBP-1).  This response was mediated by Akt; however, clinical data from rapamycin-treated patients showed that SREBP-1 activation was independent of the mammalian target of rapamycin complex 1, possibly explaining rapamycin's poor efficacy in the treatment of such tumors.  Glioblastomas without constitutively active EGFR signaling were resistant to inhibition of fatty acid synthesis, whereas introduction of a constitutively active mutant form of EGFR, EGFRvIII, sensitized tumor xenografts in mice to cell death, which was augmented by the hydroxymethylglutaryl coenzyme A reductase inhibitor atorvastatin.  These results identify a previously undescribed EGFR-mediated prosurvival metabolic pathway and suggest new therapeutic approaches to treating EGFR-activated glioblastomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXniRaZIvVxeR_TJajKxJDfW6udTcc2eZkCjQTu8j4Wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfisFWnsA%253D%253D&md5=5b64f105bfb1011d1932368049b8d140</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000446%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DDang%26aufirst%3DJ.%26aulast%3DKuga%26aufirst%3DD.%26aulast%3DIwanami%26aufirst%3DA.%26aulast%3DSoto%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DAkhavan%26aufirst%3DD.%26aulast%3DHock%26aufirst%3DM.%2BB.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DKofman%26aufirst%3DA.%2BA.%26aulast%3DBensinger%26aufirst%3DS.%2BJ.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DA.%2BD.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DRobins%26aufirst%3DH.%2BI.%26aulast%3DMehta%26aufirst%3DM.%2BP.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DDeAngelis%26aufirst%3DL.%2BM.%26aulast%3DPrados%26aufirst%3DM.%2BD.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DEGFR%2520signaling%2520through%2520an%2520Akt-SREBP-1-dependent%252C%2520rapamycin-resistant%2520pathway%2520sensitizes%2520glioblastomas%2520to%2520antilipogenic%2520therapy%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3Dra82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">van de Donk, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamphuis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhorst, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloem, A. C.</span><span> </span><span class="NLM_article-title">The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1362-1371&author=N.+W.+van+de+Donkauthor=M.+M.+Kamphuisauthor=H.+M.+Lokhorstauthor=A.+C.+Bloem&title=The+cholesterol+lowering+drug+lovastatin+induces+cell+death+in+myeloma+plasma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BDonk%26aufirst%3DN.%2BW.%26aulast%3DKamphuis%26aufirst%3DM.%2BM.%26aulast%3DLokhorst%26aufirst%3DH.%2BM.%26aulast%3DBloem%26aufirst%3DA.%2BC.%26atitle%3DThe%2520cholesterol%2520lowering%2520drug%2520lovastatin%2520induces%2520cell%2520death%2520in%2520myeloma%2520plasma%2520cells%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D1362%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Graaf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Noorden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchelaar, H. J.</span><span> </span><span class="NLM_article-title">Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1016%2Fj.ctrv.2004.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15531395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=609-641&author=M.+R.+Graafauthor=D.+J.+Richelauthor=C.+J.+van+Noordenauthor=H.+J.+Guchelaar&title=Effects+of+statins+and+farnesyltransferase+inhibitors+on+the+development+and+progression+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer</span></div><div class="casAuthors">Graaf, Matthijs R.; Richel, Dick J.; van Noorden, Cornelis J. F.; Guchelaar, Henk-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-641</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Statins (3-hydroxy-3-methylglutaryl-CoA reductase inhibitors - HMG-CoA reductase inhibitors) have been approved for the treatment of lipid disorders.  Recently, in vivo studies with exptl. animals and in vitro studies indicated a possible role for statins in the treatment of malignancies.  Inhibition of the enzyme HMG-CoA reductase results in decreased farnesylation and geranylgeranylation of several proteins essential for cellular proliferation and survival.  Inhibition of Ras farnesylation was originally thought to be the mechanism that mediates statin-induced effects in cancer.  Consequently, specific inhibitors of the enzyme farnesyltransferase (FTIs) were developed.  Currently, the mechanisms that mediate statin- and FTI-induced antitumor effects are questioned.  It remains unclear which proteins and signal transduction cascades are involved.  This review focuses on the effects and possible therapeutic application of statins and FTIs.  Antitumor properties such as induction of growth arrest and apoptosis, inhibition of metastasis and inhibition of angiogenesis are discussed.  Furthermore, the mechanisms of statin- and farnesyltransferase inhibitor-induced effects and the involvement of a no. of cellular components (such as farnesylated and geranylgeranylated proteins, the mitogen-activated protein kinase signaling pathway, the phosphoinositide 3'-kinase signaling pathway, and cell cycle regulatory proteins) are reviewed.  In addn., clin. and epidemiol. data with respect to statins and farnesyltransferase inhibitors are summarized.  We propose that inhibitors of the mevalonate pathway are particularly effective when administered in combination with other drugs.  Therefore, the mechanisms and effects of combined therapy of statins or farnesyltransferase inhibitors with chemotherapeutics, biphosphonates, non-steroidal anti-inflammatory drugs, specific inhibitors of geranyltransferase and inhibitors of tyrosine kinase activity are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoESyyHl6XZlbVg90H21EOLACvtfcHk0lj8bNpz7_Lz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOltb0%253D&md5=b1694cb6866d6fb1fdb3af08440407f8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2004.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2004.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DGraaf%26aufirst%3DM.%2BR.%26aulast%3DRichel%26aufirst%3DD.%2BJ.%26aulast%3Dvan%2BNoorden%26aufirst%3DC.%2BJ.%26aulast%3DGuchelaar%26aufirst%3DH.%2BJ.%26atitle%3DEffects%2520of%2520statins%2520and%2520farnesyltransferase%2520inhibitors%2520on%2520the%2520development%2520and%2520progression%2520of%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2004%26volume%3D30%26spage%3D609%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirshahi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirshahi-Khorassani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, C.</span><span> </span><span class="NLM_article-title">Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=159-166&author=L.+Vincentauthor=W.+Chenauthor=L.+Hongauthor=F.+Mirshahiauthor=Z.+Mishalauthor=T.+Mirshahi-Khorassaniauthor=J.+P.+Vannierauthor=J.+Soriaauthor=C.+Soria&title=Inhibition+of+endothelial+cell+migration+by+cerivastatin%2C+an+HMG-CoA+reductase+inhibitor%3A+contribution+to+its+anti-angiogenic+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DMirshahi%26aufirst%3DF.%26aulast%3DMishal%26aufirst%3DZ.%26aulast%3DMirshahi-Khorassani%26aufirst%3DT.%26aulast%3DVannier%26aufirst%3DJ.%2BP.%26aulast%3DSoria%26aufirst%3DJ.%26aulast%3DSoria%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520endothelial%2520cell%2520migration%2520by%2520cerivastatin%252C%2520an%2520HMG-CoA%2520reductase%2520inhibitor%253A%2520contribution%2520to%2520its%2520anti-angiogenic%2520effect%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26spage%3D159%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Park, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iruela-Arispe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galper, J. B.</span><span> </span><span class="NLM_article-title">3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=143-150&author=H.+J.+Parkauthor=D.+Kongauthor=L.+Iruela-Arispeauthor=U.+Begleyauthor=D.+Tangauthor=J.+B.+Galper&title=3-Hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitors+interfere+with+angiogenesis+by+inhibiting+the+geranylgeranylation+of+RhoA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DIruela-Arispe%26aufirst%3DL.%26aulast%3DBegley%26aufirst%3DU.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DGalper%26aufirst%3DJ.%2BB.%26atitle%3D3-Hydroxy-3-methylglutaryl%2520coenzyme%2520A%2520reductase%2520inhibitors%2520interfere%2520with%2520angiogenesis%2520by%2520inhibiting%2520the%2520geranylgeranylation%2520of%2520RhoA%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Weis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeschen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassford, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, J. P.</span><span> </span><span class="NLM_article-title">Statins have biphasic effects on angiogenesis</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2002&pages=739-745&author=M.+Weisauthor=C.+Heeschenauthor=A.+J.+Glassfordauthor=J.+P.+Cooke&title=Statins+have+biphasic+effects+on+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DM.%26aulast%3DHeeschen%26aufirst%3DC.%26aulast%3DGlassford%26aufirst%3DA.%2BJ.%26aulast%3DCooke%26aufirst%3DJ.%2BP.%26atitle%3DStatins%2520have%2520biphasic%2520effects%2520on%2520angiogenesis%26jtitle%3DCirculation%26date%3D2002%26volume%3D105%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jozkowicz, A.</span><span> </span><span class="NLM_article-title">Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.2174%2F156800905774932824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16375664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=579-594&author=J.+Dulakauthor=A.+Jozkowicz&title=Anti-angiogenic+and+anti-inflammatory+effects+of+statins%3A+relevance+to+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-angiogenic and anti-inflammatory effects of statins: Relevance to anti-cancer therapy</span></div><div class="casAuthors">Dulak, Jozef; Jozkowicz, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-594</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is indispensable for the growth of solid tumors and angiogenic factors are also involved in the progression of hematol. malignancies.  Targeting the formation of blood vessels is therefore regarded as a promising strategy in cancer therapy.  Interestingly, besides demonstration of some beneficial effects of novel anti-angiogenic compds., recent data on the activity of already available drugs point to their potential application in anti-angiogenic therapy.  Among these are the statins, the inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase.  Statins are very efficient in the treatment of hypercholesterolemia in cardiovascular disorders; however, their effects are pleiotropic and some are not directly related to the inhibition of cholesterol synthesis.  Some reports particularly highlight the pro-angiogenic effects of statins, which are caused by low, nanomolar concns. and are regarded as beneficial for the treatment of cardiovascular diseases.  On the other hand, the anti-angiogenic activities, obsd. at micromolar concns. of statins, may be of special significance for cancer therapy.  Those effects are caused by the inhibition of both proliferation and migration and induction of apoptosis in endothelial cells.  Moreover, the statin-mediated inhibition of vascular endothelial growth factor synthesis, the major angiogenic mediator, may contribute to the attenuation of angiogenesis.  It has been suggested that the anti-cancer effect of statins can be potentially exploited for the cancer therapy.  However, several clin. trials aimed at the inhibition of tumor growth by treatment with very high doses of statins did not provide conclusive data.  Herein, the reasons for those outcomes are discussed and the rationale for further studies is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB1SwH-H3DS7Vg90H21EOLACvtfcHk0lj7l6J5KwdkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbfO&md5=07b5e4fca48272427faf638ee9fb0e5a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156800905774932824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800905774932824%26sid%3Dliteratum%253Aachs%26aulast%3DDulak%26aufirst%3DJ.%26aulast%3DJozkowicz%26aufirst%3DA.%26atitle%3DAnti-angiogenic%2520and%2520anti-inflammatory%2520effects%2520of%2520statins%253A%2520relevance%2520to%2520anti-cancer%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2005%26volume%3D5%26spage%3D579%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jakobisiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golab, J.</span><span> </span><span class="NLM_article-title">Statins can modulate effectiveness of antitumor therapeutic modalities</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19526461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=102-135&author=M.+Jakobisiakauthor=J.+Golab&title=Statins+can+modulate+effectiveness+of+antitumor+therapeutic+modalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Statins can modulate effectiveness of antitumor therapeutic modalities</span></div><div class="casAuthors">Jakobisiak, Marek; Golab, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-135</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Despite significant, frequently very strong, antiproliferative and tumoricidal effects of statins demonstrated in vitro, their antitumor effects in animal models are modest, and their efficacy in clin. trials has not been proven.  As such, statins seem unlikely to be ever regarded as antitumor agents.  However, statins are regularly taken by many elderly cancer patients for the prevention of cardiovascular events.  Owing to their pleiotropic effects in normal and tumor cells, statins interact in various ways with many antitumor treatment modalities, either potentiating or diminishing their effectiveness.  Elucidation of these interactions might affect the choice of treatment to be planned in cancer patients as some combinations might be contraindicated, whereas others might elicit potentiated antitumor effects but at a cost of increased general toxicity.  Some other combinations might induce either comparable or even stronger antitumor effects, but with a beneficial concomitant redn. of specific side effects.  Most of the studies reviewed in this article have been carried in vitro or in exptl. tumor models, but clin. relevance of the findings is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2TkIht3SE7Vg90H21EOLACvtfcHk0lj7l6J5KwdkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOgs7s%253D&md5=75ab40c894c808fe51d3701b5f18c0fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakobisiak%26aufirst%3DM.%26aulast%3DGolab%26aufirst%3DJ.%26atitle%3DStatins%2520can%2520modulate%2520effectiveness%2520of%2520antitumor%2520therapeutic%2520modalities%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2010%26volume%3D30%26spage%3D102%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Perchellet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perchellet, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crow, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buszek, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span> </span><span class="NLM_article-title">Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.3892%2Fijmm_00000274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=19787197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=633-643&author=J.+P.+Perchelletauthor=E.+M.+Perchelletauthor=K.+R.+Crowauthor=K.+R.+Buszekauthor=N.+Brownauthor=S.+Ellappanauthor=G.+Gaoauthor=D.+Luoauthor=M.+Minatoyaauthor=G.+H.+Lushington&title=Novel+synthetic+inhibitors+of+3-hydroxy-3-methylglutaryl-coenzyme+A+%28HMG-CoA%29+reductase+activity+that+inhibit+tumor+cell+proliferation+and+are+structurally+unrelated+to+existing+statins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins</span></div><div class="casAuthors">Perchellet, Jean-Pierre H.; Perchellet, Elisabeth M.; Crow, Kyle R.; Buszek, Keith R.; Brown, Neil; Ellappan, Sampathkumar; Gao, Ge; Luo, Diheng; Minatoya, Machiko; Lushington, Gerald H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Pilot-scale libraries of eight-membered medium ring lactams (MRLs) and related tricyclic compds. (either seven-membered lactams, thiolactams or amines) were screened for their ability to inhibit the catalytic activity of human recombinant 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase in vitro.  A dozen of the synthetic compds. mimic the inhibition of purified HMG-CoA reductase activity caused by pravastatin, fluvastatin and sodium salts of lovastatin, mevastatin and simvastatin in this cell-free assay, suggesting direct interaction with the rate-limiting enzyme of cholesterol biosynthesis.  Moreover, several MRLs inhibit the metabolic activity of L1210 tumor cells in vitro to a greater degree than fluvastatin, lovastatin, mevastatin and simvastatin, whereas pravastatin is inactive.  Although the correlation between the concn.-dependent inhibitions of HMG-CoA reductase activity over 10 min in the cell-free assay and L1210 tumor cell proliferation over 4 days in culture is unclear, some bioactive MRLs elicit interesting combinations of statin-like (IC50: 7.4-8.0 μM) and anti-tumor (IC50: 1.4-2.3 μM) activities.  The HMG-CoA reductase-inhibiting activities of pravastatin and an MRL persist in the presence of increasing concns. of NADPH.  But increasing concns. of HMG-CoA block the HMG-CoA reductase-inhibiting activity of pravastatin without altering that of an MRL, suggesting that MRLs and existing statins may have different mechanisms of enzyme interaction and inhibition.  When tested together, suboptimal concns. of synthetic MRLs and existing statins have additive inhibitory effects on HMG-CoA reductase activity.  Preliminary mol. docking studies with MRL-based inhibitors indicate that these ligands fit sterically well into the HMG-CoA reductase statin-binding receptor model and, in contrast to mevastatin, may occupy a narrow channel housing the pyridinium moiety on NADP+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9i59AXS1MwbVg90H21EOLACvtfcHk0liiUdcqMMIuuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgtb3M&md5=e9ee144bc8bad5386535b394a1f4a8c7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3892%2Fijmm_00000274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm_00000274%26sid%3Dliteratum%253Aachs%26aulast%3DPerchellet%26aufirst%3DJ.%2BP.%26aulast%3DPerchellet%26aufirst%3DE.%2BM.%26aulast%3DCrow%26aufirst%3DK.%2BR.%26aulast%3DBuszek%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DEllappan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DMinatoya%26aufirst%3DM.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26atitle%3DNovel%2520synthetic%2520inhibitors%2520of%25203-hydroxy-3-methylglutaryl-coenzyme%2520A%2520%2528HMG-CoA%2529%2520reductase%2520activity%2520that%2520inhibit%2520tumor%2520cell%2520proliferation%2520and%2520are%2520structurally%2520unrelated%2520to%2520existing%2520statins%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2009%26volume%3D24%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gains, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengsfeld, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span> </span><span class="NLM_article-title">Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=373-390&author=O.+H.+Morandauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=Y.+H.+Jiauthor=N.+Gainsauthor=H.+Lengsfeldauthor=J.+Himber&title=Ro+48-8.071%2C+a+new+2%2C3-oxidosqualene%3Alanosterol+cyclase+inhibitor+lowering+plasma+cholesterol+in+hamsters%2C+squirrel+monkeys%2C+and+minipigs%3A+comparison+to+simvastatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DY.%2BH.%26aulast%3DGains%26aufirst%3DN.%26aulast%3DLengsfeld%26aufirst%3DH.%26aulast%3DHimber%26aufirst%3DJ.%26atitle%3DRo%252048-8.071%252C%2520a%2520new%25202%252C3-oxidosqualene%253Alanosterol%2520cyclase%2520inhibitor%2520lowering%2520plasma%2520cholesterol%2520in%2520hamsters%252C%2520squirrel%2520monkeys%252C%2520and%2520minipigs%253A%2520comparison%2520to%2520simvastatin%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1997%26volume%3D38%26spage%3D373%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Balliano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliaro-Bosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaldaferri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taramino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span> </span><span class="NLM_article-title">Oxidosqualene cyclase from <i>Saccharomyces cerevisiae</i>, <i>Trypanosoma cruzi</i>, <i>Pneumocystis carinii</i> and <i>Arabidopsis thaliana</i> expressed in yeast: a model for the development of novel antiparasitic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=718-723&author=G.+Ballianoauthor=H.+Dehmlowauthor=S.+Oliaro-Bossoauthor=M.+Scaldaferriauthor=S.+Taraminoauthor=F.+Violaauthor=G.+Caronauthor=J.+Aebiauthor=J.+Ackermann&title=Oxidosqualene+cyclase+from+Saccharomyces+cerevisiae%2C+Trypanosoma+cruzi%2C+Pneumocystis+carinii+and+Arabidopsis+thaliana+expressed+in+yeast%3A+a+model+for+the+development+of+novel+antiparasitic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalliano%26aufirst%3DG.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DOliaro-Bosso%26aufirst%3DS.%26aulast%3DScaldaferri%26aufirst%3DM.%26aulast%3DTaramino%26aufirst%3DS.%26aulast%3DViola%26aufirst%3DF.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DAckermann%26aufirst%3DJ.%26atitle%3DOxidosqualene%2520cyclase%2520from%2520Saccharomyces%2520cerevisiae%252C%2520Trypanosoma%2520cruzi%252C%2520Pneumocystis%2520carinii%2520and%2520Arabidopsis%2520thaliana%2520expressed%2520in%2520yeast%253A%2520a%2520model%2520for%2520the%2520development%2520of%2520novel%2520antiparasitic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D718%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolidon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von der Mark, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021120f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3354-3370&author=H.+Dehmlowauthor=J.+D.+Aebiauthor=S.+Jolidonauthor=Y.+H.+Jiauthor=E.+M.+von+der+Markauthor=J.+Himberauthor=O.+H.+Morand&title=Synthesis+and+structure%E2%80%93activity+studies+of+novel+orally+active+non-terpenoic+2%2C3-oxidosqualene+cyclase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm021120f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021120f%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DY.%2BH.%26aulast%3Dvon%2Bder%2BMark%26aufirst%3DE.%2BM.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%2520novel%2520orally%2520active%2520non-terpenoic%25202%252C3-oxidosqualene%2520cyclase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3354%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lenhart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinert, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene–hopene cyclase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2083</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0211218" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2083-2092&author=A.+Lenhartauthor=D.+J.+Reinertauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=O.+H.+Morandauthor=G.+E.+Schulz&title=Binding+structures+and+potencies+of+oxidosqualene+cyclase+inhibitors+with+the+homologous+squalene%E2%80%93hopene+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0211218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0211218%26sid%3Dliteratum%253Aachs%26aulast%3DLenhart%26aufirst%3DA.%26aulast%3DReinert%26aufirst%3DD.%2BJ.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DBinding%2520structures%2520and%2520potencies%2520of%2520oxidosqualene%2520cyclase%2520inhibitors%2520with%2520the%2520homologous%2520squalene%25E2%2580%2593hopene%2520cyclase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2083%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rowe, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argmann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyez, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegele, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, M. W.</span><span> </span><span class="NLM_article-title">Enhanced synthesis of the oxysterol 24(<i>S</i>),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=717-725&author=A.+H.+Roweauthor=C.+A.+Argmannauthor=J.+Y.+Edwardsauthor=C.+G.+Sawyezauthor=O.+H.+Morandauthor=R.+A.+Hegeleauthor=M.+W.+Huff&title=Enhanced+synthesis+of+the+oxysterol+24%28S%29%2C25-epoxycholesterol+in+macrophages+by+inhibitors+of+2%2C3-oxidosqualene%3Alanosterol+cyclase%3A+a+novel+mechanism+for+the+attenuation+of+foam+cell+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DA.%2BH.%26aulast%3DArgmann%26aufirst%3DC.%2BA.%26aulast%3DEdwards%26aufirst%3DJ.%2BY.%26aulast%3DSawyez%26aufirst%3DC.%2BG.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DHegele%26aufirst%3DR.%2BA.%26aulast%3DHuff%26aufirst%3DM.%2BW.%26atitle%3DEnhanced%2520synthesis%2520of%2520the%2520oxysterol%252024%2528S%2529%252C25-epoxycholesterol%2520in%2520macrophages%2520by%2520inhibitors%2520of%25202%252C3-oxidosqualene%253Alanosterol%2520cyclase%253A%2520a%2520novel%2520mechanism%2520for%2520the%2520attenuation%2520of%2520foam%2520cell%2520formation%26jtitle%3DCirc.%2520Res.%26date%3D2003%26volume%3D93%26spage%3D717%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Telford, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, M. W.</span><span> </span><span class="NLM_article-title">A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2608</span><span class="NLM_x">–</span> <span class="NLM_lpage">2614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1161%2F01.ATV.0000189158.28455.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16210564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Crt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2608-2614&author=D.+E.+Telfordauthor=S.+M.+Lipsonauthor=P.+H.+Barrettauthor=B.+G.+Sutherlandauthor=J.+Y.+Edwardsauthor=J.+D.+Aebiauthor=H.+Dehmlowauthor=O.+H.+Morandauthor=M.+W.+Huff&title=A+novel+inhibitor+of+oxidosqualene%3Alanosterol+cyclase+inhibits+very+low-density+lipoprotein+apolipoprotein+B100+%28apoB100%29+production+and+enhances+low-density+lipoprotein+apoB100+catabolism+through+marked+reduction+in+hepatic+cholesterol+content"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content</span></div><div class="casAuthors">Telford, Dawn E.; Lipson, Sara M.; Barrett, P. Hugh R.; Sutherland, Brian G.; Edwards, Jane Y.; Aebi, Johannes D.; Dehmlow, Henrietta; Morand, Olivier H.; Huff, Murray W.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2608-2614</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Inhibition of 2,3-oxidosqualene:lanosterol cyclase (OSC), an enzyme in the cholesterol synthesis pathway, has the unique ability to inhibit cholesterol synthesis while simultaneously enhancing oxysterol synthesis.  Our objectives were to det., in vivo, if a novel OSC inhibitor reduced low-d. lipoprotein (LDL) cholesterol and to define the mechanism(s) involved.  Methods and Results- Miniature pigs received the OSC inhibitor RO0717625 or placebo and a diet contg. fat (34% of energy) and 400 mg per day of cholesterol.  Treatment decreased plasma total cholesterol (-20%) and LDL cholesterol (-29%).  Apolipoprotein B (apoB) kinetic parameters were detd.  Very low-d. lipoprotein (VLDL) apoB pool size decreased 22% because of inhibition of VLDL prodn. (-43%).  LDL apoB pool size decreased 22% because of a 1.5-fold increase in fractional catabolic rate (FCR).  The increased FCR was assocd. with a 2-fold increase in hepatic LDL receptor mRNA.  Hepatic total and microsomal cholesterol were reduced by 16% and 27%, resp.  Plasma lathosterol concns. decreased 57%, reflecting inhibition of hepatic cholesterol synthesis.  Treatment reduced plasma plant sterols and decreased postprandial cholesterol transport in chylomicrons.  Conclusions- A novel OSC inhibitor, RO0717625, decreased VLDL and LDL apoB100 through decreased VLDL prodn. and enhanced LDL clearance.  Thus, OSC represents a potential therapeutic target for dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrth2VAtZAgNbVg90H21EOLACvtfcHk0li9FYXX-eJqlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Crt77K&md5=b23c92d64a726121408ede4088a0a076</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000189158.28455.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000189158.28455.94%26sid%3Dliteratum%253Aachs%26aulast%3DTelford%26aufirst%3DD.%2BE.%26aulast%3DLipson%26aufirst%3DS.%2BM.%26aulast%3DBarrett%26aufirst%3DP.%2BH.%26aulast%3DSutherland%26aufirst%3DB.%2BG.%26aulast%3DEdwards%26aufirst%3DJ.%2BY.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26aulast%3DHuff%26aufirst%3DM.%2BW.%26atitle%3DA%2520novel%2520inhibitor%2520of%2520oxidosqualene%253Alanosterol%2520cyclase%2520inhibits%2520very%2520low-density%2520lipoprotein%2520apolipoprotein%2520B100%2520%2528apoB100%2529%2520production%2520and%2520enhances%2520low-density%2520lipoprotein%2520apoB100%2520catabolism%2520through%2520marked%2520reduction%2520in%2520hepatic%2520cholesterol%2520content%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D2608%26epage%3D2614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitor for farnesyl pyrophosphate synthase in the mevalonate pathway</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5340</span><span class="NLM_x">–</span> <span class="NLM_lpage">5342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=5340-5342&author=J.+Gaoauthor=X.+Chuauthor=Y.+Qiuauthor=L.+Wuauthor=Y.+Qiaoauthor=J.+Wuauthor=D.+Li&title=Discovery+of+potent+inhibitor+for+farnesyl+pyrophosphate+synthase+in+the+mevalonate+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitor%2520for%2520farnesyl%2520pyrophosphate%2520synthase%2520in%2520the%2520mevalonate%2520pathway%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D5340%26epage%3D5342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisele, B.</span><span> </span><span class="NLM_article-title">Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=148-158&author=M.+Markauthor=P.+Mullerauthor=R.+Maierauthor=B.+Eisele&title=Effects+of+a+novel+2%2C3-oxidosqualene+cyclase+inhibitor+on+the+regulation+of+cholesterol+biosynthesis+in+HepG2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMark%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DEisele%26aufirst%3DB.%26atitle%3DEffects%2520of%2520a%2520novel%25202%252C3-oxidosqualene%2520cyclase%2520inhibitor%2520on%2520the%2520regulation%2520of%2520cholesterol%2520biosynthesis%2520in%2520HepG2%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1996%26volume%3D37%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Eisele, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budzinski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span> </span><span class="NLM_article-title">Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=564-575&author=B.+Eiseleauthor=R.+Budzinskiauthor=P.+M%C3%BCllerauthor=M.+Mark&title=Effects+of+a+novel+2%2C3-oxidosqualene+cyclase+inhibitor+on+cholesterol+biosynthesis+and+lipid+metabolism+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DB.%26aulast%3DBudzinski%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DP.%26aulast%3DMark%26aufirst%3DM.%26atitle%3DEffects%2520of%2520a%2520novel%25202%252C3-oxidosqualene%2520cyclase%2520inhibitor%2520on%2520cholesterol%2520biosynthesis%2520and%2520lipid%2520metabolism%2520in%2520vivo%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1997%26volume%3D38%26spage%3D564%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dollis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuber, F.</span><span> </span><span class="NLM_article-title">Effects of 2,3-oxidosqualene-lanosterol cyclase inhibitor, 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line Hep-G2</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=49-57&author=D.+Dollisauthor=F.+Schuber&title=Effects+of+2%2C3-oxidosqualene-lanosterol+cyclase+inhibitor%2C+2%2C3%3A22%2C23-dioxidosqualene+and+24%2C25-epoxycholesterol+on+the+regulation+of+cholesterol+biosynthesis+in+human+hepatoma+cell+line+Hep-G2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollis%26aufirst%3DD.%26aulast%3DSchuber%26aufirst%3DF.%26atitle%3DEffects%2520of%25202%252C3-oxidosqualene-lanosterol%2520cyclase%2520inhibitor%252C%25202%252C3%253A22%252C23-dioxidosqualene%2520and%252024%252C25-epoxycholesterol%2520on%2520the%2520regulation%2520of%2520cholesterol%2520biosynthesis%2520in%2520human%2520hepatoma%2520cell%2520line%2520Hep-G2%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D48%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Peffley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O. H.</span><span> </span><span class="NLM_article-title">Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4′-(6-allyl-ethyl-amino-hexyloxy)-2′-fluoro-phenyl]-(4-bromophenyl)-methanone (RO0488071): comparison to simvastatin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=439-449&author=D.+M.+Peffleyauthor=A.+K.+Gayenauthor=O.+H.+Morand&title=Down-regulation+of+3-hydroxy-3-methylglutaryl+coenzyme+A+reductase+mRNA+levels+and+synthesis+in+syrian+hamster+C100+cells+by+the+oxidosqualene+cyclase+inhibitor+%5B4%E2%80%B2-%286-allyl-ethyl-amino-hexyloxy%29-2%E2%80%B2-fluoro-phenyl%5D-%284-bromophenyl%29-methanone+%28RO0488071%29%3A+comparison+to+simvastatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeffley%26aufirst%3DD.%2BM.%26aulast%3DGayen%26aufirst%3DA.%2BK.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DDown-regulation%2520of%25203-hydroxy-3-methylglutaryl%2520coenzyme%2520A%2520reductase%2520mRNA%2520levels%2520and%2520synthesis%2520in%2520syrian%2520hamster%2520C100%2520cells%2520by%2520the%2520oxidosqualene%2520cyclase%2520inhibitor%2520%255B4%25E2%2580%25B2-%25286-allyl-ethyl-amino-hexyloxy%2529-2%25E2%2580%25B2-fluoro-phenyl%255D-%25284-bromophenyl%2529-methanone%2520%2528RO0488071%2529%253A%2520comparison%2520to%2520simvastatin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D56%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gardner, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, S. P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, R. Y.</span><span> </span><span class="NLM_article-title">An oxysterol-derived positive signal for 3-hydroxy-3-methylglutaryl-CoA reductase degradation in yeast</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">8681</span><span class="NLM_x">–</span> <span class="NLM_lpage">8694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=8681-8694&author=R.+G.+Gardnerauthor=H.+Shanauthor=S.+P.+T.+Matsudaauthor=R.+Y.+Hampton&title=An+oxysterol-derived+positive+signal+for+3-hydroxy-3-methylglutaryl-CoA+reductase+degradation+in+yeast"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DR.%2BG.%26aulast%3DShan%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DS.%2BP.%2BT.%26aulast%3DHampton%26aufirst%3DR.%2BY.%26atitle%3DAn%2520oxysterol-derived%2520positive%2520signal%2520for%25203-hydroxy-3-methylglutaryl-CoA%2520reductase%2520degradation%2520in%2520yeast%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D8681%26epage%3D8694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum-Kaelin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chucholowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maerki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von der Mark, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span> </span><span class="NLM_article-title">Oxidosqualene cyclase (OSC) inhibitors for the treatment of dyslipidemia</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=72-76&author=H.+Dehmlowauthor=J.+Ackermannauthor=J.+Aebiauthor=D.+Blum-Kaelinauthor=A.+Chucholowskiauthor=P.+Coassoloauthor=P.+Hartmanauthor=M.+Kansyauthor=H.+P.+Maerkiauthor=O.+Morandauthor=E.+Von+der+Markauthor=N.+Pandayauthor=A.+Rufauthor=R.+Thomaauthor=T.+Schulz-Gasch&title=Oxidosqualene+cyclase+%28OSC%29+inhibitors+for+the+treatment+of+dyslipidemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAckermann%26aufirst%3DJ.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DChucholowski%26aufirst%3DA.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DHartman%26aufirst%3DP.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMaerki%26aufirst%3DH.%2BP.%26aulast%3DMorand%26aufirst%3DO.%26aulast%3DVon%2Bder%2BMark%26aufirst%3DE.%26aulast%3DPanday%26aufirst%3DN.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26atitle%3DOxidosqualene%2520cyclase%2520%2528OSC%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520dyslipidemia%26jtitle%3DChimia%26date%3D2005%26volume%3D59%26spage%3D72%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Jolidon, S.; Polak-Wyss, A.; Hartman, P. G.; Guerry, P.</span><span> </span><span class="NLM_article-title">2,3-Oxidosqualenelanosterol Cyclase: An Attractive Target for Antifungal Drug Design</span>. In  <span class="citation_source-book">Recent Advances in the Chemistry of Anti-Infective Agents</span>; <span class="NLM_contrib-group">Bentley, P. H.; Ponsford, R</span>, Eds.; <span class="NLM_publisher-name">Bookcraft Ltd.</span>: <span class="NLM_publisher-loc">Bath, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=223-233&author=S.+Jolidon&author=A.+Polak-Wyss&author=P.+G.+Hartman&author=P.+Guerryauthor=P.+H.+Bentley&author=R+Ponsford&title=Recent+Advances+in+the+Chemistry+of+Anti-Infective+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJolidon%26aufirst%3DS.%26atitle%3D2%252C3-Oxidosqualenelanosterol%2520Cyclase%253A%2520An%2520Attractive%2520Target%2520for%2520Antifungal%2520Drug%2520Design%26btitle%3DRecent%2520Advances%2520in%2520the%2520Chemistry%2520of%2520Anti-Infective%2520Agents%26aulast%3DBentley%26aufirst%3DP.%2BH.%26pub%3DBookcraft%2520Ltd%26date%3D1993%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span> </span><span class="NLM_article-title">Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=118-122&author=R.+Thomaauthor=T.+Schulz-Gaschauthor=B.+D%E2%80%99Arcyauthor=J.+Benzauthor=J.+Aebiauthor=H.+Dehmlowauthor=M.+Hennigauthor=M.+Stihleauthor=A.+Ruf&title=Insight+into+steroid+scaffold+formation+from+the+structure+of+human+oxidosqualene+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DAebi%26aufirst%3DJ.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DInsight%2520into%2520steroid%2520scaffold%2520formation%2520from%2520the%2520structure%2520of%2520human%2520oxidosqualene%2520cyclase%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span> </span><span class="NLM_article-title">Synthetic method for conversion of formyl groups into ethynyl groups</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1972&pages=3769-3772&author=E.+J.+Coreyauthor=P.+L.+Fuchs&title=Synthetic+method+for+conversion+of+formyl+groups+into+ethynyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26atitle%3DSynthetic%2520method%2520for%2520conversion%2520of%2520formyl%2520groups%2520into%2520ethynyl%2520groups%26jtitle%3DTetrahedron%2520Lett.%26date%3D1972%26volume%3D36%26spage%3D3769%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">Amino acid salt catalyzed intramolecular Robinson annulation</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5412</span><span class="NLM_x">–</span> <span class="NLM_lpage">5414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=5412-5414&author=P.+Liauthor=H.+Yamamoto&title=Amino+acid+salt+catalyzed+intramolecular+Robinson+annulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DAmino%2520acid%2520salt%2520catalyzed%2520intramolecular%2520Robinson%2520annulation%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D36%26spage%3D5412%26epage%3D5414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Carlsen, P. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3936</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00332a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=3936-3938&author=P.+H.+J.+Carlsenauthor=T.+Katsukiauthor=V.+S.+Martinauthor=K.+B.+Sharpless&title=A+greatly+improved+procedure+for+ruthenium+tetroxide+catalyzed+oxidations+of+organic+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds</span></div><div class="casAuthors">Carlsen, Per H. J.; Katsuki, Tsutomu; Martin, Victor S.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3936-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Addn. of MeCN to the traditional CCl4/H2O solvent system for RuO4-catalyzed oxidns. causes a great improvement apparently by preventing formation of insol. Ru species and thereby maintaining high catalyst activity.  Applications of the new catalytic system to the oxidn. of org. substrates (olefins, alcs., 1,2-diols, arom. rings, and ethers) are described.  Primary Me ethers are oxidized directly to the esters.  The Ru analog of the abnormal permanganate oxidn. of 1,5-dienes was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRHM2swdg5rVg90H21EOLACvtfcHk0lhR36aokZFE8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFChsro%253D&md5=ed05bc7a5eb549752691f363f6f2893c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00332a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00332a045%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsen%26aufirst%3DP.%2BH.%2BJ.%26aulast%3DKatsuki%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DV.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520greatly%2520improved%2520procedure%2520for%2520ruthenium%2520tetroxide%2520catalyzed%2520oxidations%2520of%2520organic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D3936%26epage%3D3938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Brusselmans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Sande, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Veldhoven, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claessens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, J. V.</span><span> </span><span class="NLM_article-title">Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">18777</span><span class="NLM_x">–</span> <span class="NLM_lpage">18785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=18777-18785&author=K.+Brusselmansauthor=L.+Timmermansauthor=T.+Van+de+Sandeauthor=P.+P.+Van+Veldhovenauthor=G.+Guanauthor=I.+Schechterauthor=F.+Claessensauthor=G.+Verhoevenauthor=J.+V.+Swinnen&title=Squalene+synthase%2C+a+determinant+of+Raft-associated+cholesterol+and+modulator+of+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrusselmans%26aufirst%3DK.%26aulast%3DTimmermans%26aufirst%3DL.%26aulast%3DVan%2Bde%2BSande%26aufirst%3DT.%26aulast%3DVan%2BVeldhoven%26aufirst%3DP.%2BP.%26aulast%3DGuan%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DClaessens%26aufirst%3DF.%26aulast%3DVerhoeven%26aufirst%3DG.%26aulast%3DSwinnen%26aufirst%3DJ.%2BV.%26atitle%3DSqualene%2520synthase%252C%2520a%2520determinant%2520of%2520Raft-associated%2520cholesterol%2520and%2520modulator%2520of%2520cancer%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D18777%26epage%3D18785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span> <span class="citation_source-journal">Pharm. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1124%2Fpr.58.3.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=16968952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=621-681&author=T.+C.+Chou&title=Theoretical+basis%2C+experimental+design%2C+and+computerized+simulation+of+synergism+and+antagonism+in+drug+combination+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-681</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The median-effect equation derived from the mass-action law principle at equil. steady state via math. induction and deduction for different reaction sequences and mechanisms and different types of inhibition has been shown to be the unified theory for the Michaelis-Menten equation, Hill equation, Henderson-Hasselbalch equation, and Scatchard equation.  It is shown that dose and effect are interchangeable via defined parameters.  This general equation for the single drug effect has been extended to the multiple drug effect equation for n drugs.  These equations provide the theor. basis for the combination index (CI)-isobologram equation that allows quant. detn. of drug interactions, where CI < 1, = 1, and > 1 indicate synergism, additive effect, and antagonism, resp.  Based on these algorithms, computer software has been developed to allow automated simulation of synergism and antagonism at all dose or effect levels.  It displays the dose-effect curve, median-effect plot, combination index plot, isobologram, dose-redn. index plot, and polygonogram for in vitro or in vivo studies.  This theor. development, exptl. design, and computerized data anal. have facilitated dose-effect anal. for single drug evaluation or carcinogen and radiation risk assessment, as well as for drug or other entity combinations in a vast field of disciplines of biomedical sciences.  In this review, selected examples of applications are given, and step-by-step examples of exptl. designs and real data anal. are also illustrated.  The merging of the mass-action law principle with math. induction-deduction has been proven to be a unique and effective scientific method for general theory development.  The median-effect principle and its mass-action law based computer software are gaining increased applications in biomedical sciences, from how to effectively evaluate a single compd. or entity to how to beneficially use multiple drugs or modalities in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToLhZ8Njyh7Vg90H21EOLACvtfcHk0liqUBaKhGM-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL&md5=374c53e0772c679d1cdb08ff3112be90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.10%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DTheoretical%2520basis%252C%2520experimental%2520design%252C%2520and%2520computerized%2520simulation%2520of%2520synergism%2520and%2520antagonism%2520in%2520drug%2520combination%2520studies%26jtitle%3DPharm.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D621%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotan, R.</span><span> </span><span class="NLM_article-title">Interaction index and different methods for determining drug interaction in combination therapy</span> <span class="citation_source-journal">J. Biopharm. Stat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1080%2F10543400701199593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=17479394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ntVaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=461-480&author=J.+J.+Leeauthor=M.+Kongauthor=G.+D.+Ayersauthor=R.+Lotan&title=Interaction+index+and+different+methods+for+determining+drug+interaction+in+combination+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction index and different methods for determining drug interaction in combination therapy</span></div><div class="casAuthors">Lee J J; Kong M; Ayers G D; Lotan R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biopharmaceutical statistics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-80</span>
        ISSN:<span class="NLM_cas:issn">1054-3406</span>.
    </div><div class="casAbstract">Studying and understanding the joint effect of combined treatments is important in pharmacology and in the development of combination therapies.  The Loewe additivity model is one of the best general reference models for evaluating drug interactions.  Based on this model, synergy occurs when the interaction index is less than one, while antagonism occurs when interaction index is greater than one.  We expanded the meaning of the interaction index, and propose a procedure to calculate the interaction index and its associated confidence interval under the assumption that the dose-effect curve for a single agent follows Chou and Talalay's median effect equation.  In addition, we review four response surface models based on the Loewe additivity model using a single parameter to determine drug interactions.  We describe each of these models in the context of Loewe additivity model and discuss their relative advantages and disadvantages.  We also provide S-PLUS/R code for each approach to facilitate the implementation of these commonly used methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEZu1z3QFjiIFEOhA_Im3cfW6udTcc2eYdLeHsDgBWQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ntVaqsw%253D%253D&md5=e9e3cca66e2099f4c5bc549b147d3a96</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F10543400701199593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10543400701199593%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKong%26aufirst%3DM.%26aulast%3DAyers%26aufirst%3DG.%2BD.%26aulast%3DLotan%26aufirst%3DR.%26atitle%3DInteraction%2520index%2520and%2520different%2520methods%2520for%2520determining%2520drug%2520interaction%2520in%2520combination%2520therapy%26jtitle%3DJ.%2520Biopharm.%2520Stat.%26date%3D2007%26volume%3D17%26spage%3D461%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wuitschik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Oxetanes in drug discovery: structural and synthetic insights</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+Muller&title=Oxetanes+in+drug+discovery%3A+structural+and+synthetic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0liqUBaKhGM-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520drug%2520discovery%253A%2520structural%2520and%2520synthetic%2520insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeability assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeability+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljinkMDPvUR0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bjorkhem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, S.</span><span> </span><span class="NLM_article-title">Brain cholesterol: long secret life behind a barrier</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">806</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1161%2F01.ATV.0000120374.59826.1b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=14764421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3jtlKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=806-815&author=I.+Bjorkhemauthor=S.+Meaney&title=Brain+cholesterol%3A+long+secret+life+behind+a+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Brain cholesterol: long secret life behind a barrier</span></div><div class="casAuthors">Bjorkhem Ingemar; Meaney Steve</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, thrombosis, and vascular biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">806-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although an immense knowledge has accumulated concerning regulation of cholesterol homeostasis in the body, this does not include the brain, where details are just emerging.  Approximately 25% of the total amount of the cholesterol present in humans is localized to this organ, most of it present in myelin.  Almost all brain cholesterol is a product of local synthesis, with the blood-brain barrier efficiently protecting it from exchange with lipoprotein cholesterol in the circulation.  Thus, there is a highly efficient apolipoprotein-dependent recycling of cholesterol in the brain, with minimal losses to the circulation.  Under steady-state conditions, most of the de novo synthesis of cholesterol in the brain appears to be balanced by excretion of the cytochrome P-450-generated oxysterol 24S-hydroxycholesterol.  This oxysterol is capable of escaping the recycling mechanism and traversing the blood-brain barrier.  Cholesterol levels and cholesterol turnover are affected in neurodegenerating disorders, and the capacity for cholesterol transport and recycling in the brain seems to be of importance for the development of such diseases.  The possibility has been discussed that administration of inhibitors of cholesterol synthesis may reduce the prevalence of Alzheimer disease.  No firm conclusions can, however, be drawn from the studies presented thus far.  In the present review, the most recent advances in our understanding of cholesterol turnover in the brain is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTADxmZBcvS7GLFM_lbR1VmfW6udTcc2eYJhMbU71y2_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3jtlKktw%253D%253D&md5=4273c1fb2054333fdeca963d01ba6fd8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000120374.59826.1b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000120374.59826.1b%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkhem%26aufirst%3DI.%26aulast%3DMeaney%26aufirst%3DS.%26atitle%3DBrain%2520cholesterol%253A%2520long%2520secret%2520life%2520behind%2520a%2520barrier%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D806%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dietschy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turley, S. D.</span><span> </span><span class="NLM_article-title">Cholesterol metabolism in the central nervous system during early development and in the mature animal</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1375-1397&author=J.+M.+Dietschyauthor=S.+D.+Turley&title=Cholesterol+metabolism+in+the+central+nervous+system+during+early+development+and+in+the+mature+animal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26aulast%3DTurley%26aufirst%3DS.%2BD.%26atitle%3DCholesterol%2520metabolism%2520in%2520the%2520central%2520nervous%2520system%2520during%2520early%2520development%2520and%2520in%2520the%2520mature%2520animal%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D1375%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Natali, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siculella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnoni, G. V.</span><span> </span><span class="NLM_article-title">Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=1966-1975&author=F.+Nataliauthor=L.+Siculellaauthor=S.+Salvatiauthor=G.+V.+Gnoni&title=Oleic+acid+is+a+potent+inhibitor+of+fatty+acid+and+cholesterol+synthesis+in+C6+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatali%26aufirst%3DF.%26aulast%3DSiculella%26aufirst%3DL.%26aulast%3DSalvati%26aufirst%3DS.%26aulast%3DGnoni%26aufirst%3DG.%2BV.%26atitle%3DOleic%2520acid%2520is%2520a%2520potent%2520inhibitor%2520of%2520fatty%2520acid%2520and%2520cholesterol%2520synthesis%2520in%2520C6%2520glioma%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2007%26volume%3D48%26spage%3D1966%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Prasanna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samid, D.</span><span> </span><span class="NLM_article-title">Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1046%2Fj.1471-4159.1996.66020710.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=8592143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADyaK28XnsFCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=710-716&author=P.+Prasannaauthor=A.+Thibaultauthor=L.+Liuauthor=D.+Samid&title=Lipid+metabolism+as+a+target+for+brain+cancer+therapy%3A+synergistic+activity+of+lovastatin+and+sodium+phenylacetate+against+human+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells</span></div><div class="casAuthors">Prasanna, Premakala; Thibault, Alain; Liu, Lei; Samid, Dvorit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-16</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Malignant gliomas, the most common form of primary brain tumors, are highly dependent on the mevalonate (MVA) pathway for the synthesis of lipid moieties crit. to cell replication.  Human glioblastoma cells were uniquely vulnerable to growth arrest by lovastatin, a competitive inhibitor of the enzyme regulating MVA synthesis, 3-hydroxy-3-methylglutaryl CoA reductase.  The sodium salt of phenylacetic acid (NaPA), an inhibitor of MVA-pyrophosphate decarboxylase, the enzyme that controls MVA use, acted synergistically with lovastatin to suppress malignant growth.  When used at pharmacol. attainable concns., the two compds. induced profound cytostasis and loss of malignant properties such as invasiveness and expression of the transforming growth factor-β2 gene, coding for a potent immunosuppressive cytokine.  Supplementation with exogenous ubiquinone, an end product of the MVA pathway, failed to rescue the cells, suggesting that decreased synthesis of intermediary products are responsible for the antitumor effects obsd.  In addn. to blocking the MVA pathway, lovastatin alone and in combination with NaPA increased the expression of the peroxisome proliferator-activated receptor, a transcription factor implicated in the control of lipid metab., cell growth, and differentiation.  The results indicate that targeting lipid metab. with lovastatin, used alone or in combination with the arom. fatty acid NaPA, may offer a novel approach to the treatment of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeUuw69KG02LVg90H21EOLACvtfcHk0liw0ABtZ98iOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFCrsQ%253D%253D&md5=de460f19aa8823b663f61749e88ead30</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.66020710.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.66020710.x%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DP.%26aulast%3DThibault%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSamid%26aufirst%3DD.%26atitle%3DLipid%2520metabolism%2520as%2520a%2520target%2520for%2520brain%2520cancer%2520therapy%253A%2520synergistic%2520activity%2520of%2520lovastatin%2520and%2520sodium%2520phenylacetate%2520against%2520human%2520glioma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D710%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brown, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, V.</span><span> </span><span class="NLM_article-title">Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1046%2Fj.1471-4159.2000.740847.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=10646538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFyhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=847-859&author=R.+C.+Brownauthor=C.+Cascioauthor=V.+Papadopoulos&title=Pathways+of+neurosteroid+biosynthesis+in+cell+lines+from+human+brain%3A+regulation+of+dehydroepiandrosterone+formation+by+oxidative+stress+and+beta-amyloid+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and β-amyloid peptide</span></div><div class="casAuthors">Brown, Rachel C.; Cascio, Caterina; Papadopoulos, Vassilios</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">847-859</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Neurosteroids in rodents can originate from peripheral tissues or be locally synthesized in specific brain areas.  There is, as yet, no information about the synthesis and regulation of neurosteroids in human brain.  The authors examd. the ability of human brain cells to synthesize steroids from a radiolabeled precursor and the mRNA and protein expression of key components of peripheral steroidogenic machinery.  Oligodendrocytes are the source of pregnenolone in human brain.  Human astrocytes do not synthesize radiolabeled pregnenolone, nor do human neurons.  There is potential for all three cell types to metabolize pregnenolone to other neurosteroids, including dehydroepiandrosterone.  MRNA and protein for cytochrome P 450 17α-hydroxylase were found in all cell types, although no activity could be demonstrated.  The authors examd. the ability of the cells to make dehydroepiandrosterone via an alternative pathway induced by treatment with Fe2+.  Oligodendrocytes and astrocytes make dehydroepiandrosterone via this pathway, but neurons do not.  In searching for a natural regulator of dehydroepiandrosterone formation, the authors obsd. that treating oligodendrocytes with β-amyloid, which increases reactive oxygen species, also increased dehydroepiandrosterone formation.  These effects of β-amyloid were blocked by vitamin E.  These results indicate that human brain makes steroids in a cell-specific manner and suggest that dehydroepiandrosterone synthesis can be regulated by intracellular free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEpV7929f0LVg90H21EOLACvtfcHk0liw0ABtZ98iOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFyhtg%253D%253D&md5=5c3cf430542dc6a7a4acc6f93d97b94b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.740847.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.740847.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DCascio%26aufirst%3DC.%26aulast%3DPapadopoulos%26aufirst%3DV.%26atitle%3DPathways%2520of%2520neurosteroid%2520biosynthesis%2520in%2520cell%2520lines%2520from%2520human%2520brain%253A%2520regulation%2520of%2520dehydroepiandrosterone%2520formation%2520by%2520oxidative%2520stress%2520and%2520beta-amyloid%2520peptide%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D847%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Bababeygy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polevaya, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youssef, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prugpichailers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veeravagu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, V.</span><span> </span><span class="NLM_article-title">HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4901</span><span class="NLM_x">–</span> <span class="NLM_lpage">4908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=20044596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=4901-4908&author=S.+R.+Bababeygyauthor=N.+V.+Polevayaauthor=S.+Youssefauthor=A.+Sunauthor=A.+Xiongauthor=T.+Prugpichailersauthor=A.+Veeravaguauthor=L.+C.+Houauthor=L.+Steinmanauthor=V.+Tse&title=HMG-CoA+reductase+inhibition+causes+increased+necrosis+and+apoptosis+in+an+in+vivo+mouse+glioblastoma+multiforme+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model</span></div><div class="casAuthors">Bababeygy, Simon R.; Polevaya, Nika V.; Youssef, Sawsan; Sun, Amy; Xiong, Anming; Prugpichailers, Tiffany; Veeravagu, Anand; Hou, Lewis C.; Steinman, Lawrence; Tse, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4901-4908</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Statins are thought to have tumorolytic properties, reducing angiogenesis by inhibiting pro-angiogenic factors and inducing apoptosis of mural pericytes within the tumor vascular tree.  Materials and Methods: An orthotopic mouse glioblastoma (GL-26) model was used to investigate the effect of simvastatin on glioblastoma vasculature in vivo.  GL-26 cells were implanted into the striatum of C5LKa mice treated with either control, low- or high-dose simvastatin.  Brains were analyzed for necrotic vol., apoptosis, morphol. and pericytic cells within the vascular tree.  Results: Low-dose simvastatin increased necrosis and apoptosis compared to both control and high-dose simvastatin groups.  High-dose simvastatin increased vessel caliber by reducing pericytic cells along the tumor vessel wall compared to both control and low-dose simvastatin groups.  Conclusion: Simvastatin has a dual effect on tumorigenesis.  At high doses, it may worsen instead of "normalizing" tumor angio-architecture, albeit low doses affect tumor cell survival by promoting necrosis and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_a8Gg8UmX_rVg90H21EOLACvtfcHk0lgSQAWLCbwtVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gqtb4%253D&md5=5a33d79a148a329594cca5c98b37e593</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBababeygy%26aufirst%3DS.%2BR.%26aulast%3DPolevaya%26aufirst%3DN.%2BV.%26aulast%3DYoussef%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DPrugpichailers%26aufirst%3DT.%26aulast%3DVeeravagu%26aufirst%3DA.%26aulast%3DHou%26aufirst%3DL.%2BC.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DTse%26aufirst%3DV.%26atitle%3DHMG-CoA%2520reductase%2520inhibition%2520causes%2520increased%2520necrosis%2520and%2520apoptosis%2520in%2520an%2520in%2520vivo%2520mouse%2520glioblastoma%2520multiforme%2520model%26jtitle%3DAnticancer%2520Res.%26date%3D2009%26volume%3D29%26spage%3D4901%26epage%3D4908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Bouterfa, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattelmeyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czub, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vordermark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2761</span><span class="NLM_x">–</span> <span class="NLM_lpage">2771</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=10953355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=2761-2771&author=H.+L.+Bouterfaauthor=V.+Sattelmeyerauthor=S.+Czubauthor=D.+Vordermarkauthor=K.+Roosenauthor=J.+C.+Tonn&title=Inhibition+of+Ras+farnesylation+by+lovastatin+leads+to+downregulation+of+proliferation+and+migration+in+primary+cultured+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells</span></div><div class="casAuthors">Bouterfa, Hakim L.; Sattelmeyer, Vera; Czub, Stefanie; Vordermark, Dirk; Roosen, Klaus; Tonn, Jorg Christian</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2761-2771</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Malignant astrocytomas are the most common primary intracranial human tumors.  All therapeutic approaches are limited due to their high proliferative capacity and their ability to diffusely invade the brain.  Amplification of tyrosine kinase receptors and their signaling pathways have been implicated as contributing to the mol. pathogenesis of astrocytomas, providing possible new targets for therapeutic intervention.  In particular, astrocytomas, although lacking oncogenic Ras mutations, have elevated levels of activated Ras.  Lovastatin, an inhibitor of the β-hydroxy-β-methylglutary CoA reductase (HMG-CoA-reductase), is currently used to treat patients with hypercholesterolemia.  In addn., it inhibits isoprenylation of several members of the Ras superfamily of proteins and therefore has multiple cellular effects including the redn. of proliferation.  Materials and methods: In this study, we investigated the impact of lovastatin on two human glioma cell lines and on 15 primary cell cultures established from biopsies of patients with glioblastoma multiforme (GBM).  Proliferation of glioma cell lines and primary tumor cells was detd. by cell counting and by using the MTT assay.  The cell morphol. was analyzed by staining of actin filaments with phalloidin.  Apoptosis was measured using the TUNEL assay.  To investigate the influence of this drug on glioma cell motility, tumor cell migration was investigated using three dimensional spheroid disintegration assays.  In addn., tumor cell invasion was analyzed with a confrontational assay between tumor spheroids and rat brain aggregates.  Results: Inhibition of farnesyl biosynthesis using lovastatin led to a block in Ras mediated signaling, indicated by lower MAPK activity.  Consequently, tumor cell proliferation was reduced up to 80%.  Lovastatin appeared to decrease glioma viability by inducing apoptosis, as indicated by morphol. changes and increase of TUNEL pos. cells.  Lovastatin acts through isoprenoid depletion, because supplementation of the media with 50-100 μM mevalonate restored all τηε obsd. effects.  Invasion of tumor cells into brain tissue was not effected while migration was reduced βν about 30-40% in cells treated with high concns. (≥100 μM) of lovastatin.  This was surprising because drug treatment at lower concns. led to a disruption of the actin cytoskeleton, as indicated by Phalloidin staining.  Conclusion: Our data strongly suggest that inhibition of elevated Ras activity by lovastatin effectively targets the MAPK and probably other signaling pathways thus offering a pharmacol. based approach for a potential treatment of human astrocytomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTsVV-qEOx5rVg90H21EOLACvtfcHk0lgSQAWLCbwtVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGjurc%253D&md5=8d4f1f80c307f4e26f96f49cfe4841b4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouterfa%26aufirst%3DH.%2BL.%26aulast%3DSattelmeyer%26aufirst%3DV.%26aulast%3DCzub%26aufirst%3DS.%26aulast%3DVordermark%26aufirst%3DD.%26aulast%3DRoosen%26aufirst%3DK.%26aulast%3DTonn%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520Ras%2520farnesylation%2520by%2520lovastatin%2520leads%2520to%2520downregulation%2520of%2520proliferation%2520and%2520migration%2520in%2520primary%2520cultured%2520human%2520glioblastoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2000%26volume%3D20%26spage%3D2761%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Chan, D. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. C.</span><span> </span><span class="NLM_article-title">Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs11060-007-9475-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=17928957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=273-283&author=D.+Y.+L.+Chanauthor=G.+G.+Chenauthor=W.+S.+Poonauthor=P.+C.+Liu&title=Lovastatin+sensitized+human+glioblastoma+cells+to+TRAIL-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis</span></div><div class="casAuthors">Chan, David Y. L.; Chen, George G.; Poon, Wai S.; Liu, Pi C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-283</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synergy study with chemotherapeutic agents is a common in vitro strategy in the search for effective cancer therapy.  For non-chemotherapeutic agents, efficacious synergistic effects are uncommon.  Here, we have examd. two non-chemotherapeutic agents for synergistic effects: lovastatin and Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) for synergistic effects; on three human malignant glioblastoma cell lines, M059K, M59J, and A172.  Cells treated with lovastatin plus TRAIL for 48 h showed 50% apoptotic cell death, whereas TRAIL alone (1,000 ng/mL) did not, suggesting that lovastatin sensitized the glioblastoma cells to TRAIL attack.  Cell cycle anal. indicated that lovastatin increased G0-G1 arrest in these cells.  Annexin V study demonstrated that apoptosis was the predominant mode of cell death.  We conclude that the combination of lovastatin and TRAIL enhances apoptosis synergistically.  Moreover, lovastatin sensitized glioblastoma cells to TRAIL, suggesting a new strategy to treat glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdhZO34oWmsLVg90H21EOLACvtfcHk0lgSQAWLCbwtVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVKrtr4%253D&md5=97904c857897914d2728183c34f92889</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11060-007-9475-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-007-9475-3%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BY.%2BL.%26aulast%3DChen%26aufirst%3DG.%2BG.%26aulast%3DPoon%26aufirst%3DW.%2BS.%26aulast%3DLiu%26aufirst%3DP.%2BC.%26atitle%3DLovastatin%2520sensitized%2520human%2520glioblastoma%2520cells%2520to%2520TRAIL-induced%2520apoptosis%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2008%26volume%3D86%26spage%3D273%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lytle, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashikubo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, K. M.</span><span> </span><span class="NLM_article-title">Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1111%2Fj.1471-4159.2004.02319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=15030401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtValtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=168-178&author=Z.+Jiangauthor=X.+Zhengauthor=R.+A.+Lytleauthor=R.+Higashikuboauthor=K.+M.+Rich&title=Lovastatin-induced+up-regulation+of+the+BH3-only+protein%2C+Bim%2C+and+cell+death+in+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells</span></div><div class="casAuthors">Jiang, Zhihong; Zheng, Xiao; Lytle, Richard A.; Higashikubo, Ryuji; Rich, Keith M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-178</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mechanism of lovastatin-induced cell death was examd. in three established human glioblastoma cell lines; U87, U251, and U138.  Changes in potential modifiers of apoptosis, including Bcl-2 family proteins and MAP kinase targets after such lovastatin treatment, were evaluated.  Lovastatin (5 μM) treatment causes extensive cell death in two of the cell lines, U87 and U251; but only minimal in a third, U138.  Lovastatin-induced death occurs in correlation with significantly increased levels of the BH3-only protein, Bim.  The up-regulation of Bim levels was directly assocd. with an increased incidence of apoptosis.  Lovastatin treatment in U87 cells results in activation of targets of three major mitogen-activating protein kinase cascades including Erk1/2, JNK and p38.  Changes in levels of Bim, as well as increase phosphorylation of Erk1/2, c-jun, and p38 are all prevented by co-incubation of lovastatin and the isoprenylation metabolite, geranylgeranyl pyrophosphate.  Inhibition of the MAP kinase pathways failed to block the increased expression of Bim expression or cell death.  Further elucidation of the mechanisms of lovastatin-induced up-regulation of Bim and apoptosis in glioblastoma cells are important in detg. a potential role for lovastatin as a chemotherapy agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquABveZl4oebVg90H21EOLACvtfcHk0lhH9iRSXwTAXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtValtrg%253D&md5=ede6f0786a97c8f1e9af1c2fac77faaf</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02319.x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLytle%26aufirst%3DR.%2BA.%26aulast%3DHigashikubo%26aufirst%3DR.%26aulast%3DRich%26aufirst%3DK.%2BM.%26atitle%3DLovastatin-induced%2520up-regulation%2520of%2520the%2520BH3-only%2520protein%252C%2520Bim%252C%2520and%2520cell%2520death%2520in%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D89%26spage%3D168%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groscurth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span> </span><span class="NLM_article-title">Lovastatin and phenylacetate induce apoptosis, but not differentiation in human malignant glioma cells</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=11307620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1ejs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=217-224&author=F.+Schmidtauthor=P.+Groscurthauthor=M.+Kermerauthor=J.+Dichgansauthor=M.+Weller&title=Lovastatin+and+phenylacetate+induce+apoptosis%2C+but+not+differentiation+in+human+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells</span></div><div class="casAuthors">Schmidt, Friederike; Groscurth, Peter; Kermer, Monika; Dichgans, Johannes; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-224</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Induction of differentiation is an attractive approach to the management of infiltrative tumors such as malignant glioma.  Here, we report that lovastatin and phenylacetate induce apoptosis, but fail to induce differentiation, in malignant glioma cell lines and untransformed rat astrocytes.  Lovastatin and phenylacetate promote p21 accumulation but fail to induce cell cycle arrest.  BCL-2 gene transfer inhibits apoptosis induced by lovastatin but not apoptosis induced by phenylacetate.  Wild-type p53 gene transfer promotes lovastatin-induced apoptosis in p53 wild-type LN-229 cells but not in p53 mutant T98G cells.  Phenylacetate-induced apoptosis is attenuated by wild-type p53 gene transfer in both cell lines.  Neither lovastatin nor phenylacetate modulate glioma cell sensitivity to CD95 ligand-induced apoptosis or cancer chemotherapy.  Thus, this study provides no rationale for clin. trials of lovastatin or phenylacetate in the differentiation therapy of malignant glioma.  We conclude that neoplastic glioma cells as well as untransformed rat astrocytes are refractory to the induction of differentiation by lovastatin and phenylacetate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqjgv3e7RILVg90H21EOLACvtfcHk0lhH9iRSXwTAXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1ejs7o%253D&md5=402b54895a8238250b2d125bdf12755e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DGroscurth%26aufirst%3DP.%26aulast%3DKermer%26aufirst%3DM.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DLovastatin%2520and%2520phenylacetate%2520induce%2520apoptosis%252C%2520but%2520not%2520differentiation%2520in%2520human%2520malignant%2520glioma%2520cells%26jtitle%3DActa%2520Neuropathol.%26date%3D2001%26volume%3D101%26spage%3D217%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Tapia-Perez, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirches, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firsching, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span> </span><span class="NLM_article-title">Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1007%2Fs00280-010-1535-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=21120479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ggur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1193-1201&author=J.+H.+Tapia-Perezauthor=E.+Kirchesauthor=C.+Mawrinauthor=R.+Firschingauthor=T.+Schneider&title=Cytotoxic+effect+of+different+statins+and+thiazolidinediones+on+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells</span></div><div class="casAuthors">Tapia-Perez, Jorge Humberto; Kirches, Elmar; Mawrin, Christian; Firsching, Raimund; Schneider, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1193-1201</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma multiforme is still a tumor with very poor prognosis.  Statins are actually used for the treatment of dyslipidemias and thiazolidinediones for improving insulin sensitivity in diabetes.  Statins are inhibitors of the cholesterol pathway, while thiazolidinediones are peroxisomal proliferator activator receptor γ (PPAR) agonists.  For both, a potent pro-apoptotic activity has been suggested.  Methods: We compared the antiglioma effect of simvastatin, atorvastatin, lovastatin, pravastatin, rosuvastatin, rosiglitazone, pioglitazone and their combinations at several concns. on human glioblastoma cell lines U87, U 138, LN 405 and rat RG II.  The cytotoxic effect was assessed using a cell proliferation assay after 48 and 144 h.  Caspase 3 activity and the addn. of isoprenoids and PPAR-γ inhibitor GW9662 were assessed.  Expts. were as well conducted under hypoxia for 24 h.  Results: We demonstrated a significant cytotoxic effect with a combination of statins plus pioglitazone.  The effect was obsd. after 48 h and dramatically increased after 144 h.  The combination of 2 types of statins (synthetic and natural) allowed a fivefold dose redn.  Statin effect was reversed with isoprenoids and partially with PPAR-γ antagonists, while thiazolidinediones effect was slightly affected by PPAR-γ antagonists.  A marked increase in caspase 3 activity was achieved by combining atorvastatin with lovastatin.  Cytotoxicity of the combination of statins and thiazolidinediones did not decrease under hypoxia.  Conclusion: The assessed combination of statins with thiazolidinediones shows a synergistic cytotoxic effect against glioblastoma cells in vitro, which could represent a feasible therapeutic schema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprue_iYzZQA7Vg90H21EOLACvtfcHk0lhH9iRSXwTAXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ggur4%253D&md5=62ff839d2e4a80f16cd54cdd9633d7ce</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1535-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1535-2%26sid%3Dliteratum%253Aachs%26aulast%3DTapia-Perez%26aufirst%3DJ.%2BH.%26aulast%3DKirches%26aufirst%3DE.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DFirsching%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DT.%26atitle%3DCytotoxic%2520effect%2520of%2520different%2520statins%2520and%2520thiazolidinediones%2520on%2520malignant%2520glioma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1193%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Larner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laws, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffrey, M.</span><span> </span><span class="NLM_article-title">A phase I–II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme</span> <span class="citation_source-journal">Am. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300256z&amp;key=10.1097%2F00000421-199812000-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300256z&amp;key=9856659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300256z&amp;key=1%3ACAS%3A280%3ADyaK1M%252Fnt1Ckuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=579-583&author=J.+Larnerauthor=J.+Janeauthor=E.+Lawsauthor=R.+Packerauthor=C.+Myersauthor=M.+Shaffrey&title=A+phase+I%E2%80%93II+trial+of+lovastatin+for+anaplastic+astrocytoma+and+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme</span></div><div class="casAuthors">Larner J; Jane J; Laws E; Packer R; Myers C; Shaffrey M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-83</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">Malignant gliomas are thought to be highly dependent on the mevalonate pathway for cell growth.  Lovastatin, a cholesterol-lowering drug, inhibits not only the rate-limiting step in the mevalonate pathway (hepatic hydroxymethyl glutaryl coenzyme A reductase), but also the prenylation of several key regulatory proteins including ras and the small guanosine triphosphate binding proteins.  Therefore, from August 1994 through March 1996, 18 patients with either anaplastic glioma or glioblastoma multiforme were entered into a trial testing the safety of high-dose lovastatin with or without radiation.  Although the response data is too premature to evaluate activity, the fact that high doses of lovastatin are well tolerated with concurrent radiation suggests that central nervous system toxicity will not be a significant limiting toxicity as more selective farnesyltransferase inhibitors are brought into the clinic as radiation sensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHlAOaaBCqzHthwrmtH4OBfW6udTcc2eYHBeTi01qtRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252Fnt1Ckuw%253D%253D&md5=e3e4d0a66e1b0df4cf46b575ac32fc63</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1097%2F00000421-199812000-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-199812000-00010%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DJ.%26aulast%3DJane%26aufirst%3DJ.%26aulast%3DLaws%26aufirst%3DE.%26aulast%3DPacker%26aufirst%3DR.%26aulast%3DMyers%26aufirst%3DC.%26aulast%3DShaffrey%26aufirst%3DM.%26atitle%3DA%2520phase%2520I%25E2%2580%2593II%2520trial%2520of%2520lovastatin%2520for%2520anaplastic%2520astrocytoma%2520and%2520glioblastoma%2520multiforme%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1998%26volume%3D21%26spage%3D579%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehmlow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum-Kaelin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Endothelin-converting-enzyme-1 inhibition and growth of human glioblastoma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040857x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=483-498&author=Y.+Bergerauthor=H.+Dehmlowauthor=D.+Blum-Kaelinauthor=E.+A.+Kitasauthor=B.+M.+L%C3%B6fflerauthor=J.+D.+Aebiauthor=L.+Juillerat-Jeanneret&title=Endothelin-converting-enzyme-1+inhibition+and+growth+of+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm040857x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040857x%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DKitas%26aufirst%3DE.%2BA.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.%2BM.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DEndothelin-converting-enzyme-1%2520inhibition%2520and%2520growth%2520of%2520human%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D483%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/jm300256z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41071"></div></div></div></div></div><hr /></hr><p class="last">Detailed protocols for chemical synthesis and characterization of compounds <b>12</b>–<b>16</b> and <b>18</b>–<b>23</b>; in vitro inhibitory stability and chemical stability of OSCi <b>1</b>–<b>10</b>; cytotoxicity of compounds <b>1</b>–<b>10</b> and AT after 24–72 h of cell exposure; IC<sub>50</sub> values for inhibition of DNA synthesis after 24 h of exposure of cells to compounds <b>1</b>–<b>10</b> and AT; evaluation of synergism or additivity of the effects of combination of compounds with AT in human endothelial and glioblastoma cells; evaluation of synergism of the effects of combination of compound <b>3</b> with AT in human LN229 glioblastoma cells. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300256z/suppl_file/jm300256z_si_001.pdf">jm300256z_si_001.pdf (414.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300256z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-11%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm300256z%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300256z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b2c035a81227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
